Nitin Jain, M.D.

Peer-Reviewed Articles

1. Goulart H, Short NJ, Borthakur G, Jain N, DiNardo C, Loghavi S, Khouri R, Hachem M, Ravandi F, Daver N, Kadia TM, Yilmaz M, Issa G, Bazinet A, Swaminathan M, Montalban-Bravo G, Haddad F, Garris R, Kantarjian H, Jabbour E. Mutations in isocitrate dehydrogenase portend a poor prognosis in adult patients with acute lymphoblastic leukemia. Blood Adv 10(9):3276-3280, 2026. e-Pub 2026. PMID: 41860396.
2. Timofeeva N, Herrera B, Fujiwara H, Asami T, Endo H, Hatakeyama M, Nakajima F, Ohmoto H, Nishioka Y, Miyamoto K, Arimura A, Tantawy SI, Pinilla-Ibarz J, Coombs CC, Jain N, Sawa M, Gandhi V. Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations. Blood Cancer J, 2026. e-Pub 2026. PMID: 42098067.
3. Swaminathan M, Ferrajoli A, Thompson PA, Burger J, Borthakur G, Takahashi K, Estrov Z, Bharathi V, Bataller A, Kadia TM, Pemmaraju N, Daver N, Jabbour E, Bose P, Kanagal-Shamanna R, Patel KP, Wang SA, Garg N, Hwang H, Wang X, Qiao W, Xu X, Cruz N, Ayala A, Pierce S, Plunkett W, Sampath D, Kantarjian HM, Keating MJ, Gandhi V, Wierda WG, Jain N. Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study. Blood Cancer Discov 7(3):431-440, 2026. e-Pub 2026. PMID: 41678768.
4. Edwards RR, Tarpey T, Ashburn M, Baer C, Campbell A, Dworkin RH, Gaspard G, Flynn M, Hade E, Jain N, Judge H, Kamp C, Li Y, Meropol S, Petkova E, Philip A, Przkora R, Rathmell JP, Robinson-Papp J, Samuels J, Sehgal N, Sienty J, Stacey B, Wallace M, Wasan AD, Wise B, Yu C, Fava M, Troxel AB. A double-blind, placebo-controlled, multi-crossover trial of treatment with a chemokine antagonist for knee osteoarthritis pain. Pain 167(5):1137-1145, 2026. e-Pub 2026. PMID: 41468282.
5. Tang, G, Wang, SA, Jen, WY, Medeiros, LJ, Wang, W, Fang, H, Hu, S, Jain, N, Jabbour, EJ, Zou, Y, Xu, J. Acute leukemia with BCL11B rearrangements. Human Pathology 171, 2026. e-Pub 2026. PMID: 41581705.
6. Tang, G, Reynolds, A, Ravandi-Kashani, F, Medeiros, LJ, Kornblau, SM, Jabbour, EJ, Jain, N, Short, NJ, Hu, S, Wei, Q, Loghavi, S, Ok, CY, Toruner, GA, Ling, J, Liang, S, Verma, T, Zou, Y, Wang, S. Comprehensive Cytogenomic Profiling of T-Lymphoblastic Leukemia Using Optical Genome Mapping, Karyotyping, and Next-Generation Sequencing. Modern Pathology 39(5), 2026. e-Pub 2026. PMID: 41796805.
7. Kadia TM, Bataller A, Bazinet A, Borthakur G, Daver N, Short NJ, DiNardo C, Jabbour E, Rausch CR, Issa GC, Pemmaraju N, Ohanian M, Maiti A, Montalban-Bravo G, Sasaki K, Bouligny IM, Yilmaz M, Haddad FG, Masarova L, Chien K, Alvarado Y, Jain N, Popat U, Shpall E, Loghavi S, Qiao W, Wang X, Garcia-Manero G, Ravandi F, Kantarjian HM. Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia. Am J Hematol, 2026. e-Pub 2026. PMID: 42035228.
8. Kantarjian, HM, Qiao, W, Jain, N, Jen, WY, Kugler, E, Short, NJ, Garris, R, Pierce, S, Kebriaei, P, Wang, SA, Haddad, FG, Ravandi-Kashani, F, Huang, X, Jabbour, EJ. Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia. Cancer 132(8), 2026. e-Pub 2026. PMID: 41954167.
9. Furman RR, Wierda WG, Patten PE, Chaves JM, Brown JR, Munir T, Martin P, Awan FT, Stephens DM, Ghia P, Barrientos JC, Patel K, Woyach JA, de Borja M, Wang MH, Jain N, O'Brien SM MD, Byrd JC. Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia. Blood Adv, 2026. e-Pub 2026. PMID: 41915892.
10. Goulart H, Braish J, Short NJ, Jain N, Sasaki K, Kantarjian H, Jabbour EJ. A Case Report of Tyrosine Kinase Inhibitor Interruption in a Patient with Multilineage Philadelphia Positive Acute Lymphoblastic Leukemia. Acta Haematol:1-8, 2026. e-Pub 2026. PMID: 41915597.
11. Nguyen D, Jabbour E, Kantarjian HM, Macaron W, Jain N, Nasnas C, Kebriaei P, Shpall EJ, Khouri I, Haddad F, Karrar O, Maroun M, Garris R, Ravandi F, Short NJ. Impact of high-sensitivity next-generation sequencing, measurable residual disease and subsequent stem cell transplant in patients receiving blinatumomab for MRD-positive B-cell acute lymphoblastic leukemia. Haematologica, 2026. e-Pub 2026. PMID: 41885010.
12. Bazinet A, Ferrajoli A, Jain N, Burger JA, Yilmaz M, Swaminathan M, Kantarjian HM, Keating M, Thompson PA, Wierda WG. NGS-based measurable residual disease in long-term progression-free CLL survivors following FCR therapy. Blood Adv, 2026. e-Pub 2026. PMID: 41879712.
13. Simske NM, Sandler AB, Gilat R, Scanaliato JP, Jain N, Tyler J, Parnes N. Arthroscopic Posterior Labral Repair of the Shoulder in Active-Duty Military Patients Shows Improvements in Patient-Reported Outcomes and High Return to Sports and Military Duty at a Minimum 10 Years Follow-Up. Arthroscopy, 2026. e-Pub 2026. PMID: 41879643.
14. Hazan Mea J, Liu W, Pathak R, Atem FD, Jain NB, Gao C. Trends and risk factors for spinal cord injury-induced heterotopic ossification: A retrospective population-based cross-sectional study using the 2016-2021 National Inpatient Sample (NIS). J Spinal Cord Med:1-13, 2026. e-Pub 2026. PMID: 41874325.
15. Prakash R, Basnet TB, Liu W, Breyer MA, Ueland SD, Khazzam MS, Wolf BR, Li X, Baumgarten KM, Cabrera A, DeAngelis JP, Giri A, Jain NB. Family history and heritability of rotator cuff tears. J Shoulder Elbow Surg, 2026. e-Pub 2026. PMID: 41865829.
16. Pierson CJ, Jain NB, Hansen K, Hisel TZ, Frost SK, Whitehair VC, Konda C, DeVahl JM, Van Acker G 3rd, DiLorenzo DR, Chae J, Gunzler DD, Kim CH, Wilson RD. Efficacy of Standardized Physical Therapy and Axillary Motor Stimulation for Chronic Shoulder Pain: A Randomized Controlled Trial. Am J Phys Med Rehabil 105(3S Suppl 2):S96-S104, 2026. e-Pub 2026. PMID: 41707131.
17. Singh A, Daver N, Loghavi S, Kadia T, Ravandi F, DiNardo C, Borthakur G, Pierce S, Futreal A, Aung PP, Cuglievan B, Jain N, Jabbour E, Garcia-Manero G, Konopleva M, Qazilbash M, Pemmaraju N. Ten-year long-term survivors of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Leuk Lymphoma:1-4, 2026. e-Pub 2026. PMID: 41711093.
18. DiNardo, C, Croden, J, Abdel-Salam, HM, Kadia, TM, Molica, M, Bazinet, A, Bose, P, Maiti, A, Haddad, FG, Burger, JA, Kantarjian, HM, Wierda, WG, Jain, N, Ferrajoli, A. Clinical, genetic, and familial features of POT1 tumor predisposition syndrome. Cancer 132(4), 2026. e-Pub 2026. PMID: 41686515.
19. Nasr AJ, Wang H, Khazzam M, Jain NB, Lin YS. Quantitative assessments of ultrasound-based rotator cuff muscle quality. PM R, 2026. e-Pub 2026. PMID: 41660777.
20. Pathak R, Aagesen AL, Bounajem G, Du L, Ayers GD, Khazzam M, Atem FD, Jain NB. Changes in Trends of Shoulder and Knee Arthroscopy Because of the COVID-19 Pandemic. J Am Acad Orthop Surg Glob Res Rev 10(2), 2026. e-Pub 2026. PMID: 41678780.
21. Tiwari S, Jain NK, Agrawal SK. Clinical Evaluation of Benign Paroxysmal Positional Vertigo in Patients after Mild to Moderate Head Trauma. J Pharm Bioallied Sci 18(Suppl 1):S236-S238, 2026. e-Pub 2026. PMID: 41853000.
22. Azevedo, RS, Jabbour, EJ, Kantarjian, HM, Lavu, S, Loghavi, S, Jain, N, Sasaki, K, Garris, R, Takahashi, K, Ravandi-Kashani, F, Short, NJ. Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemia. Blood 147(5):547-556, 2026. e-Pub 2026. PMID: 41335402.
23. Short, NJ, Kantarjian, HM, Jain, N, Kadia, TM, Senapati, J, Haddad, FG, Maroun, MM, Sasaki, K, Xiao, L, Huang, X, Karrar, OS, Abramova, R, Zhao, M, Garris, R, Konopleva, M, Ravandi-Kashani, F, Jabbour, EJ. Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia. Blood Advances 10(1):25-28, 2026. e-Pub 2026. PMID: 40763277.
24. Gordon, B, Muhowski, E, Singh, J, Ravikrishnan, J, Peris Cuesta, A, Diaz-Rohena, DY, Sanchez, JR, Thangavadivel, S, Benrashid, S, He, A, Marr, AR, Mitchell, A, Urrutia, JM, Misra, S, Lai, TH, Yu, L, Walker, B, Perry, E, Shukla, SA, Grieselhuber, NR, Rogers, KA, Lapalombella, R, Blachly, JS, Kittai, AS, Bhat, S, Jain, N, Wierda, WG, Byrd, JC, Niesman, M, Zhang, K, Sampath, D, Woyach, JA. PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia. Blood Cancer Discovery 7(1):85-103, 2026. e-Pub 2026. PMID: 41190953.
25. Braish, J, Kantarjian, HM, Short, NJ, Tang, G, Daver, N, Kadia, TM, Senapati, J, Jen, WY, Takahashi, K, Garris, R, Garcia-Manero, G, Ravandi-Kashani, F, Jabbour, EJ, Jain, N. Tyrosine Kinase Inhibitors During Frontline Therapy in Adults With Acute Lymphoblastic Leukemia With ABL-class Rearrangements. Clinical Lymphoma, Myeloma and Leukemia 26(1):e110-e113.e1, 2026. e-Pub 2026. PMID: 41125471.
26. Pasvolsky, O, Shimony, S, Saliba, RM, Marcoux, C, Ledesma, C, Rondon, G, Tewari, P, Ragoonanan, D, Short, NJ, Jabbour, EJ, Gooptu, M, Ho, VT, Soiffer, RJ, Antin, JH, Koreth, J, Cutler, C, Paolino, JD, Duncan, C, Lehmann, L, DeAngelo, DJ, Jain, N, Champlin, RE, Shpall, E, Luskin, MR, Kebriaei, P. Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia—A Retrospective, Dual-Center Study. American journal of hematology 101(1):16-25, 2026. e-Pub 2026. PMID: 41051170.
27. Sanchez, JR, Liu, C, Pawar, V, Huang, Y, Diaz-Rohena, DY, Singh, J, Koppikar, P, Lai, TH, St John, L, Puduvalli, VK, Molldrem, JJ, Thandapani, P, Jain, N, Lapalombella, R, Sampath, D. NAMPT inhibition uncovers therapeutic vulnerabilities to venetoclax and chemotherapy in acute myelogenous leukemia. Leukemia and Lymphoma 67(1):97-107, 2026. e-Pub 2026. PMID: 41401031.
28. Kasitinon D, Williams R, Peraka V, Ozcakar L, Jain NB. Accuracy and Efficacy of Intra-articular Knee Injections/Aspirations Under Ultrasound Versus Landmark Guidance: A Systematic Review. Am J Phys Med Rehabil 105(1):1-11, 2026. e-Pub 2026. PMID: 40729535.
29. Sabitha, P, Goel, A, Kumar, S, R, C, Fernandes, S, Jain, N, Pemmaraju, N, Sharma, A, Sahoo, RK. Blastic plasmacytoid dendritic cell neoplasm. Leukemia Research Reports 25, 2026. e-Pub 2026. PMID: 41890270.
30. Bharathi V, Jen WY, Venugopal S, Thakral B, Daver N, Chien K, Bose P, Masarova L, Pemmaraju N, Tang G, Jain N. Durable complete remission with imatinib monotherapy in a patient with FIP1L1-PDGFRA rearranged myeloid neoplasm with extramedullary involvement. Leuk Lymphoma 67(1):225-228, 2026. e-Pub 2026. PMID: 41194520.
31. Talwar D, Maturu VN, Meshram PL, Mittal S, Praveen JV, Guleria R, Kumar A, Agarwal A, Verma AK, Mohan M, Narasimhan R, Jain N, Sharma R, Kumar R, Parakh U, Momi G. Safety and effectiveness of benralizumab in Indian patients with severe eosinophilic asthma: results from the FAST study. Front Med (Lausanne) 13:1706737, 2026. e-Pub 2026. PMID: 42089065.
32. Short, NJ, Kantarjian, HM, Furudate, K, Jain, N, Ravandi-Kashani, F, Karrar, OS, Loghavi, S, Nasr, L, Haddad, FG, Senapati, J, Garris, R, Takahashi, K, Jabbour, EJ. Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab. Journal of Hematology and Oncology 18(1), 2025. e-Pub 2025. PMID: 40369607.
33. Short, NJ, Jabbour, EJ, Macaron, W, Jain, N, Haddad, FG, Loghavi, S, Kadia, TM, Kebriaei, P, Kugler, E, Matthews, JA, Garris, R, Ravandi-Kashani, F, Kantarjian, HM. Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL. Blood cancer journal 15(1), 2025. e-Pub 2025. PMID: 41120271.
34. Goulart, H, Ravandi-Kashani, F, Short, NJ, Jain, N, Daver, N, Kadia, TM, DiNardo, C, Borthakur, G, Takahashi, K, Pemmaraju, N, Haddad, FG, Montalban Bravo, G, Alvarado, Y, Issa, GC, Bataller Torralba, A, Pierce, S, Loghavi, S, Tang, G, Wang, S, Thakral, B, Shpall, E, Champlin, RE, Khouri, IF, Kebriaei, P, Garcia-Manero, G, Sasaki, K, Jabbour, EJ, Senapati, J. Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 41370732.
35. Enriquez R, Jones E, Ozcakar L, Jain NB. Accuracy and Efficacy of Ultrasound-Guided Glenohumeral Joint Injections: A Systematic Review. Am J Phys Med Rehabil 104(12):1071-1085, 2025. e-Pub 2025. PMID: 40856504.
36. Arani N, Rausch CR, Geppner A, Borthakur G, Jain N, Ferrajoli A, Jabbour E, Sampath D, Hosing C, Vega F, Kantarjian HM, Kadia TM. Cladribine and venetoclax combined with alemtuzumab in patients with relapsed/refractory T-cell prolymphocytic leukemia. Leuk Lymphoma 66(14):2794-2798, 2025. e-Pub 2025. PMID: 41124080.
37. Suryavanshi M, Mehta P, Jain N, Bhurani D, Boya RR, Mishra PC, Kumar D, Dhandha S, Kumar M, Das N, Mishra S. Validation of an Adapted NGS-Based Clonality Assay for MRD Monitoring in B-ALL Using Archived and Follow-Up Samples. EJHaem 6(6):e70202, 2025. e-Pub 2025. PMID: 41425693.
38. Mann GS, Gupta NA, Jain N. When Wernicke's encephalopathy mimics stroke: A case report of atypical thalamic involvement. IBRO Neurosci Rep 19:50-53, 2025. e-Pub 2025. PMID: 40525137.
39. Nakamura R, Aagesen A, Berri H, Chandran S, Kasitinon D, Lewno A, Jain NB. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 107(21):2345-2351, 2025. e-Pub 2025. PMID: 40938971.
40. Enriquez R, Cleland T, Gharib M, Kasitinon D, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Glenohumeral Joint (Posterior Approach) Injection Technique. Am J Phys Med Rehabil 104(11):e157, 2025. e-Pub 2025. PMID: 41105749.
41. Nirmalanantham, P, Quesada, AE, Ghosh, A, Lin, P, Ok, CY, Yang, RK, Fang, H, Garces, S, Kanagal Shamanna, R, Loghavi, S, Routbort, MJ, Yin, CC, Wei, W, Pasyar, S, Bassett Jr, R, El Hussein, S, Jain, N, Burger, JA, Wierda, WG, Wang, S, Bueso-Ramos, CE, Patel, KP, Medeiros, LJ, Jelloul, FZ. Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia. Cancers 17(21), 2025. e-Pub 2025. PMID: 41228377.
42. Goulart, H, Jabbour, EJ, Short, NJ, Kadia, TM, Pemmaraju, N, Takahashi, K, Ravandi-Kashani, F, Konopleva, M, Jain, N. A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 25(11):800-807, 2025. e-Pub 2025. PMID: 40500616.
43. Pierson CJ, Jain NB, Brewer-Mixon K, Wang J, Wilson RD. Identifying the relative contributions of shoulder dysfunction in patients with subacromial pain syndrome. Pain Med 26(11):749-757, 2025. e-Pub 2025. PMID: 40353838.
44. Uyanik MS, Jabbour E, Short N, Sasaki K, Paul S, Garcia-Manero G, Kadia T, Ravandi F, Jain N. Nelarabine-related rhabdomyolysis in adult patients with T-cell lymphoblastic leukemia/lymphoma: a report of 6 patients. Leuk Lymphoma 66(11):2132-2134, 2025. e-Pub 2025. PMID: 40618389.
45. Kasitinon D, Cleland T, Enriquez R, Gharib M, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Intra-articular Hip Injection Technique. Am J Phys Med Rehabil 104(10):e144, 2025. e-Pub 2025. PMID: 40968443.
46. Mann GS, Nandwani S, Jain N. Microscopic Polyangiitis With a Twist: A Rare Case of CRAO and Brainstem Infarction. J Neuroimmunol 406:578685, 2025. e-Pub 2025. PMID: 40651296.
47. Enriquez R, Cleland T, Gharib M, Kasitinon D, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Median Nerve Perineural Injection at the Carpal Tunnel Technique. Am J Phys Med Rehabil 104(9):e132, 2025. e-Pub 2025. PMID: 40813852.
48. Habib, D, Jabbour, EJ, Bataller Torralba, A, Sasaki, K, Tang, G, Loghavi, S, Li, S, Senapati, J, Short, NJ, Jain, N, Kantarjian, HM, Haddad, FG. Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18). Clinical Lymphoma, Myeloma and Leukemia 25(9):672-675, 2025. e-Pub 2025. PMID: 40222876.
49. Hill JW, Marvin-Peek J, Sasaki K, Bresser S, Dabaja BS, Jain N, Borthakur G, Abbas HA. Central nervous system relapse of core-binding factor acute myeloid leukemia. Leuk Lymphoma 66(9):1745-1748, 2025. e-Pub 2025. PMID: 40386862.
50. Senapati, J, Kantarjian, HM, Kadia, TM, Kekedjian, J, Borthakur, G, Daver, N, DiNardo, C, Jabbour, EJ, Bose, P, Short, NJ, Yilmaz, M, Jain, N, Pemmaraju, N, Abbas, HA, Issa, GC, Maiti, A, Bravo, GM, Deshmukh, I, Shpall, E, Kebriaei, P, Popat, UR, Loghavi, S, Thakral, B, Tang, G, Haddad, FG, Alvarado, Y, Manero, GG, Ravandi-Kashani, F. Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia. Cancer 131(16), 2025. e-Pub 2025. PMID: 40772501.
51. Berkman, AM, Andersen, C, Puthenpura, V, Short, NJ, Merriman, K, Swaminathan, M, Cuglievan, B, McCall, DC, DiNardo, C, Nunez, CA, Jain, N, Kadia, TM, Issa, GC, Gibson, A, Garcia, MB, Andrew Livingston, J, Parsons, SK, Hildebrandt, MA, Roth, M. Risk of early death after acute leukemia diagnosis among adolescents and young adults. JNCI Cancer Spectrum 9(4), 2025. e-Pub 2025. PMID: 40579211.
52. Kharfan-Dabaja, MA, Kumar, A, Pinilla-Ibarz, J, Brown, JR, Shadman, M, Awan, FT, Kenderian, S, Siddiqi, T, Abramson, JS, Al-Juhaishi, T, Brander, D, Coombs, CC, Furman, RR, Jain, N, Khan, N, Saba, N, Collins, JM, Beitinjaneh, AM, Stephens, DM, Woyach, JA, Hamadani, M. Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy. Transplantation and Cellular Therapy 31(8):494-504, 2025. e-Pub 2025. PMID: 40514010.
53. Kasitinon D, Cleland T, Enriquez R, Gharib M, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Intra-articular Knee Injection. Am J Phys Med Rehabil 104(8):e125, 2025. e-Pub 2025. PMID: 40676761.
54. Jain N, Eyre TA, Winfree KB, Bhandari NR, Khanal M, Sugihara T, Chen Y, Abada P, Patel K. Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 66(8):1400-1412, 2025. e-Pub 2025. PMID: 40122053.
55. Hajomer AAE, Kanitschar F, Jain N, Hentschel M, Zhang R, Lutkenhaus N, Andersen UL, Pacher C, Gehring T. Experimental composable key distribution using discrete-modulated continuous variable quantum cryptography. Light Sci Appl 14(1):255, 2025. e-Pub 2025. PMID: 40721405.
56. Uryu, H, Saeki, K, Haeno, H, Kapadia, C, Furudate, D.M.D., Ph.D., K, Nangalia, J, Spencer Chapman, M, Zhao, L, Hsu, JI, Zhao, C, Chen, S, Tanaka, T, Li, Z, Ogata, S, Hanache, S, Yang, H, DiNardo, C, Daver, N, Pemmaraju, N, Jain, N, Ravandi-Kashani, F, Zhang, J, Song, X, Thompson, EJ, Tang, H, Little, L, Gumbs, C, Orlowski, R, Qazilbash, MH, Bhalla, K, Colla, S, Kantarjian, HM, Kanagal Shamanna, R, Bueso-Ramos, CE, Nakada, D, Al-Atrash, G, Molldrem, JJ, Futreal, A, Shpall, E, Goodell, MA, Garcia-Manero, G, Takahashi, K. Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation. Nature Genetics 57(7):1695-1707, 2025. e-Pub 2025. PMID: 40596442.
57. Chien, KS, Curry, JL, Pemmaraju, N, Jain, N. Leukemia Cutis in the Setting of Indolent Chronic Lymphocytic Leukemia. American journal of hematology 100(7):1240-1241, 2025. e-Pub 2025. PMID: 40062658.
58. Kasitinon D, Cleland T, Enriquez R, Gharib M, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Tibiotalar Joint Injection Technique. Am J Phys Med Rehabil 104(7):e109, 2025. e-Pub 2025. PMID: 40551337.
59. Konda C, Cleland T, Enriquez R, Gharib M, Kasitinon D, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Suprascapular Nerve Injection Technique. Am J Phys Med Rehabil 104(6):e82, 2025. e-Pub 2025. PMID: 40420340.
60. McNamara-Pittler EN, Prakash R, Atem FD, Pathak R, Liu W, Khazzam M, Jain NB. Risk Factor Prediction and Categorization for Glenohumeral Osteoarthritis: A Classification and Regression Tree Analysis. Am J Phys Med Rehabil 104(5):401-406, 2025. e-Pub 2025. PMID: 39235849.
61. Sasaki, K, Garcia-Manero, G, Nigo, M, Jabbour, EJ, Ravandi-Kashani, F, Wierda, WG, Jain, N, Takahashi, K, Montalban Bravo, G, Daver, N, Thompson, PA, Pemmaraju, N, Kontoyiannis, DP, Sato, J, Karimaghaei, S, Soltysiak, KA, Raad, II, Kantarjian, HM, Carter, B. Artificial Intelligence Assessment of Chest Radiographs for COVID-19. Clinical Lymphoma, Myeloma and Leukemia 25(5):319-327, 2025. e-Pub 2025. PMID: 39710565.
62. Senapati, J, Loghavi, S, Marvin-Peek, J, Garcia-Manero, G, Kadia, TM, Borthakur, G, Daver, N, Short, NJ, Jain, N, Issa, GC, Haddad, FG, Hammond, D, Chien, KS, Tang, G, Thakral, B, Montalban Bravo, G, Pemmaraju, N, Bazinet, A, Swaminathan, M, Pierce, S, Abbas, HA, Reville, PK, Popat, UR, Shpall, EJ, Champlin, RE, Jabbour, EJ, Ravandi-Kashani, F, Kantarjian, HM, DiNardo, C. Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia. American journal of hematology 100(5):758-769, 2025. e-Pub 2025. PMID: 39921561.
63. Ratan SK, Bhomaj H, Jain N, Upreti S, Ahmad MF, Mandal S, Sehgal M, Garg R. Vaginal Duplication Cyst - A Rare Isolated Anomaly Masquerading as a Colonic Duplication Cyst. J Indian Assoc Pediatr Surg 30(3):415-417, 2025. e-Pub 2025. PMID: 40406335.
64. Goulart, H, Kantarjian, HM, Borthakur, G, Daver, N, DiNardo, C, Jabbour, EJ, Pemmaraju, N, Alvarado, Y, Atluri, H, Yilmaz, M, Haddad, FG, Marx, K, Rausch, C, Loghavi, S, Jain, N, Garcia-Manero, G, Ravandi-Kashani, F, Kadia, TM. Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia. Cancer 131(8), 2025. e-Pub 2025. PMID: 40193193.
65. Goulart, H, Kantarjian, HM, Borthakur, G, Daver, N, DiNardo, C, Jabbour, EJ, Pemmaraju, N, Alvarado, Y, Atluri, H, Yilmaz, M, Haddad, FG, Marx, K, Rausch, C, Loghavi, S, Jain, N, Garcia-Manero, G, Ravandi-Kashani, F, Kadia, TM. Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia. Cancer 131(8), 2025. e-Pub 2025. PMID: 40193193.
66. Pierson C, Wilson R, Brewer-Mixon K, Tzen YT, Williamson J, Hansen K, Hisel T, Jain N. Pressure pain sensitivity is independent of structural pathology in patients with subacromial pain syndrome: a cross-sectional analysis. Pain Med 26(4):173-179, 2025. e-Pub 2025. PMID: 39589920.
67. Williams R, Cleland T, Enriquez R, Gharib M, Kasitinon D, Konda C, Schaaf S, Song A, Ozcakar L, Jain NB. Ultrasound-Guided Subtalar Joint (Posterior Peri-Achilles Approach) Injection Technique. Am J Phys Med Rehabil 104(4):e63, 2025. e-Pub 2025. PMID: 40111043.
68. DiNardo, C, Jen, WY, Takahashi, K, Kadia, TM, Loghavi, S, Daver, N, Xiao, L, Reville, PK, Issa, GC, Short, NJ, Sasaki, K, Wang, S, Mullin, JK, Pierce, S, Bradley, C, Borthakur, G, Maiti, A, Alvarado, Y, Pemmaraju, N, Ferrajoli, A, Swaminathan, M, Ohanian, M, Abbas, HA, Hammond, D, Burger, JA, Haddad, FG, Montalban Bravo, G, Chien, KS, Masarova, L, Yilmaz, M, Jain, N, Andreeff, M, Garcia-Manero, G, Kornblau, SM, Ravandi-Kashani, F, Jabbour, EJ, Konopleva, M, Kantarjian, HM. Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia. Leukemia 39(4):854-863, 2025. e-Pub 2025. PMID: 40000842.
69. Jain, H, Karulkar, A, Kalra, D, Ravikumar, S, Shah, S, Firfiray, A, Pendhari, J, Jaiswal, AK, Khan, A, Sundharam, M, Vaibhaw, A, Saroha, A, Rajyopadhye, S, Basu, M, Asija, S, Chowdhury, A, Beher, R, Banik, A, Dwivedi, A, Purwar, S, Narula, G, Banavali, SD, Jain, N, Highfill, SL, Stroncek, DF, Fry, TJ, Melinkeri, S, Wilson, L, Agarwal, N, Aribandi, A, Boyella, PK, Shah, N, Neelapu, SS, Sengar, M, Purwar, R. Talicabtagene autoleucel for relapsed or refractory B-cell malignancies. The Lancet Haematology 12(4):e282-e293, 2025. e-Pub 2025. PMID: 40090352.
70. Pierson CJ, Javed N, Jain NB, Konda C. Peripheral Nerve Stimulation of the Axillary Nerve Improves Chronic Shoulder Pain and Dysfunction After Reverse Total Shoulder Arthroplasty: A Case Report. Am J Phys Med Rehabil 104(4):e58-e60, 2025. e-Pub 2025. PMID: 38958183.
71. Herzberg SD, Garduno-Rapp NE, Ong HH, Gangireddy S, Chandrashekar AS, Wei WQ, LeClere LE, Wen W, Hartmann KE, Jain NB, Giri A. Standardizing phenotypic algorithms for the classification of degenerative rotator cuff tear from electronic health record systems. JAMIA Open 8(2):ooaf014, 2025. e-Pub 2025. PMID: 40103752.
72. Gandhi V, Tantawy S, Aslan B, Manyam G, Iles L, Timofeeva N, Singh N, Jain N, Ferrajoli A, Thompson P, Patel K, Desikan SP, Wierda W. Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression. Res Sq, 2025. e-Pub 2025. PMID: 40235506.
73. Marvin-Peek, J, Shelton, V, Brassil, KJ, Fellman, B, Barr, A, Chien, KS, Hammond, DE, Swaminathan, M, Jain, N, Wierda, WG, Ferrajoli, A, DiNardo, C. Effect of Digital Health Coaching on Self-Efficacy and Patient-Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia. Acta haematologica 148(2):233-243, 2025. e-Pub 2025. PMID: 38861934.
74. Jain N, Sharma D, Jain NK. Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 months. Lung India 42(2):140-146, 2025. e-Pub 2025. PMID: 40013634.
75. Enriquez R, Cleland T, Gharib M, Kasitinon D, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Iliopsoas Bursa Injection Technique. Am J Phys Med Rehabil 104(3):e44, 2025. e-Pub 2025. PMID: 39898631.
76. Kugler, E, Kantarjian, H, Jabbour, EJ, Khaire, N, Short, NJ, Kadia, TM, Haddad, FG, Sasaki, K, Kanagal Shamanna, R, Garris, R, Ravandi-Kashani, F, Jain, N. Treatment-free remission in nontransplanted patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer 131(5), 2025. e-Pub 2025. PMID: 39980368.
77. Kantarjian, HM, Short, NJ, Jain, N, Haddad, FG, Kadia, TM, Yilmaz, M, Ferrajoli, A, Sasaki, K, Alvarado, Y, Pemmaraju, N, Senapati, J, Garris, R, Ravandi-Kashani, F, Jabbour, EJ. Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. American journal of hematology 100(3):402-407, 2025. e-Pub 2025. PMID: 39757533.
78. Garduno-Rapp NE, Herzberg S, Ong HH, Kao C, Lehmann CU, Gangireddy S, Jain NB, Giri A. Application of an Externally Developed Algorithm to Identify Research Cases and Controls from EHR Data: Trials and Triumphs. Appl Clin Inform 16(2):314-326, 2025. e-Pub 2025. PMID: 39855267.
79. Mann GS, Gupta NA, Jain N. A rare presentation of acute onset metronidazole-induced leukoencephalopathy with rapid resolution: a case report. Neuroradiology 67(3):593-598, 2025. e-Pub 2025. PMID: 39969572.
80. Kannan, S, Li, Y, Baran, N, Yang, X, Ghotbaldini, S, Tatarata, QZ, Yoshimura, S, Li, Z, Hsiao, YC, Balachander, S, Andersen, C, Cidado, J, Yu, J, Jain, N, Yang, JJ, Konopleva, M. Antileukemia efficacy of the dual BCL2/BCL-XL inhibitor AZD0466 in acute lymphoblastic leukemia preclinical models. Blood Advances 9(3):473-487, 2025. e-Pub 2025. PMID: 39561378.
81. Luskin, MR, Shimony, S, Keating, J, Winer, ES, Garcia, JS, Stone, RM, Jabbour, EJ, Flamand, Y, Stevenson, KE, Ryan, J, Zeng, Z, Letai, AG, Konopleva, M, Jain, N, DeAngelo, DJ. Venetoclax plus low-intensity chemotherapy for adults with acute lymphoblastic leukemia. Blood Advances 9(3):617-626, 2025. e-Pub 2025. PMID: 39546748.
82. Konda C, Cleland T, Enriquez R, Gharib M, Kasitinon D, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided Greater Trochanteric Bursa Injection Technique. Am J Phys Med Rehabil 104(2):e25, 2025. e-Pub 2025. PMID: 39748166.
83. Jen, WY, Marvin-Peek, J, Kantarjian, HM, Alvarado, Y, Borthakur, G, Jabbour, EJ, Wierda, WG, Kadia, TM, Daver, N, DiNardo, C, Short, NJ, Jain, N, Ferrajoli, A, Kornblau, SM, Yilmaz, M, Ohanian, M, McCue, D, Burger, JA, Hammond, DE, Patel, K, Issa, GC, Pemmaraju, N, Sasaki, K, Maiti, A, Abbas, HA, Chien, KS, Takahashi, K, Haddad, FG, Bose, P, Masarova, L, Montalban Bravo, G, Swaminathan, M, Brandt, M, Pierce, S, Garcia-Manero, G, Ravandi, F. Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia. Cancer 131(1), 2025. e-Pub 2025. PMID: 39584789.
84. Ravikrishnan, J, Diaz-Rohena, DY, Muhowski, E, Mo, X, Lai, TH, Misra, S, Williams, CD, Sanchez, JR, Mitchell, A, Satpati, S, Perry, E, Kaufman, T, Liu, C, Lozanski, A, Lozanski, G, Rogers, KA, Kittai, AS, Bhat, S, Collins, M, Davids, MS, Jain, N, Wierda, WG, Lapalombella, R, Byrd, JC, Tan, F, Chen, Y, Chen, Y, Shen, Y, Anthony, SP, Woyach, JA, Sampath, D. LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia. Haematologica 110(1):78-91, 2025. e-Pub 2025. PMID: 39113656.
85. Bhingradia YM, Gupta S, Ghia D, Shah S, Patel NK, Salim T, Kumari P, Vasudevan B, Shah S, Jain N, Borkhatariya PB, Mitra D, Prasad D. Consensus statement on the surgical management of vitiligo. J Cutan Aesthet Surg 18(1):27-33, 2025. e-Pub 2025. PMID: 40027541.
86. Prakash R, Pathak R, Chen Z, Tai D, BezanPetric U, Rapp EG, Atem FD, Khazzam MS, Jain NB. Risk factors associated with degenerative glenohumeral osteoarthritis. BMJ Open Sport Exerc Med 11(1):e002247, 2025. e-Pub 2025. PMID: 39926023.
87. Kantarjian, H, Short, NJ, Haddad, FG, Jain, N, Huang, X, Montalban-Bravo, G, Kanagal-Shamanna, R, Kadia, TM, Daver, N, Chien, KS, Alvarado, Y, Garcia-Manero, G, Issa, GC, Garris, R, Nasnas, C, Nasr, L, Ravandi, F, Jabbour, EJ. Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. Journal of Clinical Oncology 42(36):4246-4251, 2024. e-Pub 2024. PMID: 39028925.
88. Kim, E, Chen, SS, Campbell, M, Hwang, H, Huang, X, Ferrajoli, A, Jain, N, Wierda, WG, Wodarz, D, Chiorazzi, N, Burger, JA. Deuterated water labeling in ibrutinib-treated patients with CLL. Blood 144(25):2678-2681, 2024. e-Pub 2024. PMID: 39441901.
89. Williams R, Cleland T, Enriquez R, Gharib M, Kasitinon D, Konda C, Schaaf S, Song A, Ozcakar L, Jain NB. Ultrasound-Guided Plantar Fascia (Perifascial) Injection Technique. Am J Phys Med Rehabil 103(12):e187, 2024. e-Pub 2024. PMID: 39671527.
90. Kismali, G, Manyam, GC, Jain, N, Ivan, C, Lamothe, B, Ayres, M, Iles, LR, Wierda, WG, Gandhi, VV. Transcriptomic clustering of chronic lymphocytic leukemia. Blood cancer journal 14(1), 2024. e-Pub 2024. PMID: 39695112.
91. Zhang, R, Khare, P, Banerjee, P, Ivan, C, Schneider, S, Barbaglio, F, Dwyer, KC, Jensen, VB, Thompson, EJ, Mendoza, M, Chiorazzi, N, Chen, SS, Yan, XJ, Jain, N, Ghia, P, Caligaris-Cappio, F, Mendonsa, R, Kasimsetty, S, Swoboda, R, Bayraktar, R, Wierda, WG, Gandhi, VV, Calin, GA, Keating, M, Bertilaccio, MS. The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia. Blood cancer journal 14(1), 2024. e-Pub 2024. PMID: 39438453.
92. Abdel Rahman, Z, Othman, T, Saliba, RM, Vanegas, YM, Mohty, R, Ledesma, C, Rondon, G, Jain, N, Jabbour, EJ, Pullarkat, V, Alkhateeb, HB, Kantarjian, HM, Greipp, PT, Nakamura, R, Kharfan-Dabaja, MA, Champlin, RE, Forman, SJ, Shpall, E, Litzow, M, Foran, J, Aldoss, I, Koller, PB, Kebriaei, P. A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete Remission. Transplantation and Cellular Therapy 30(12):1197-1205, 2024. e-Pub 2024. PMID: 39332807.
93. Bounajem GJ, DeClercq J, Collett G, Ayers GD, Jain N. Does interaction occur between risk factors for revision total knee arthroplasty?. Arch Orthop Trauma Surg 144(12):5061-5070, 2024. e-Pub 2024. PMID: 37902892.
94. Kasitinon D, Hemeida A, Williams RC, Gharib M, Raiser S, Wise A, Jain NB. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 106(22):2055-2062, 2024. e-Pub 2024. PMID: 39292764.
95. Braish, J, Kugler, E, Jabbour, EJ, Woodman, K, Ravandi-Kashani, F, Nicholas, S, Jain, N, Kantarjian, HM, Sasaki, K. Incidence and Clinical Presentation of Severe Neurotoxicity from Nelarabine in Patients with T-Cell Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 24(11):783-788, 2024. e-Pub 2024. PMID: 39013740.
96. Phan, L, Jabbour, EJ, Antonoff, MB, Jain, N, Lin, P, Moran, C, Pemmaraju, N. Unexpected Mediastinal Mass Etiology in B-Acute Lymphoblastic Leukemia. Journal of Immunotherapy and Precision Oncology 7(4):314-316, 2024. e-Pub 2024. PMID: 39524462.
97. Braish, J, Kugler, E, Jabbour, EJ, Woodman, K, Ravandi-Kashani, F, Nicholas, S, Jain, N, Kantarjian, HM, Sasaki, K. Incidence and Clinical Presentation of Severe Neurotoxicity from Nelarabine in Patients with T-Cell Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 24(11):783-788, 2024. e-Pub 2024. PMID: 39013740.
98. Jain NB, Cleland T, Enriquez R, Gharib M, Kasitinon D, Konda C, Schaaf S, Song A, Williams R, Ozcakar L. Art of Interventional Musculoskeletal Ultrasound. Am J Phys Med Rehabil 103(11):970, 2024. e-Pub 2024. PMID: 39420462.
99. Gharib M, Cleland T, Enriquez R, Kasitinon D, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound-Guided First Carpometacarpal Joint Injection Technique. Am J Phys Med Rehabil 103(11):e171, 2024. e-Pub 2024. PMID: 39420466.
100. Ratan SK, Ahmad MF, Jain N, Kumar N, Neogi S, Mandal S. Spontaneous Intrathoracic Rupture of Abdominal Neuroblastoma in a 2-year-old Child: A Rare Case Report. J Indian Assoc Pediatr Surg 29(6):623-626, 2024. e-Pub 2024. PMID: 39691931.
101. Yoshimura, S, Li, Z, Gocho, Y, Yang, W, Crews, KR, Lee, SH, Roberts, KG, Mullighan, CG, Relling, M, Yu, J, Yeoh, AJ, Loh, ML, Saygin, C, Litzow, M, Jeha, S, Karol, S, Inaba, H, Pui, CH, Konopleva, M, Jain, N, Stock, W, Paietta, E, Jabbour, EJ, Kornblau, SM, Evans, W, Yang, JJ. Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 42(29):3478-3490, 2024. e-Pub 2024. PMID: 39102629.
102. Ali, MA, Aiman, W, Kantarjian, HM, Jabbour, EJ, Ravandi-Kashani, F, Jain, N, Short, NJ, Sasaki, K. Efficacy of Chemotherapy-Free Regimens in the Treatment of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 24(10):e376-e384, 2024. e-Pub 2024. PMID: 38972767.
103. Shah, BD, Mattison, R, Abboud, R, Abdelmessieh, P, Aldoss, I, Burke, PW, DeAngelo, DJ, Dinner, S, Fathi, AT, Gauthier, J, Haddadin, M, Jain, N, Jonas, BA, Kirby, S, Liedtke, M, Litzow, M, Logan, AC, Long, M, Luger, SM, Mangan, JK, Massaro, S, Stratford May, W, Oluwole, OO, Park, JH, Przespolewski, A, Rangaraju, S, Saygin, C, Schwartz, M, Shami, PJ, Tomlinson, B, Webster, JA, Awotiwon, A, Stehman, K. Acute Lymphoblastic Leukemia, Version 2.2024. JNCCN Journal of the National Comprehensive Cancer Network 22(8):563-576, 2024. e-Pub 2024. PMID: 39413812.
104. Jain N, Jain M, Chaturvedi A, Jain NK. Stockout of anti-TB drugs: Are we going to lose the gains achieved in year 2022-2023?. Lung India 41(5):333-334, 2024. e-Pub 2024. PMID: 39215974.
105. Gibson A, Nunez C, Robusto L, Kammerer B, Garcia M, Roth M, Sheth R, Tewari P, Hittle A, Toepfer L, Torres R, Short NJ, Jabbour E, Jain N, Cuglievan B, McCall D. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica 109(9):3042-3047, 2024. e-Pub 2024. PMID: 38779719.
106. Rao I, Zhou AE, Jain NP, Grant-Kels JM. Ethics of patients losing insurance coverage due to hospital-insurer contract disagreements. Clin Dermatol 42(5):559-561, 2024. e-Pub 2024. PMID: 38777205.
107. Mann GS, Gupta N, Jain N. Rare insights: Atypical MRI features of juvenile SLE. Radiol Case Rep 19(9):3874-3877, 2024. e-Pub 2024. PMID: 39040829.
108. Cernosek T, Dalphin M, Jain N, Richter N, Beard S, Wang J, Osborne J, Stone T, Mellal M, Behrens S, Wunderli P. Analytical Quality by Design as applied to the development of a SEC-HPLC platform procedure for the determination of monoclonal antibody purity without mobile phase additives. J Pharm Biomed Anal 246:116220, 2024. e-Pub 2024. PMID: 38795426.
109. Bose P, Masarova L, Pemmaraju N, Bledsoe SD, Daver NG, Jabbour EJ, Kadia TM, Estrov Z, Kornblau SM, Andreeff M, Jain N, Cortes JE, Borthakur G, Alvarado Y, Richie MA, Dobbins MH, McCrackin SA, Zhou L, Pierce SA, Wang X, Pike AM, Garcia-Manero G, Kantarjian HM, Verstovsek S. Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study. Haematologica 109(8):2660-2664, 2024. e-Pub 2024. PMID: 38572554.
110. Cernosek T, Dalphin M, Jain N, Lor J, Richter N, Mellal M, Behrens S, Wunderli P. A case study application of AQbD to the re-development and validation of an affinity chromatography analytical procedure for mAb titer quantitation. J Chromatogr B Analyt Technol Biomed Life Sci 1242:124205, 2024. e-Pub 2024. PMID: 38880058.
111. Zhao Y, Short NJ, Kantarjian HM, Chang TC, Ghate PS, Qu C, Macaron W, Jain N, Thakral B, Phillips A, Khoury JD, Garcia-Manero G, Zhang W, Fan Y, Yang H, Garris R, Nasr LF, Kriwacki R, Roberts KG, Konopleva MY, Jabbour EJ, Mullighan CG. Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. Blood 144(1):61-73, 2024. e-Pub 2024. PMID: 38551807.
112. Short NJ, Jabbour E, Nasr LF, Jain N, Haddad FG, Issa GC, Sasaki K, Senapati J, Kebriaei P, Garris R, Konopleva M, Ravandi F, Kantarjian H. Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. Am J Hematol 99(7):1423-1426, 2024. e-Pub 2024. PMID: 38607091.
113. Kittai AS, Bond D, Huang Y, Bhat SA, Blyth E, Byrd JC, Chavez JC, Davids MS, Dela Cruz JP, Dowling MR, Duffy C, Ho C, Jacobson C, Jaglowski S, Jain N, Lin KH, Miller C, McCarthy C, Omer Z, Parry E, Rai M, Rogers KA, Saha A, Schachter L, Scott H, Senapati J, Shadman M, Siddiqi T, Stephens DM, Vanguru V, Wierda W, Woyach JA, Thompson PA. Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study. J Clin Oncol 42(17):JCO2400033, 2024. e-Pub 2024. PMID: 38552193.
114. Pierson CJ, Velez N, Jain NB, Konda C. Changing Stimulation Frequency Improves Implanted Peripheral Nerve Stimulator Effects After Posttraumatic Total Hip Arthroplasty: A Case Report. Am J Phys Med Rehabil 103(6):e67-e70, 2024. e-Pub 2024. PMID: 38466169.
115. Kadia TM, Huang M, Pemmaraju N, Abbas HA, Ly C, Masarova L, Yilmaz M, Lyu MA, Zeng K, Sadeghi T, Cook R, DiNardo CD, Daver N, Issa GC, Jabbour E, Borthakur G, Jain N, Garcia-Manero G, Parmar S, Flowers C, Kantarjian H, Verstovsek S. Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes. NEJM Evid 3(6):EVIDoa2300362, 2024. e-Pub 2024. PMID: 38804782.
116. Raghunathan V, Dhaliwal M, Pahwa D, Jain N, Rijhwani A. The case of the disappearing foreign body. Pediatr Pulmonol 59(6):1781-1782, 2024. e-Pub 2024. PMID: 38441407.
117. Uryu H, Saeki K, Haeno H, Kapadia CD, Furudate K, Nangalia J, Chapman MS, Zhao L, Hsu JI, Zhao C, Chen S, Tanaka T, Li Z, Yang H, DiNardo C, Daver N, Pemmaraju N, Jain N, Ravandi F, Zhang J, Song X, Thompson E, Tang H, Little L, Gumbs C, Orlowski RZ, Qazilbash M, Bhalla K, Colla S, Kantarjian H, Shamanna RK, Ramos CB, Nakada D, Futreal PA, Shpall E, Goodell M, Garcia-Manero G, Takahashi K. Clonal evolution of hematopoietic stem cells after cancer chemotherapy. bioRxiv, 2024. e-Pub 2024. PMID: 38826462.
118. Khouri IF, Alzahrani K, Kantarjian H, Milton DR, Gulbis AM, Sasaki K, Jain N, Short NJ, Kadia T, Daher M, Rafei H, Im JS, Marin D, Olson AL, Popat U, Qazilbash M, Ramdial J, Rondon G, Srour S, Kebriaei P, Shpall E, Champlin R, Jabbour EJ. Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. Am J Hematol 99(5):836-843, 2024. e-Pub 2024. PMID: 38400519.
119. Kinjalk M, Sehgal M, Ratan SK, Jain N, Gupta CK, Neogi S, Kumar P, Bhoria D, Arora V, Chellani G. Foreign Body Ingestion in Children: An Experience of 99 Cases in a Tertiary Care Center in Delhi. J Indian Assoc Pediatr Surg 29(3):223-232, 2024. e-Pub 2024. PMID: 38912028.
120. Jain N, Mitra A, Ratan SK, Panda SS. "Necklace of magnets" in the abdomen: an unusual case with "multiple" bowel perforations. Med J Armed Forces India 80(3):365-368, 2024. e-Pub 2024. PMID: 38800006.
121. Huang X, Li Y, Zhang J, Yan L, Zhao H, Ding L, Bhatara S, Yang X, Yoshimura S, Yang W, Karol SE, Inaba H, Mullighan C, Litzow M, Zhu X, Zhang Y, Stock W, Jain N, Jabbour E, Kornblau SM, Konopleva M, Pui CH, Paietta E, Evans W, Yu J, Yang JJ. Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia. Cancer Cell 42(4):552-567.e6, 2024. e-Pub 2024. PMID: 38593781.
122. Bazinet A, Garcia-Manero G, Short N, Alvarado Y, Bataller A, Abuasab T, Islam R, Montalbano K, Issa G, Maiti A, Yilmaz M, Jain N, Masarova L, Kornblau S, Jabbour E, Montalban-Bravo G, Rausch CR, Pierce S, DiNardo CD, Kadia T, Daver N, Konopleva M, Huang X, Kantarjian H, Ravandi F. Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 study. Lancet Haematol 11(4):e276-e286, 2024. e-Pub 2024. PMID: 38452788.
123. Short NJ, Jabbour E, Jamison T, Paul S, Cuglievan B, McCall D, Gibson A, Jain N, Haddad FG, Nasr LF, Marx KR, Rausch C, Savoy JM, Garris R, Ravandi F, Kantarjian H. Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 24(4):e168-e173, 2024. e-Pub 2024. PMID: 38212207.
124. Berendsen Russell S, Seimon RV, Dixon E, Murphy M, Vukasovic M, Bohlken N, Taylor S, Cooper Z, Scruton J, Jain N, Dinh MM. Applying Sydney Triage to Admission Risk Tool (START) to improve patient flow in emergency departments: a multicentre randomised, implementation study. BMC Emerg Med 24(1):39, 2024. e-Pub 2024. PMID: 38454324.
125. Cernosek T, Jain N, Dalphin M, Behrens S, Wunderli P. Accelerated development of a SEC-HPLC procedure for purity analysis of monoclonal antibodies using design of experiments. J Chromatogr B Analyt Technol Biomed Life Sci 1235:124037, 2024. e-Pub 2024. PMID: 38335765.
126. Hampel PJ, Swaminathan M, Rogers KA, Parry EM, Burger JA, Davids MS, Ding W, Ferrajoli A, Hyak JM, Jain N, Kenderian SS, Wang Y, Wierda WG, Woyach JA, Parikh SA, Thompson PA. A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood Adv. e-Pub 2024. PMID: 38537065.
127. Short NJ, Jabbour E, Jain N, Senapati J, Nasr L, Haddad FG, Li Z, Hsiao YC, Yang JJ, Pemmaraju N, Ohanian M, Wierda WG, Montalban-Bravo G, Borthakur G, Han L, Xiao L, Huang X, Abramova R, Zhao M, Garris R, Konopleva M, Ravandi F, Kantarjian H. A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia. Blood Adv 8(4):909-915, 2024. e-Pub 2024. PMID: 38207208.
128. Jabbour E, Haddad FG, Short NJ, Senapati J, Jain N, Sasaki K, Jorgensen J, Wang SA, Alvarado Y, Wang X, DiNardo C, Masarova L, Kadia T, Garris RS, Ravandi F, Kantarjian H. Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission. Blood 143(5):417-421, 2024. e-Pub 2024. PMID: 37879077.
129. Jain N, Croner LJ, Allan JN, Siddiqi T, Tedeschi A, Badoux XC, Eckert K, Cheung LWK, Mukherjee A, Dean JP, Szafer-Glusman E, Seymour JF. Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clin Cancer Res 30(3):498-505, 2024. e-Pub 2024. PMID: 37955424.
130. Hajomer AAE, Derkach I, Jain N, Chin HM, Andersen UL, Gehring T. Long-distance continuous-variable quantum key distribution over 100-km fiber with local local oscillator. Sci Adv 10(1):eadi9474, 2024. e-Pub 2024. PMID: 38170766.
131. Gharib M, Cleland T, Enriquez R, Kasitinon D, Konda C, Schaaf S, Song A, Williams R, Ozcakar L, Jain NB. Ultrasound Guided Intra-Articular Radiocapitellar Joint (Lateral Approach) Injection. Am J Phys Med Rehabil 104(1):e13, 2024. e-Pub 2024. PMID: 39668440.
132. Kinjalk M, Jain N, Neogi S, Ratan SK, Panda SS, Sehgal M, Arora V. Pediatric Age-adjusted Shock Index (SIPA): From Injury to Outcome in Blunt Abdominal Trauma. J Indian Assoc Pediatr Surg 29(1):33-38, 2024. e-Pub 2024. PMID: 38405261.
133. Tian Z, Shi C, Yang G, Allen JK, Shi Q, Al-Shami A, Olson JW, Smith MG, Chang Q, Kaur J, You J, Lofton TE, Gonzalez MA, Zhang Q, Zha D, Tasian SK, Jain N, Konopleva MY, Heffernan T, Molldrem JJ. Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL. Leukemia 38(1):226, 2024. e-Pub 2024. PMID: 38036631.
134. Herzberg SD, Zhao Z, Freeman TH, Prakash R, Baumgarten KM, Bishop JY, Carey JL, Jones GL, McCarty EC, Spencer EE, Vidal AF, Jain NB, Giri A, Kuhn JE, Khazzam MS, Matzkin EG, Brophy RH, Dunn WR, Ma CB, Marx RG, Poddar SK, Smith MV, Wolf BR, Wright RW. Obesity is associated with muscle atrophy in rotator cuff tear. BMJ Open Sport Exerc Med 10(2):e001993, 2024. e-Pub 2024. PMID: 38974096.
135. Lin YS, DeClercq JJ, Ayers GD, Gilmor RJ, Collett G, Jain NB. Incidence and Clinical Risk Factors of Post-Operative Complications following Primary Total Hip Arthroplasty: A 10-Year Population-Based Cohort Study. J Clin Med 13(1), 2023. e-Pub 2023. PMID: 38202167.
136. Zhao Y, Short NJ, Kantarjian HM, Chang TC, Ghate PS, Qu C, Macaron W, Jain N, Thakral B, Phillips AH, Khoury J, Garcia-Manero G, Zhang W, Fan Y, Yang H, Garris RS, Nasr LF, Kriwacki RW, Roberts KG, Konopleva M, Jabbour EJ, Mullighan CG. Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL. medRxiv, 2023. e-Pub 2023. PMID: 38106221.
137. Short, NJ, Muftuoglu, M, Ong, F, Nasr, L, Macaron, W, Montalban Bravo, G, Alvarado, Y, Basyal, M, Daver, N, DiNardo, C, Borthakur, G, Jain, N, Ohanian, M, Jabbour, EJ, Issa, GC, Qiao, W, Huang, X, Kanagal Shamanna, R, Patel, KP, Bose, P, Ravandi-Kashani, F, Delumpa, R, Abramova, R, Garcia-Manero, G, Andreeff, M, Cortes, JE, Kantarjian, HM. A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents. Journal of Hematology and Oncology 16(1), 2023. e-Pub 2023. PMID: 37422688.
138. Short, NJ, Muftuoglu, M, Ong, F, Nasr, L, Macaron, W, Montalban Bravo, G, Alvarado, Y, Basyal, M, Daver, N, DiNardo, C, Borthakur, G, Jain, N, Ohanian, M, Jabbour, EJ, Issa, GC, Qiao, W, Huang, X, Kanagal Shamanna, R, Patel, KP, Bose, P, Ravandi-Kashani, F, Delumpa, R, Abramova, R, Garcia-Manero, G, Andreeff, M, Cortes, JE, Kantarjian, HM. A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents. Journal of Hematology and Oncology 16(1), 2023. e-Pub 2023. PMID: 37422688.
139. Sasaki, K, Haddad, FG, Short, NJ, Jain, N, Issa, GC, Jabbour, EJ, Kantarjian, HM. Outcome of Philadelphia chromosome-positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019. Cancer 129(23):3805-3814, 2023. e-Pub 2023. PMID: 37769040.
140. Short, NJ, Muftuoglu, M, Ong, F, Nasr, L, Macaron, W, Montalban Bravo, G, Alvarado, Y, Basyal, M, Daver, N, DiNardo, C, Borthakur, G, Jain, N, Ohanian, M, Jabbour, EJ, Issa, GC, Qiao, W, Huang, X, Kanagal Shamanna, R, Patel, KP, Bose, P, Ravandi-Kashani, F, Delumpa, R, Abramova, R, Garcia-Manero, G, Andreeff, M, Cortes, JE, Kantarjian, HM. A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents. Journal of Hematology and Oncology 16(1), 2023. e-Pub 2023. PMID: 37422688.
141. Short, NJ, Muftuoglu, M, Ong, F, Nasr, L, Macaron, W, Montalban Bravo, G, Alvarado, Y, Basyal, M, Daver, N, DiNardo, C, Borthakur, G, Jain, N, Ohanian, M, Jabbour, EJ, Issa, GC, Qiao, W, Huang, X, Kanagal Shamanna, R, Patel, KP, Bose, P, Ravandi-Kashani, F, Delumpa, R, Abramova, R, Garcia-Manero, G, Andreeff, M, Cortes, JE, Kantarjian, HM. A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents. Journal of Hematology and Oncology 16(1), 2023. e-Pub 2023. PMID: 37422688.
142. Kadia, TM, Ravandi-Kashani, F, Molica, M, Bataller, A, Borthakur, G, Daver, N, Jabbour, EJ, DiNardo, C, Pemmaraju, N, Jain, N, Ferrajoli, A, Ylimaz, M, Bose, P, Tidwell, R, Marx, KR, Rausch, CR, Kanagal Shamanna, R, Wang, S, Islam, R, Champlin, RE, Shpall, E, Konopleva, M, Garcia-Manero, G, Kantarjian, HM. Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology 98(11):1711-1720, 2023. e-Pub 2023. PMID: 37635400.
143. Senapati, J, Fiskus, WC, Daver, N, Wilson, NR, Ravandi-Kashani, F, Garcia-Manero, G, Kadia, TM, DiNardo, C, Jabbour, EJ, Burger, JA, Short, NJ, Alvarado, Y, Jain, N, Masarova, L, Issa, GC, Qiao, W, Khoury, J, Pierce, SR, Miller, D, Sasaki, K, Konopleva, M, Bhalla, K, Borthakur, G, Pemmaraju, N. Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clinical Cancer Research 29(21):4352-4360, 2023. e-Pub 2023. PMID: 37585491.
144. Parry, EM, Lemvigh, C, Deng, S, Dangle, N, Ruthen, NG, Knisbacher, BA, Broséus, J, Hergalant, S, Guièze, R, Li, S, Zhang, W, Johnson, C, Long, JM, Yin, S, Werner, L, Anandappa, AJ, Purroy, N, Gohil, SH, Oliveira, G, Bachireddy, P, Shukla, SA, Huang, T, Khoury, J, Thakral, B, Dickinson, M, Tam, C, Livak, KJ, Getz, G, Neuberg, D, Feugier, P, Kharchenko, PV, Wierda, WG, Olsen, LR, Jain, N, Wu, C. ZNF683 marks a CD8+ T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome. Cancer cell 41(10):1803-1816.e8, 2023. e-Pub 2023. PMID: 37738974.
145. Jia Y, Han L, Ramage CL, Wang Z, Weng CC, Yang L, Colla S, Ma H, Zhang W, Andreeff M, Daver N, Jain N, Pemmaraju N, Bhalla K, Mustjoki S, Zhang P, Zheng G, Zhou D, Zhang Q, Konopleva M. Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells. Haematologica 108(10):2626-2638, 2023. e-Pub 2023. PMID: 37078252.
146. Tian, Z, Shi, C, Yang, G, Allen, J, Shi, Q, AI-Shami, A, Olson, JW, Smith, M, Chang, Q, Kaur, J, You, J, Lofton, T, Gonzalez, MA, Zhang, Q, Zha, D, Tasian, SK, Jain, N, Konopleva, M, Heffernan, TP, Molldrem, JJ. Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL. Leukemia 37(10):2006-2016, 2023. e-Pub 2023. PMID: 37634013.
147. Haddad, FG, Sasaki, K, Bidikian, A, Issa, GC, Kadia, TM, Jain, N, Alvarado, Y, Short, NJ, Pemmaraju, N, Loghavi, S, Patel, KP, Kanagal Shamanna, R, Yilmaz, M, Masarova, L, Jabbour, EJ, Kantarjian, HM. Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era. American journal of hematology 98(10):1619-1626, 2023. e-Pub 2023. PMID: 37485584.
148. Thakur B, Ayers GD, Atem F, DeClercq JJ, Jain NB. Statistical and Methodological Considerations for Randomized Controlled Trial Design in Physical Medicine and Rehabilitation. Am J Phys Med Rehabil 102(10):855-860, 2023. e-Pub 2023. PMID: 36882301.
149. Roccograndi LM, Lovell AR, Ferrajoli A, Thompson PA, Burger JA, Wierda WG, Jain N, Rausch CR. Incidence of major bleeding in patients with chronic lymphocytic leukemia receiving ibrutinib and therapeutic anticoagulation. Leuk Lymphoma 64(9):1554-1561, 2023. e-Pub 2023. PMID: 37317991.
150. Short, NJ, Jabbour, EJ, Macaron, W, Ravandi-Kashani, F, Jain, N, Kanagal Shamanna, R, Patel, KP, Loghavi, S, Haddad, FG, Yilmaz, M, Issa, GC, Kebriaei, P, Kornblau, SM, Pelletier, S, Flores, W, Matthews, JA, Garris, R, Kantarjian, HM. Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1. American journal of hematology 98(8):1196-1203, 2023. e-Pub 2023. PMID: 37183966.
151. Pasvolsky O, Kebriaei P, Shah BD, Jabbour EJ, Jain N. Chimeric Antigen Receptor T Therapy for Adult B-Cell Acute Lymphoblastic Leukemia: State-of the-(C)ART and Road Ahead. Blood Adv 7(14):3350-3360, 2023. e-Pub 2023. PMID: 36912764.
152. Gordon MJ, Jones JE, George B, Peterson C, Burger JA, Jain N, Keating M, Wierda WG, Durand JB, Ferrajoli A. Long-term outcomes in patients with chronic lymphocytic leukemia treated with ibrutinib: Focus on hypertension and cardiovascular toxicity. Cancer 129(14):2192-2200, 2023. e-Pub 2023. PMID: 37016930.
153. Thompson, PA, Keating, M, Ferrajoli, A, Jain, N, Peterson, CB, Garg, N, Wang, SA, Jorgensen, JL, Kadia, TM, Bose, P, Pemmaraju, N, Short, NJ, Wierda, WG. Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD. Leukemia 37(7):1444-1453, 2023. e-Pub 2023. PMID: 37138019.
154. Jain N, Khurana P, Khurana JP. Overexpression of a rice Tubby-like protein-encoding gene, OsFBT4, confers tolerance to abiotic stresses. Protoplasma 260(4):1063-1079, 2023. e-Pub 2023. PMID: 36539640.
155. Olesinski EA, Bhatia KS, Mahesh AN, Rosli S, Mohamed JS, Jen WY, Jain N, Garcia JS, Wong GC, Ooi M, Letai A, Konopleva M, Bhatt S. BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia. Blood Adv 7(12):2917-2923, 2023. e-Pub 2023. PMID: 36763538.
156. Nasr AJ, Pierson CJ, Tzen YT, Khazzam M, Jain NB, Lin YS. Emerging Role of Quantitative Ultrasound-Based Imaging Techniques for Characterizing Rotator Cuff Tears: A Scoping Review. Diagnostics (Basel) 13(12), 2023. e-Pub 2023. PMID: 37370906.
157. El Hussein S, Medeiros LJ, Lyapichev KA, Fang H, Jelloul FZ, Fiskus W, Chen J, Wei P, Schlette E, Xu J, Li S, Kanagal-Shamanna R, Yang H, Tang Z, Thakral B, Loghavi S, Jain N, Thompson PA, Ferrajoli A, Wierda WG, Jabbour E, Patel KP, Dabaja BS, Bhalla KN, Khoury JD. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma. Pathology 55(4):514-524, 2023. e-Pub 2023. PMID: 36933995.
158. El Hussein S, Medeiros LJ, Gruschkus SK, Wei P, Schlette E, Fang H, Jelloul FZ, Wang W, Fiskus W, Kanagal-Shamanna R, Loghavi S, Yang H, Li S, Xu J, Tang Z, Thakral B, Jain N, Wierda WG, Patel K, Bhalla KN, Khoury JD. Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant. Virchows Arch 482(6):1011-1019, 2023. e-Pub 2023. PMID: 36864257.
159. Desikan SP, Senapati J, Jabbour E, Abuasab T, Short N, Tang G, Wang S, Kebriaei P, Kadia T, Borthakur G, Ravandi F, Roberts K, Mullighan C, Konopleva M, Kantarjian H, Jain N. Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia. Am J Hematol 98(6):E142-E144, 2023. e-Pub 2023. PMID: 36877196.
160. Yoshimura S, Panetta JC, Hu J, Li L, Gocho Y, Du G, Umezawa A, Karol SE, Pui CH, Mullighan CG, Konopleva M, Stock W, Teachey DT, Jain N, Yang JJ. Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia. Leukemia 37(6):1194-1203, 2023. e-Pub 2023. PMID: 37076694.
161. Jabbour E, Short NJ, Senapati J, Jain N, Huang X, Daver N, DiNardo CD, Pemmaraju N, Wierda W, Garcia-Manero G, Montalban Bravo G, Sasaki K, Kadia TM, Khoury J, Wang SA, Haddad FG, Jacob J, Garris R, Ravandi F, Kantarjian HM. Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial. Lancet Haematol 10(6):e433-e444, 2023. e-Pub 2023. PMID: 37187201.
162. Jain N, Senapati J, Thakral B, Ferrajoli A, Thompson P, Burger J, Basu S, Kadia T, Daver N, Borthakur G, Konopleva M, Pemmaraju N, Parry E, Wu CJ, Khoury J, Bueso-Ramos C, Garg N, Wang X, Lopez W, Ayala A, O'Brien S, Kantarjian H, Keating M, Allison J, Sharma P, Wierda W. A Phase 2 Study of Nivolumab Combined with Ibrutinib in Patients with Diffuse Large B-cell Richter Transformation of CLL. Blood Adv 7(10):1958-1966, 2023. e-Pub 2023. PMID: 36287248.
163. Kantarjian H, Haddad FG, Jain N, Sasaki K, Short NJ, Loghavi S, Kanagal-Shamanna R, Jorgensen J, Khouri I, Kebriaei P, Alvarado Y, Kadia T, Paul S, Garcia-Manero G, Dabaja B, Yilmaz M, Jacob J, Garris R, O'Brien S, Ravandi F, Jabbour E. Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia. J Hematol Oncol 16(1):44, 2023. e-Pub 2023. PMID: 37131217.
164. Pirri C, Stecco C, Guvener O, Mezian K, Ricci V, Jacisko J, Novotny T, Kara M, Chang KV, Dughbaj M, Jain NB, Ozcakar L. EURO-MUSCULUS/USPRM Dynamic Ultrasound Protocols for Knee. Am J Phys Med Rehabil 102(5):e67-e72, 2023. e-Pub 2023. PMID: 36729007.
165. Singh S, Vergish S, Jain N, Sharma AK, Khurana P, Khurana JP. OsCRY2 and OsFBO10 co-regulate photomorphogenesis and photoperiodic flowering in indica rice. Plant Sci 330:111631, 2023. e-Pub 2023. PMID: 36773757.
166. Senapati J, Jabbour E, Konopleva M, Short NJ, Tang G, Daver N, Kebriaei P, Kadia T, Pemmaraju N, Takahashi K, DiNardo C, Sasaki K, Borthakur G, Thakral B, Kanagal-Shamanna R, Patel K, Ravandi F, Roberts K, Mullighan C, Kantarjian H, Jain N. Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements. JCO Precis Oncol 7:e2200707, 2023. e-Pub 2023. PMID: 37196217.
167. Sasaki K, Ravandi F, Kadia TM, Borthakur G, Short NJ, Jain N, Daver NG, Jabbour EJ, Garcia-Manero G, Loghavi S, Patel KP, Montalban-Bravo G, Masarova L, DiNardo CD, Kantarjian HM. Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia. Cancer 129(7):1017-1029, 2023. e-Pub 2023. PMID: 36715486.
168. Jabbour EJ, Sasaki K, Haddad FG, Issa GC, Garcia-Manero G, Kadia TM, Jain N, Yilmaz M, DiNardo CD, Patel KP, Kanagal-Shamanna R, Champlin R, Khouri IF, Dellasala S, Pierce SA, Kantarjian H. The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors. Am J Hematol 98(4):658-665, 2023. e-Pub 2023. PMID: 36683287.
169. Kantarjian H, Short NJ, Jain N, Sasaki K, Huang X, Haddad FG, Khouri I, DiNardo CD, Pemmaraju N, Wierda W, Garcia-Manero G, Kebriaei P, Garris R, Loghavi S, Jorgensen J, Kwari M, O'Brien S, Ravandi F, Jabbour E. Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. Am J Hematol 98(3):493-501, 2023. e-Pub 2023. PMID: 36600670.
170. Boddu PC, Senapati J, Ravandi-Kashani F, Jabbour EJ, Jain N, Ayres M, Chen Y, Keating MJ, Kantarjian HM, Gandhi V, Kadia TM. A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies. Cancer 129(4):580-589, 2023. e-Pub 2023. PMID: 36448227.
171. Jain N, Khurana P, Khurana JP. AtTLP2, a Tubby-like protein, plays intricate roles in abiotic stress signalling. Plant Cell Rep 42(2):235-252, 2023. e-Pub 2023. PMID: 36437308.
172. Cutler HS, DeClercq J, Ayers GD, Serbin P, Jain N, Khazzam M. Risk of Revision Shoulder Arthroplasty After Anatomic and Reverse Total Shoulder Arthroplasty. J Am Acad Orthop Surg 31(1):17-25, 2023. e-Pub 2023. PMID: 36548151.
173. Yanik EL, Keener JD, Stevens MJ, Walker-Bone KE, Dale AM, Ma Y, Colditz GA, Wright RW, Saccone NL, Jain NB, Evanoff BA. Occupational demands associated with rotator cuff disease surgery in the UK Biobank. Scand J Work Environ Health 49(1):53-63, 2023. e-Pub 2023. PMID: 36228192.
174. Marx KR, Rausch CR, Lovell AR, Short NJ, Paul S, Jain N, Lee J, Savoy JM, Ravandi F, Jabbour E. Incidence of adverse effects in patients receiving ponatinib with concomitant azole antifungals. Leuk Lymphoma 64(1):1-8, 2023. e-Pub 2023. PMID: 36222579.
175. Paul S, Kantarjian H, Sasaki K, Marx K, Jain N, Savoy JM, DiPippo A, Jammal N, Bravo GM, Kadia T, Garcia-Manero G, Short NJ, Ravandi F, Jabbour E. Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. Am J Hematol 98(1):E11-E14, 2023. e-Pub 2023. PMID: 35633516.
176. Jabbour E, Short NJ, Jain N, Huang X, Montalban-Bravo G, Banerjee P, Rezvani K, Jiang X, Kim KH, Kanagal-Shamanna R, Khoury JD, Patel K, Kadia TM, Daver N, Chien K, Alvarado Y, Garcia-Manero G, Issa GC, Haddad FG, Kwari M, Thankachan J, Delumpa R, Macaron W, Garris R, Konopleva M, Ravandi F, Kantarjian H. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial. Lancet Haematol 10(1):e24-e34, 2023. e-Pub 2023. PMID: 36402146.
177. Parry EM, Leshchiner I, Guièze R, Johnson C, Tausch E, Parikh SA, Lemvigh C, Broséus J, Hergalant S, Messer C, Utro F, Levovitz C, Rhrissorrakrai K, Li L, Rosebrock D, Yin S, Deng S, Slowik K, Jacobs R, Huang T, Li S, Fell G, Redd R, Lin Z, Knisbacher BA, Livitz D, Schneider C, Ruthen N, Elagina L, Taylor-Weiner A, Persaud B, Martinez A, Fernandes SM, Purroy N, Anandappa AJ, Ma J, Hess J, Rassenti LZ, Kipps TJ, Jain N, Wierda W, Cymbalista F, Feugier P, Kay NE, Livak KJ, Danysh BP, Stewart C, Neuberg D, Davids MS, Brown JR, Parida L, Stilgenbauer S, Getz G, Wu CJ. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. Nat Med 29(1):158-169, 2023. e-Pub 2023. PMID: 36624313.
178. Jabbour E, Short NJ, Jain N, Thompson PA, Kadia TM, Ferrajoli A, Huang X, Yilmaz M, Alvarado Y, Patel KP, Garcia-Manero G, Macaron W, Garris R, Konopleva M, Ravandi F, Kantarjian H. Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial. Lancet Haematol 9(12):e878-e885, 2022. e-Pub 2022. PMID: 36279879.
179. Tzen YT, Champagne PT, Rao V, Wang J, Tan WH, Klakeel M, Jain NB, Wukich DK, Koh TJ. Utilisation of skin blood flow as a precursor for pressure injury development in persons with acute spinal cord injury: A proof of concept. Int Wound J 19(8):2191-2199, 2022. e-Pub 2022. PMID: 35543296.
180. Kasitinon D, Williams R, Gharib M, Flowers R, Raiser S, Jain NB. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 104(22):1961-1967, 2022. e-Pub 2022. PMID: 36126120.
181. Mezian K, Ricci V, Guvener O, Jacisko J, Novotny T, Kara M, Chang KV, Nanka O, Pirri C, Stecco C, Dughbaj M, Jain NB, Ozcakar L. EURO-MUSCULUS/USPRM Dynamic Ultrasound Protocols for (Adult) Hip. Am J Phys Med Rehabil 101(11):e162-e168, 2022. e-Pub 2022. PMID: 35687784.
182. Jabbour E, Sasaki K, Haddad FG, Issa GC, Skinner J, Dellasala S, Yilmaz M, Ferrajoli A, Bose P, Thompson P, Alvarado Y, Jain N, Garcia-Manero G, Takahashi K, Borthakur G, Pemmaraju N, Pierce S, Kantarjian H. Low-dose dasatinib 50?mg/day versus standard-dose dasatinib 100?mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis. Am J Hematol 97(11):1413-1418, 2022. e-Pub 2022. PMID: 36054032.
183. Dupouy S, Marchiq I, Derippe T, Almena-Carrasco M, Jozwik A, Fouliard S, Adimy Y, Geronimi J, Graham C, Jain N, Maus MV, Mohty M, Boissel N, Teshima T, Kato K, Benjamin R, Balandraud S. Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia. Cancer Res Commun 2(11):1520-1531, 2022. e-Pub 2022. PMID: 36970059.
184. Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M, Group CS. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial. Lancet Haematol 9(11):e833-e843, 2022. e-Pub 2022. PMID: 36228643.
185. Pemmaraju N, Wilson NR, Senapati J, Economides MP, Guzman ML, Neelapu SS, Kazemimood R, Davis RE, Jain N, Khoury JD, Sugita M, Cai T, Smith J, Frattini MG, Garton A, Roboz G, Konopleva M. CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights. Leuk Res 121:106928, 2022. e-Pub 2022. PMID: 35963025.
186. Haddad FG, Kantarjian H, Short NJ, Konopleva M, Jain N, Huang X, Ravandi F, Wierda W, Borthakur G, Sasaki K, Issa G, Alvarado Y, Pemmaraju N, Garcia-Manero G, Thankachan J, Garris R, Jabbour E. ALL-424 Updated Results from the Phase II Study of Blinatumomab in Combination With Ponatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 22 Suppl 2:S204, 2022. e-Pub 2022. PMID: 36163747.
187. Abuasab T, Alvarado Y, Issa G, Islam R, James N, Yilmaz M, Jain N, Masarova L, Kornblau S, Jabbour E, Pemmaraju N, Bravo GM, Pierce S, DiNardo C, Kadia T, Daver N, Konopleva M, Garcia-Manero G, Ravandi F. AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazuridine) Plus Venetoclax in Patients With Relapsed/Refractory Acute Myeloid Leukemia or Previously Untreated, Older Adult Patients Unfit for Chemotherapy. Clin Lymphoma Myeloma Leuk 22 Suppl 2:S237, 2022. e-Pub 2022. PMID: 36163813.
188. Bazinet A, Kantarjian H, Borthakur G, Yilmaz M, Bose P, Jabbour E, Alvarado Y, Chien K, Pemmaraju N, Takahashi K, Short N, Daver N, Issa G, Jain N, Bull-Linderman D, DiNardo C, Montalban-Bravo G, Garcia-Manero G, Sasaki K, Ravandi F, Kadia T. AML-342 A Phase II Study of Azacitidine and Venetoclax as Maintenance Therapy in Patients With Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk 22 Suppl 2:S239-S240, 2022. e-Pub 2022. PMID: 36163817.
189. Rozovski U, Veletik I, Harris D, Li P, Liu Z, Jain P, Manshouri T, Ferrajoli A, Burger J, Bose P, Thompson P, Jain N, Wierda W, Verstovsek S, Keating M, Estrov Z. CLL-162 PTX3 is Constitutively Active in CLL Cells. Clin Lymphoma Myeloma Leuk 22 Suppl 2:S271, 2022. e-Pub 2022. PMID: 36163878.
190. Timofeeva N, Jain N, Irajizad E, Aslan B, Katayama H, Cai Y, Ayres M, Iles L, Vykoukal J, Dennison J, Hanash S, Wierda W, Gandhi V. CLL-532 Changes in Proteome of CLL (Chronic Lymphocytic Leukemia) Lymphocytes During Investigator-Initiated Trial of Ibrutinib Alone and in Combination With Venetoclax in Treatment-Naïve Patients With CLL. Clin Lymphoma Myeloma Leuk 22 Suppl 2:S283, 2022. e-Pub 2022. PMID: 36163901.
191. Baran N, Babakhanlou R, Sasaki K, Takahashi K, Short N, Ravandi F, Garcia-Manero G, Jabbour EJ, Kantarjian HM, Jain N. ALL-346 Acute Lymphoblastic Leukemia Following Multiple Myeloma Therapy: A Single-Center Experience With 9 Patients. Clin Lymphoma Myeloma Leuk 22 Suppl 2:S201-S202, 2022. e-Pub 2022. PMID: 36163741.
192. Saini NY, Swoboda DM, Greenbaum U, Ma J, Patel RD, Devashish K, Das K, Tanner MR, Strati P, Nair R, Fayad L, Ahmed S, Lee HJ, Iyer SP, Steiner R, Jain N, Nastoupil L, Loghavi S, Tang G, Bassett RL, Jain P, Wang M, Westin JR, Green MR, Sallman DA, Padron E, Davila ML, Locke FL, Champlin RE, Garcia-Manero G, Shpall EJ, Kebriaei P, Flowers CR, Jain MD, Wang F, Futreal AP, Gillis N, Neelapu SS, Takahashi K. Clonal hematopoiesis is associated with increased risk of severe neurotoxicity in axicabtagene ciloleucel therapy of large B-cell lymphoma. Blood Cancer Discov 3(5):385-393, 2022. e-Pub 2022. PMID: 35533245.
193. Jabbour EJ, Short NJ, Jain N, Jammal N, Jorgensen J, Wang S, Wang X, Ohanian M, Alvarado Y, Kadia T, Sasaki K, Garris R, Garcia-Manero G, Ravandi F, Kantarjian HM. Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higher. Am J Hematol 97(9):1135-1141, 2022. e-Pub 2022. PMID: 35713551.
194. Talwar D, Talwar D, Jain N, Prajapat D, Pahuja S. A retrospective observational study on pheno-endotypes of severe asthma among adults attending asthma clinic in a tertiary care centre in India. Lung India 39(5):393-400, 2022. e-Pub 2022. PMID: 36629198.
195. Jain N, Chin HM, Mani H, Lupo C, Nikolic DS, Kordts A, Pirandola S, Pedersen TB, Kolb M, Omer B, Pacher C, Gehring T, Andersen UL. Practical continuous-variable quantum key distribution with composable security. Nat Commun 13(1):4740, 2022. e-Pub 2022. PMID: 35961965.
196. Cherng HJ, Khwaja R, Kanagal-Shamanna R, Tang G, Burger J, Thompson P, Ferrajoli A, Estrov Z, Sasaki K, Sampath D, Wang X, Kantarjian H, Keating M, Wierda WG, Jain N. TP53-altered CLL Treated with Firstline Bruton's Tyrosine Kinase Inhibitor-based Therapy: A Retrospective Analysis. Am J Hematol 97(8):1005-1012, 2022. e-Pub 2022. PMID: 35567779.
197. Ricci V, Guvener O, Chang KV, Wu WT, Mezian K, Kara M, Leblebicioglu G, Pirri C, Ata AM, Dughbaj M, Jain NB, Stecco C, Ozcakar L. EURO-MUSCULUS/USPRM Dynamic Ultrasound Protocols for Elbow. Am J Phys Med Rehabil 101(6):e83-e92, 2022. e-Pub 2022. PMID: 34930863.
198. Short NJ, Macaron W, Konopleva M, Ravandi F, Jain N, Issa GC, Kadia T, Sasaki K, Kebriaei P, Yilmaz M, Thompson PA, Takahashi K, Abbas HA, Wierda WG, Garris R, Kantarjian HM, Jabbour E. Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. Am J Hematol 97(6):E201-E204, 2022. e-Pub 2022. PMID: 35266566.
199. Kadia TM, Reville PK, Wang X, Rausch CR, Borthakur G, Pemmaraju N, Daver NG, DiNardo CD, Sasaki K, Issa GC, Ohanian M, Montalban-Bravo G, Short NJ, Jain N, Ferrajoli A, Bhalla KN, Jabbour E, Takahashi K, Malla R, Quagliato K, Kanagal-Shamanna R, Popat UR, Andreeff M, Garcia-Manero G, Konopleva MY, Ravandi F, Kantarjian HM. Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. J Clin Oncol:JCO2102823. e-Pub 2022. PMID: 35704787.
200. Berkman AM, Andersen CR, Cuglievan B, McCall DC, Lupo PJ, Parsons SK, DiNardo CD, Short NJ, Jain N, Kadia TM, Livingston JA, Roth ME. Long-Term Outcomes among Adolescent and Young Adult Survivors of Acute Leukemia: A Surveillance, Epidemiology, and End Results Analysis. Cancer Epidemiol Biomarkers Prev 31(6):OF1-OF9, 2022. e-Pub 2022. PMID: 35553621.
201. DiNardo CD, Lachowiez CA, Takahashi K, Loghavi S, Kadia T, Daver N, Xiao L, Adeoti M, Short NJ, Sasaki K, Wang SA, Borthakur G, Issa G, Maiti A, Alvarado Y, Pemmaraju N, Montalban Bravo G, Masarova L, Yilmaz M, Jain N, Andreeff M, Garcia-Manero G, Kornblau S, Ravandi F, Jabbour E, Konopleva MY, Kantarjian HM. Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia. Am J Hematol. e-Pub 2022. PMID: 35583199.
202. Yilmaz M, Kantarjian H, Short NJ, Reville P, Konopleva M, Kadia T, DiNardo C, Borthakur G, Pemmaraju N, Maiti A, Jabbour E, Jain N, Issa G, Takahashi K, Sasaki K, Ohanian M, Pierce S, Tang G, Loghavi S, Patel K, Wang SA, Garcia-Manero G, Andreeff M, Ravandi F, Daver N. Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood Cancer J 12(5):77, 2022. e-Pub 2022. PMID: 35501304.
203. Sasaki Y, Kantarjian HM, Short NJ, Wang F, Furudate K, Uryu H, Garris R, Jain N, Sasaki K, Ravandi F, Konopleva M, Garcia-Manero G, Little L, Gumbs C, Zhao L, Futreal PA, Takahashi K, Jabbour E. Correction: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib. Leukemia 36(5):1448, 2022. e-Pub 2022. PMID: 35411096.
204. Rozovski U, Veletic I, Harris DM, Li P, Liu Z, Jain P, Manshouri T, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Verstovsek S, Keating MJ, Estrov Z. STAT3 Activates the Pentraxin 3 Gene in Chronic Lymphocytic Leukemia Cells. J Immunol. e-Pub 2022. PMID: 35595309.
205. Short NJ, Kantarjian HM, Ravandi F, Konopleva MY, Jain N, Kanagal-Shamanna R, Patel KP, Macaron W, Kadia TM, Wang SA, Jorgensen JL, Khoury JD, Yilmaz M, Kebriaei P, Takahashi K, Garcia-Manero G, Daver NG, Post SM, Huang X, Kornblau SM, Pelletier S, Flores W, Matthews J, Garris R, Jabbour EJ. High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse. Blood Adv. e-Pub 2022. PMID: 35533262.
206. Jelloul FZ, Yang R, Garces S, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Bassett RL, Wierda W, Jain N, Thompson P, Luthra R, Medeiros LJ, Patel KP. Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. Leuk Res 116:106827, 2022. e-Pub 2022. PMID: 35430388.
207. Ly AJ, Reddy YC, Jain NB, Du L, Atem F, Khazzam M. The role of familial predisposition in imaging-confirmed atraumatic rotator cuff tears. J Shoulder Elbow Surg 31(4):819-823, 2022. e-Pub 2022. PMID: 34699989.
208. Mukherjee A, Milton DR, Jabbour EJ, Gulbis AM, Kadia T, Jain N, Ledesma C, Burger J, Ferrajoli A, Wierda W, Medeiros LJ, Kantarjian H, Champlin R, Khouri IF. Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors. Leuk Lymphoma 63(4):885-893, 2022. e-Pub 2022. PMID: 35225133.
209. Sasaki K, Ravandi F, Kadia T, DiNardo C, Borthakur G, Short N, Jain N, Daver N, Jabbour E, Garcia-Manero G, Khoury J, Konoplev S, Loghavi S, Patel K, Montalban-Bravo G, Masarova L, Konopleva M, Kantarjian H. Prediction of survival with intensive chemotherapy in acute myeloid leukemia. Am J Hematol. e-Pub 2022. PMID: 35384048.
210. Kim K, Konopleva M, DiNardo CD, Borthakur G, Loghavi S, Tang G, Daver N, Pemmaraju N, Jabbour E, Rausch CR, Yilmaz M, Sasaki K, Short NJ, Jain N, Brandt M, Pierce S, Garcia-Manero G, Ravandi F, Kantarjian H, Kadia TM. Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. Am J Hematol. e-Pub 2022. PMID: 35413152.
211. Song A, Cannon D, Kim P, Ayers GD, Gao C, Giri A, Jain NB. Risk factors for degenerative, symptomatic rotator cuff tears: a case-control study. J Shoulder Elbow Surg 31(4):806-812, 2022. e-Pub 2022. PMID: 34687917.
212. Ricci V, Chang KV, Guvener O, Mezian K, Kara M, Leblebicioglu G, Stecco C, Pirri C, Ata AM, Dughbaj M, Jain NB, Ozcakar L. EURO-MUSCULUS/USPRM Dynamic Ultrasound Protocols for Shoulder. Am J Phys Med Rehabil 101(3):e29-e36, 2022. e-Pub 2022. PMID: 34923500.
213. Haddad FG, Sasaki K, Issa GC, Garcia-Manero G, Ravandi F, Kadia T, Cortes J, Konopleva M, Pemmaraju N, Alvarado Y, Yilmaz M, Borthakur G, DiNardo C, Jain N, Daver N, Short NJ, Jabbour E, Kantarjian H. Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors. Am J Hematol. e-Pub 2022. PMID: 35357036.
214. Jelloul FZ, Yang RK, Wang P, Garces S, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Bassett RL, Wierda WG, Jain N, Thompson PA, Luthra R, Medeiros LJ, Patel KP. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis. Am J Hematol 97(3):E100-E102, 2022. e-Pub 2022. PMID: 34989420.
215. Sasaki Y, Kantarjian HM, Short NJ, Wang F, Furudate K, Uryu H, Garris R, Jain N, Sasaki K, Ravandi F, Konopleva M, Garcia-Manero G, Little L, Gumbs C, Zhao L, Futreal PA, Takahashi K, Jabbour E. Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib. Leukemia. e-Pub 2022. PMID: 35132195.
216. Pemmaraju N, Wilson NR, Garcia-Manero G, Sasaki K, Khoury JD, Jain N, Borthakur G, Ravandi F, Daver NG, Kadia TM, DiNardo CD, Jabbour EJ, Pierce SR, Qazilbash MH, Konopleva MY, Kantarjian HM. Characteristics and Outcomes of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm Treated with Frontline HCVAD. Blood Adv. e-Pub 2022. PMID: 35061885.
217. Sasaki K, Kadia T, Begna K, DiNardo CD, Borthakur G, Short NJ, Jain N, Daver N, Jabbour E, Garcia-Manero G, Bravo GM, Masarova L, Pierce S, Konopleva M, Ravandi F, Tefferi A, Kantarjian H. Prediction of early (4-week) mortality in acute myeloid leukemia with intensive chemotherapy. Am J Hematol 97(1):68-78, 2022. e-Pub 2022. PMID: 34716921.
218. Desikan SP, Ravandi F, Pemmaraju N, Konopleva M, Loghavi S, Jabbour EJ, Daver N, Jain N, Chien KS, Maiti A, Montalban-Bravo G, Kadia TM, Macaron W, DeLumpa R, Kwari M, Borthakur G, Short NJ. A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations. Acta Haematol 145(5):529-536, 2022. e-Pub 2022. PMID: 35717939.
219. Yi X, Jain N, Iles LR, Ayres ML, Wierda WG, Gandhi V. Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia. Front Oncol 12:833714, 2022. e-Pub 2022. PMID: 35273915.
220. Gaballa MR, Banerjee PP, Milton DR, Jiang X, Ganesh C, Khazal SJ, Nandivada V, Islam S, Kaplan M, Daher M, Basar R, Alousi A, Mehta RS, Alatrash G, Khouri IF, Oran B, Marin D, Popat UR, Olson AL, Tewari P, Jain N, Jabbour EJ, Ravandi F, Kantarjian HM, Chen K, Champlin RE, Shpall EJ, Rezvani K, Kebriaei P. Blinatumomab Maintenance After Allogeneic Hematopoietic Cell Transplantation for B-lineage Acute Lymphoblastic Leukemia. Blood. e-Pub 2021. PMID: 34914826.
221. Gibson A, Trabal A, McCall D, Khazal S, Toepfer L, Bell DH, Roth M, Mahadeo KM, Nunez C, Short NJ, DiNardo C, Konopleva M, Issa GC, Ravandi F, Jain N, Borthakur G, Kantarjian HM, Jabbour E, Cuglievan B. Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Cancers (Basel) 14(1), 2021. e-Pub 2021. PMID: 35008312.
222. Mato AR, Davids MS, Sharman J, Roeker LE, Kay N, Kater AP, Rogers K, Thompson MC, Rhodes J, Goy A, Skarbnik A, Schuster SJ, Tam CS, Eyre TA, O'Brien S, Nabhan C, Lamanna N, Sun C, Shadman M, Pagel JM, Ujjani C, Brander D, Coombs CC, Jain N, Cheah CY, Brown JR, Seymour JF, Woyach JA. Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past is Prologue" (Shakespeare). Clin Cancer Res. e-Pub 2021. PMID: 34789482.
223. Ramos Perez JM, Patel KP, Loghavi S, Garcia-Manero G, Borthakur G, Jabbour E, Wierda W, Pierce S, Brandt M, Kornblau S, Kadia T, Daver N, DiNardo CD, Jain N, Yilmaz M, Short N, Verstovsek S, Ferrajoli A, Andreeff M, Konopleva M, Rivera D, McCue D, Kantarjian HM, Ravandi F. Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Leuk Lymphoma:1-4. e-Pub 2021. PMID: 34668451.
224. Huang J, Xu Q, Liu Z, Jain N, Tyagi M, Wei DQ, Hong L. Controlling the Substrate Specificity of an Enzyme through Structural Flexibility by Varying the Salt-Bridge Density. Molecules 26(18), 2021. e-Pub 2021. PMID: 34577164.
225. Forte GJ, Langelier M, Wang S, Dall TM, Reynolds RL, Chakrabarti R, Whyte J, Ankam NS, Annaswamy TM, Fredericson M, Jain NB, Karimi DP, Morgenroth DC, Slocum C, Wisotzky E. The Physiatry Workforce in 2019 and Beyond, Part 1: Results From a Cross-sectional Survey. Am J Phys Med Rehabil 100(9):866-876, 2021. e-Pub 2021. PMID: 33443853.
226. Dall TM, Reynolds RL, Chakrabarti R, Forte GJ, Langelier M, Wang S, Whyte J, Sridhara Ankam N, Annaswamy TM, Fredericson M, Jain NB, Perret Karimi D, Morgenroth DC, Slocum C, Wisotzky E. The Physiatry Workforce in 2019 and Beyond, Part 2: Modeling Results. Am J Phys Med Rehabil 100(9):877-884, 2021. e-Pub 2021. PMID: 33278133.
227. Sivina M, Kim E, Wierda WG, Ferrajoli A, Jain N, Thompson PA, Kantarjian HM, Keating MJ, Burger JA. Ibrutinib induces durable remissions in treatment-naïve patients with CLL and 17p deletion/TP53 mutations. Blood. e-Pub 2021. PMID: 34521099.
228. Brown PA, Shah B, Advani A, Aoun P, Boyer MW, Burke PW, DeAngelo DJ, Dinner S, Fathi AT, Gauthier J, Jain N, Kirby S, Liedtke M, Litzow M, Logan A, Luger S, Maness LJ, Massaro S, Mattison RJ, May W, Oluwole O, Park J, Przespolewski A, Rangaraju S, Rubnitz JE, Uy GL, Vusirikala M, Wieduwilt M, Lynn B, Berardi RA, Freedman-Cass DA, Campbell M. Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(9):1079-1109, 2021. e-Pub 2021. PMID: 34551384.
229. Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury JD, Issa GC, Haddad FG, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Konopleva MY, Daver NG, Kadia TM, Garcia-Manero G, Garris R, O'Brien SM, Jabbour EJ. Outcomes of Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement - The MD Anderson Experience. Blood Adv. e-Pub 2021. PMID: 34525185.
230. Kadia TM, Reville PK, Borthakur G, Yilmaz M, Kornblau S, Alvarado Y, Dinardo CD, Daver N, Jain N, Pemmaraju N, Short N, Wang SA, Tidwell RSS, Islam R, Konopleva M, Garcia-Manero G, Ravandi F, Kantarjian HM. Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial. Lancet Haematol 8(8):e552-e561, 2021. e-Pub 2021. PMID: 34329576.
231. Jain N. Evolving Treatment Paradigm in Frontline CLL. JCO Oncol Pract:OP2100486. e-Pub 2021. PMID: 34449250.
232. Samra B, Khoury JD, Morita K, Ravandi F, Richard-Carpentier G, Short NJ, El Hussein S, Thompson PA, Jain N, Kantarjian HM, Jabbour EJ. Long term outcome of Hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse. Blood Adv. e-Pub 2021. PMID: 34464974.
233. Pemmaraju N, Carter BZ, Bose P, Jain N, Kadia TM, Garcia-Manero G, Bueso-Ramos CE, DiNardo CD, Bledsoe S, Daver NG, Popat U, Konopleva MY, Zhou L, Pierce S, Estrov ZE, Borthakur GM, Ohanian M, Qiao W, Masarova L, Wang X, Mak PY, Cortes J, Jabbour E, Verstovsek S. Final results of a phase 2 clinical trial of LCL161, an oral SMAC mimetic for patients with myelofibrosis. Blood Adv 5(16):3163-3173, 2021. e-Pub 2021. PMID: 34424319.
234. Chien KS, Kim K, Nogueras-Gonzalez GM, Borthakur G, Naqvi K, Daver NG, Montalban-Bravo G, Cortes JE, DiNardo CD, Jabbour E, Alvarado Y, Andreeff M, Bose P, Jain N, Kadia TM, Huang X, Sheppard KB, Klingner-Winton C, Pierce SA, Dong XQ, Soltysiak KA, Kantarjian HM, Garcia-Manero G. Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome. Br J Haematol. e-Pub 2021. PMID: 34340254.
235. Yanik EL, Keener JD, Lin SJ, Colditz GA, Wright RW, Evanoff BA, Jain NB, Saccone NL. Identification of a Novel Genetic Marker for Risk of Degenerative Rotator Cuff Disease Surgery in the UK Biobank. J Bone Joint Surg Am 103(14):1259-1267, 2021. e-Pub 2021. PMID: 33979311.
236. Short NJ, Konopleva M, Kadia T, Kebriaei P, Daver N, Huang X, Masarova L, Cook R, Jain N, Jabbour E, Kantarjian H, Ravandi F. An effective chemotherapy-free regimen of ponatinib plus venetoclax for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Am J Hematol 96(7):E229-E232, 2021. e-Pub 2021. PMID: 33780038.
237. Niswander LM, Loftus JP, É L, Caye-Eude A, Pondrom M, Hottman DA, Iacobucci I, Mullighan CG, Jain N, Konopleva M, Cavé H, Baruchel A, Rohrlich PS, Tasian SK. Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia. Haematologica. e-Pub 2021. PMID: 34196168.
238. Jabbour E, Patel K, Jain N, Duose D, Luthra R, Short NJ, Zugmaier G, San Lucas A, Velasco K, Tran Q, Zaman F, Konopleva M, Kantarjian H. Impact of Philadelphia chromosome-like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study. Am J Hematol. e-Pub 2021. PMID: 34161631.
239. Jain N, Keating M, Thompson P, Ferrajoli A, Burger JA, Borthakur G, Takahashi K, Estrov Z, Sasaki K, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang SA, Garg N, Wang X, Wei C, Cruz N, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda WG. Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial. JAMA Oncol. e-Pub 2021. PMID: 34110383.
240. Sasaki K, Kantarjian HM, Morita K, Short NJ, Konopleva M, Jain N, Ravandi F, Garcia-Manero G, Wang S, Khoury JD, Jorgensen JL, Champlin RE, Khouri IF, Kebriaei P, Schroeder HM, Khouri M, Garris R, Takahashi K, O'Brien SM, Jabbour EJ. Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis. Cancer. e-Pub 2021. PMID: 34138471.
241. Jain N. How I manage chronic lymphocytic leukemia. Clin Adv Hematol Oncol 19(6):360-364, 2021. e-Pub 2021. PMID: 34106909.
242. Pemmaraju N, Wilson NR, Khoury JD, Jain N, Daver NG, Pierce SR, Jabbour EJ, Kadia TM, DiNardo CD, Garcia-Manero G, Qazilbash MH, Konopleva MY, Kantarjian HM. Central Nervous System Involvement in Blastic Plasmacytoid Dendritic Cell Neoplasm. Blood. e-Pub 2021. PMID: 34098573.
243. Song A, Kim P, Ayers G, Jain N. Characteristics of Non-Spine Musculoskeletal Ambulatory Care Visits in the United States, 2009-2016. PM R 13(5):443-452, 2021. e-Pub 2021. PMID: 32888395.
244. Jain N, Maiti A, Ravandi F, Konopleva M, Daver N, Kadia T, Pemmaraju N, Short N, Kebriaei P, Ning J, Cortes J, Jabbour E, Kantarjian H. Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. Am J Hematol. e-Pub 2021. PMID: 33991360.
245. Cherng HJ, Jammal N, Paul S, Wang X, Sasaki K, Thompson P, Burger J, Ferrajoli A, Estrov Z, O'Brien S, Keating M, Wierda WG, Jain N. Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia. Br J Haematol. e-Pub 2021. PMID: 33973230.
246. Jain N, Thompson P, Burger J, Ferrajoli A, Takahashi K, Estrov Z, Borthakur G, Bose P, Kadia T, Pemmaraju N, Sasaki K, Konopleva M, Jabbour E, Garg N, Wang X, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang S, Lopez W, Ayala A, Plunkett W, Gandhi V, Kantarjian H, O'Brien S, Keating M, Wierda WG. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia. e-Pub 2021. PMID: 34007049.
247. DiNardo CD, Lachowiez CA, Takahashi K, Loghavi S, Xiao L, Kadia T, Daver N, Adeoti M, Short NJ, Sasaki K, Wang S, Borthakur G, Issa G, Maiti A, Alvarado Y, Pemmaraju N, Montalban Bravo G, Masarova L, Yilmaz M, Jain N, Andreeff M, Jabbour E, Garcia-Manero G, Kornblau S, Ravandi F, Konopleva MY, Kantarjian HM. Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. J Clin Oncol:JCO2003736. e-Pub 2021. PMID: 34043428.
248. Grusky AZ, Song A, Kim P, Ayers GD, Higgins LD, Kuhn JE, Baumgarten KM, Matzkin E, Jain NB. Factors Associated With Symptomatic Rotator Cuff Tears: The Rotator Cuff Outcomes Workgroup Cohort Study. Am J Phys Med Rehabil 100(4):331-336, 2021. e-Pub 2021. PMID: 33443862.
249. Yang AJ, Haring RS, Swenson TL, Jain NB. Factors Influencing Fellowship Decision Making During Physical Medicine & Rehabilitation Residency. Am J Phys Med Rehabil 100(4):396-401, 2021. e-Pub 2021. PMID: 33002916.
250. Swaminathan M, Kantarjian HM, Levis M, Guerra V, Borthakur G, Alvarado Y, DiNardo CD, Kadia T, Garcia-Manero G, Ohanian M, Daver N, Konopleva M, Pemmaraju N, Ferrajoli A, Andreeff M, Jain N, Estrov Z, Jabbour EJ, Wierda WG, Pierce S, Pinsoy MR, Xiao L, Ravandi F, Cortes JE. A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Haematologica. e-Pub 2021. PMID: 33853292.
251. Morita K, Kantarjian HM, Sasaki K, Issa GC, Jain N, Konopleva M, Short NJ, Takahashi K, DiNardo CD, Kadia TM, Garcia-Manero G, Daver N, Montalban Bravo G, Cortes JE, Ravandi F, Jabbour E. Outcome of patients with chronic myeloid leukemia in lymphoid blastic phase and Philadelphia chromosome-positive acute lymphoblastic leukemia treated with hyper-CVAD and dasatinib. Cancer. e-Pub 2021. PMID: 33823073.
252. Sasaki K, Kantarjian HM, Short NJ, Samra B, Khoury JD, Kanagal Shamanna R, Konopleva M, Jain N, DiNardo CD, Khouri R, Garcia-Manero G, Kadia TM, Wierda WG, Khouri IF, Kebriaei P, Mehta RS, Champlin RE, Garris R, Cheung CM, Daver N, Thompson PA, Yilmaz M, Ravandi F, Jabbour E. Prognostic factors for progression in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors. Cancer. e-Pub 2021. PMID: 33793964.
253. Kadia TM, Ravandi F, Borthakur G, Konopleva M, DiNardo CD, Daver N, Pemmaraju N, Kanagal-Shamanna R, Wang X, Huang X, Pierce S, Rausch C, Burger J, Ferrajoli A, Jain N, Popat U, Estrov Z, Verstovsek S, Jabbour E, Garcia-Manero G, Kantarjian H. Long-term results of low-intensity chemotherapy with clofarabine or cladribine combined with low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia. Am J Hematol. e-Pub 2021. PMID: 33901324.
254. Maiti A, DiNardo CD, Wang SA, Jorgensen J, Kadia TM, Daver NG, Short NJ, Yilmaz M, Pemmaraju N, Borthakur G, Bose P, Issa GC, Ferrajoli A, Jabbour EJ, Jain N, Garcia-Manero G, Ohanian M, Takahashi K, Montalban-Bravo G, Masarova L, Burger JA, Thompson PA, Verstovsek S, Sasaki K, Andreeff M, Rausch CR, Montalbano KS, Pierce S, Qiao W, Ning J, Kantarjian HM, Konopleva MY, Ravandi F. Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia. Blood Adv 5(7):1876-1883, 2021. e-Pub 2021. PMID: 33792630.
255. Mishra RK, Jain N, Goyal K, Kedia S. Non-infectious fever in cerebral arteriovenous malformation: Central fever or paroxysmal sympathetic hyperactivity. Indian J Anaesth 65(Suppl 1):S55-S57, 2021. e-Pub 2021. PMID: 33814594.
256. Byrd JC, Woyach JA, Furman RR, Martin P, O'Brien S, Brown JR, Stephens DM, Barrientos J, Devereux S, Hillmen P, Pagel JM, Hamdy A, Izumi R, Patel P, Wang MH, Jain N, Wierda WG. Acalabrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia. Blood. e-Pub 2021. PMID: 33786588.
257. Koller P, Saliba RM, Ledesma C, Rondon G, Popat U, Alousi A, Mehta R, Oran B, Olson A, Hosing C, Qazilbash M, Khouri I, Ciurea S, Shpall E, Jorgensen J, Wang S, Jain N, Jabbour E, Kantarjian H, Champlin R, Konopleva M, Kebriaei P. Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. e-Pub 2021. PMID: 33767403.
258. Jabbour E, Sasaki K, Short NJ, Ravandi F, Huang X, Khoury JD, Kanagal-Shamanna R, Jorgensen J, Khouri IF, Kebriaei P, Jain N, Alvarado Y, Kadia TM, Paul S, Garcia-Manero G, Dabaja BS, Burger JA, DiNardo CD, Daver NA, Montalban-Bravo G, Yilmaz M, Ohanian M, Ferrajoli A, Jacob J, Rostykus M, Garris R, O'Brien S, Kantarjian HM. Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia. Cancer. e-Pub 2021. PMID: 33740268.
259. Sasaki K, Jabbour E, Short NJ, Jain N, Ravandi F, Pui CH, Kantarjian H. Acute lymphoblastic leukemia: A population- based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017. Am J Hematol. e-Pub 2021. PMID: 33709456.
260. Rozovski U, Harris DM, Li P, Liu Z, Jain P, Manshouri T, Veletic I, Ferrajoli A, Bose P, Thompson P, Jain N, Verstovsek S, Wierda W, Keating MJ, Estrov Z. STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells. Oncotarget 12(5):401-411, 2021. e-Pub 2021. PMID: 33747356.
261. Fiskus W, Mill CP, Perera D, Birdwell C, Deng Q, Yang H, Lara BH, Jain N, Burger J, Ferrajoli A, Davis JA, Saenz DT, Jin W, Coarfa C, Crews CM, Green MR, Khoury JD, Bhalla KN. BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma. Leukemia. e-Pub 2021. PMID: 33654205.
262. Maiti A, DiNardo CD, Daver NG, Rausch CR, Ravandi F, Kadia TM, Pemmaraju N, Borthakur G, Bose P, Issa GC, Short NJ, Yilmaz M, Montalban-Bravo G, Ferrajoli A, Jabbour EJ, Jain N, Ohanian M, Takahashi K, Thompson PA, Loghavi S, Montalbano KS, Pierce S, Wierda WG, Kantarjian HM, Konopleva MY. Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia. Blood Cancer J 11(2):25, 2021. e-Pub 2021. PMID: 33563904.
263. Kain K 2nd, Jain N, O' Brien K. Findings of subarachnoid fat after trauma to a tarlov cyst. Radiol Case Rep 16(2):258-261, 2021. e-Pub 2021. PMID: 33299505.
264. Morita K, Jain N, Kantarjian H, Takahashi K, Fang H, Konopleva M, El Hussein S, Wang F, Short NJ, Maiti A, Sasaki K, Garcia-Manero G, Konoplev S, Ravandi F, Khoury JD, Jabbour E. Outcome of T-cell Acute Lymphoblastic Leukemia/Lymphoma: Focus on Near-ETP Phenotype & Differential Impact of Nelarabine. Am J Hematol. e-Pub 2021. PMID: 33639000.
265. Gehring T, Lupo C, Kordts A, Solar Nikolic D, Jain N, Rydberg T, Pedersen TB, Pirandola S, Andersen UL. Homodyne-based quantum random number generator at 2.9 Gbps secure against quantum side-information. Nat Commun 12(1):605, 2021. e-Pub 2021. PMID: 33504789.
266. Abou Dalle I, Kantarjian HM, Ravandi F, Daver N, Wang X, Jabbour E, Estrov Z, DiNardo CD, Pemmaraju N, Ferrajoli A, Jain N, Wang SA, Jammal N, Borthakur G, Naqvi K, Pelletier S, Pierce S, Andreeff M, Garcia-Manero G, Cortes JE, Kadia TM. Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission. Cancer. e-Pub 2021. PMID: 33449377.
267. Nicolozakes CP, Li X, Uhl TL, Marra G, Jain NB, Perreault EJ, Seitz AL. Interprofessional Inconsistencies in the Diagnosis of Shoulder Instability: Survey Results of Physicians and Rehabilitation Providers. Int J Sports Phys Ther 16(4):1115-1125, 2021. e-Pub 2021. PMID: 34386289.
268. Schneider BJ, Haring RS, Song A, Kim P, Ayers GD, Kennedy DJ, Jain NB. Characteristics of ambulatory spine care visits in the United States, 2009-2016. J Back Musculoskelet Rehabil 34(4):657-664, 2021. e-Pub 2021. PMID: 33720875.
269. Koller PB, Zhang H, Kantarjian H, Jabbour E, Pierce S, Gocho Y, Roberts KG, Yang W, Mullighan CG, Yang J, Konopleva M, Jain N. GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis. Am J Hematol. e-Pub 2020. PMID: 33275800.
270. Maiti A, Qiao W, Sasaki K, Ravandi F, Kadia TM, Jabbour EJ, Daver NG, Borthakur G, Garcia-Manero G, Pierce SA, Montalbano KS, Pemmaraju N, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Takahashi K, Yilmaz M, Jain N, Kornblau SM, Andreeff M, Bose P, Ferrajoli A, Issa GC, Masarova L, Thompson PA, Rausch CR, Ning J, Kantarjian HM, DiNardo CD, Konopleva MY. Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality. Am J Hematol. e-Pub 2020. PMID: 33264443.
271. Benjamin R, Graham C, Yallop D, Jozwik A, Mirci-Danicar OC, Lucchini G, Pinner D, Jain N, Kantarjian H, Boissel N, Maus MV, Frigault MJ, Baruchel A, Mohty M, Gianella-Borradori A, Binlich F, Balandraud S, Vitry F, Thomas E, Philippe A, Fouliard S, Dupouy S, Marchiq I, Almena-Carrasco M, Ferry N, Arnould S, Konto C, Veys P, Qasim W, Group U. Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies. Lancet 396(10266):1885-1894, 2020. e-Pub 2020. PMID: 33308471.
272. Gao C, Fan R, Ayers GD, Giri A, Harris K, Atreya R, Teixeira PL, Jain NB. Development and Validation of an Electronic Medical Record Algorithm to Identify Phenotypes of Rotator Cuff Tear. PM R 12(11):1099-1105, 2020. e-Pub 2020. PMID: 32198840.
273. Khanna K, Mofakham FA, Gandhi D, Jain N. Desmoid fibromatosis of the pancreas--A case report with radiologic-pathologic correlation. Radiol Case Rep 15(11):2324-2328, 2020. e-Pub 2020. PMID: 32994833.
274. Gupta SK, Jain N, Tang G, Futreal A, Wang SA, Khoury JD, Yang RK, Fang H, Patel KP, Luthra R, Routbort M, Barkoh BA, Chen W, Mao X, Zhang J, Medeiros LJ, Bueso-Ramos CE, Loghavi S. A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment Implications. J Natl Compr Canc Netw 18(10):1300-1304, 2020. e-Pub 2020. PMID: 33022638.
275. Ross AH, Downey L, Devonport H, Gale RP, Kotagiri A, Mahmood S, Mehta H, Narendran N, Patel PJ, Parmar N, Jain N. Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degeneration. Eye (Lond) 34(10):1825-1834, 2020. e-Pub 2020. PMID: 31900438.
276. Lyapichev KA, Sukswai N, Angelova E, Kersh MJ, Pierce S, Konopleva M, Jain N, Jabbour EJ, Jorgensen JL, Wang SA, Medeiros LJ, Khoury JD, Konoplev S. CD123 Expression in Philadelphia Chromosome-like B Acute Lymphoblastic Leukemia/Lymphoma. Clin Lymphoma Myeloma Leuk. e-Pub 2020. PMID: 33129747.
277. Sivina M, Xiao L, Kim E, Vaca A, Chen SS, Keating MJ, Ferrajoli A, Estrov Z, Jain N, Wierda WG, Huang X, Chiorazzi N, Burger JA. CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia. Leukemia. e-Pub 2020. PMID: 33087831.
278. Cherng HJ, Jain N, Thakral B, Muzzafar T, Miranda RN, Tan D, Rashid A, Kalhor N, Hahn AW, Byers LA, Parseghian CM, Ferrajoli A, Pemmaraju N. Metastatic lung adenocarcinoma mimicking Richter transformation in a patient with chronic lymphocytic leukemia. Leuk Res 98:106445. e-Pub 2020. PMID: 32937250.
279. Yilmaz M, Kantarjian HM, Toruner G, Yin CC, Kanagal-Shamanna R, Cortes JE, Issa G, Short NJ, Khoury JD, Garcia-Manero G, Ravandi F, Kadia T, Konopleva M, Wierda WG, Jain N, Estrov Z, Sasaki K, Pierce S, O'Brien SM, Jabbour EJ. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis. Leuk Lymphoma:1-5. e-Pub 2020. PMID: 32955970.
280. Hampel PJ, Cherng HJ, Call TG, Ding W, Khanlari M, McPhail ED, Miranda RN, Lin P, Tawbi HA, Ferrajoli A, Wierda WG, Jain N, Parikh SA. Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib. Blood Adv 4(18):4508-4511, 2020. e-Pub 2020. PMID: 32946567.
281. Hans SS, Lee MM, Jain N. Ureteral stenosis following iliac artery stenting. J Vasc Surg Cases Innov Tech 6(3):469-472, 2020. e-Pub 2020. PMID: 32923750.
282. John TM, Malek AE, Mulanovich VE, Adachi JA, Raad II, Hamilton AR, Shpall EJ, Rezvani K, Aitken SL, Jain N, Klein K, Martinez F, Jacob CN, Cherian SV, Manzano JM, Muthu M, Wegner R. Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc 95(9):2038-2040, 2020. e-Pub 2020. PMID: 32861345.
283. DiNardo CD, Maiti A, Rausch CR, Pemmaraju N, Naqvi K, Daver NG, Kadia TM, Borthakur G, Ohanian M, Alvarado Y, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M, Bose P, Jabbour EJ, Takahashi K, Burger JA, Garcia-Manero G, Jain N, Kornblau SM, Thompson PA, Estrov Z, Masarova L, Sasaki K, Verstovsek S, Ferrajoli A, Weirda WG, Wang SA, Konoplev S, Chen Z, Pierce SA, Ning J, Qiao W, Ravandi F, Andreeff M, Welch JS, Kantarjian HM, Konopleva MY. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial. Lancet Haematol. e-Pub 2020. PMID: 32896301.
284. Song A, DeClercq J, Ayers GD, Higgins LD, Kuhn JE, Baumgarten KM, Matzkin E, Jain NB. Comparative Time to Improvement in Nonoperative and Operative Treatment of Rotator Cuff Tears. J Bone Joint Surg Am 102(13):1142-1150, 2020. e-Pub 2020. PMID: 32618921.
285. Jabbour E, Richard-Carpentier G, Sasaki Y, Konopleva M, Patel K, Roberts K, Gu Z, Wang F, Huang X, Sasaki K, Short NJ, Jain N, Ravandi F, Daver NG, Kadia TM, Alvarado Y, DiNardo CD, Issa GC, Pemmaraju N, Garcia-Manero G, Verstovsek S, Wang S, Khoury JD, Jorgensen J, Champlin R, Khouri I, Kebriaei P, Schroeder H, Khouri M, Mullighan CG, Takahashi K, O'Brien SM, Kantarjian H. Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial. Lancet Haematol 7(7):e523-e533, 2020. e-Pub 2020. PMID: 32589978.
286. Sasaki K, Kantarjian H, Wierda W, Ravandi-Kashani F, Jorgensen J, Wang SA, Khoury J, Daver N, Burger J, Di Nardo CD, Jain N, Short NJ, Estrov Md Z, Konopleva Md PhD M, Ohanian DO M, Garcia-Manero G, Kadia T, Alvarado-Valero Y, Yilmaz M, Pierce S, Garris R, Ingram A, Cortes J, O'Brien S, Jabbour E. Phase 2 Study of Hyper-CMAD with Liposomal Vincristine for Patients with Newly Diagnosed Acute Lymphoblastic Leukemia. Am J Hematol 95(7):734-739, 2020. e-Pub 2020. PMID: 32170867.
287. Pandey RK, DiPippo A, Kadia T, Pemmaraju N, Workeneh BT, Jabbour E, Ravandi F, Jain N. Nelarabine-related rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia. Leuk Lymphoma:1-3. e-Pub 2020. PMID: 32654562.
288. Alotaibi AS, Abdulrazzaq M, Patel KP, Ravandi F, Konoplev S, Bueso-Ramos C, Yin CC, Muzzafar T, Tang G, Futreal A, Jain N, Konopleva MY, Pemmaraju N. Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant. Leuk Lymphoma:1-3. e-Pub 2020. PMID: 32657180.
289. Paul S, Jammal N, Akhave N, Aung PP, Loghavi S, Jain N, Garcia-Manero G, Borthakur G, Verstovsek S, Jabbour E, Adachi J, Masarova L, Daver N, Ravandi F, Pemmaraju N. Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol. e-Pub 2020. PMID: 32686139.
290. Issa GC, Kantarjian HM, Xiao L, Ning J, Alvarado Y, Borthakur G, Daver N, DiNardo CD, Jabbour E, Bose P, Jain N, Kadia TM, Naqvi K, Pemmaraju N, Takahashi K, Verstovsek S, Andreeff M, Kornblau SM, Estrov Z, Ferrajoli A, Garcia-Manero G, Ohanian M, Wierda WG, Ravandi F, Cortes JE. Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality. Leukemia. e-Pub 2020. PMID: 32546726.
291. Maiti A, Rausch CR, Cortes JE, Pemmaraju N, Daver NG, Ravandi F, Garcia-Manero G, Borthakur G, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Kadia TM, Takahashi K, Yilmaz M, Jain N, Kornblau S, Montalban Bravo G, Sasaki K, Andreeff M, Bose P, Ferrajoli A, Issa GC, Jabbour EJ, Masarova L, Thompson PA, Wang S, Konoplev S, Pierce SA, Ning J, Qiao W, Welch JS, Kantarjian HM, DiNardo CD, Konopleva MY. Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens. Haematologica. e-Pub 2020. PMID: 32499238.
292. Samra B, Alotaibi AS, Short NJ, Khoury JD, Ravandi F, Garris R, Jain N, Konopleva M, Kantarjian H, Jabbour E. Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. Am J Hematol. e-Pub 2020. PMID: 32501545.
293. Frei M, Aitken SL, Jain N, Thompson P, Wierda W, Kontoyiannis DP, DiPippo AJ. Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinib. Leuk Lymphoma:1-4. e-Pub 2020. PMID: 32530347.
294. Jain NB, Borg-Stein J, Miranda-Comas G, Micheo W, Visco C, Fredericson M. Recommendations for Enhancing Sports Medicine Fellowship Training. Am J Phys Med Rehabil 99(4):348-352, 2020. e-Pub 2020. PMID: 31738281.
295. Richard-Carpentier G, Jabbour E, Short NJ, Rausch CR, Savoy JM, Bose P, Yilmaz M, Jain N, Borthakur G, Ohanian M, Alvarado Y, Rytting M, Kebriaei P, Konopleva M, Kantarjian H, Ravandi F. Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 20(4):212-218, 2020. e-Pub 2020. PMID: 32035785.
296. Cleland T, Jain NB, Chae J, Hansen KM, Hisel TZ, Gunzler DD, Whitehair VC, Kim CH, Wilson RD. The protocol for a multisite, double blind, randomized, placebo-controlled trial of axillary nerve stimulation for chronic shoulder pain. Trials 21(1):248, 2020. e-Pub 2020. PMID: 32143732.
297. Yanik EL, Colditz GA, Wright RW, Saccone NL, Evanoff BA, Jain NB, Dale AM, Keener JD. Risk factors for surgery due to rotator cuff disease in a population-based cohort. Bone Joint J 102-B(3):352-359, 2020. e-Pub 2020. PMID: 32114822.
298. Cahill KE, Karimi YH, Karrison TG, Jain N, Green M, Weiner H, Fulton N, Kadri S, Godley LA, Artz AS, Liu H, Thirman MJ, Le Beau MM, McNerney ME, Segal J, Larson RA, Stock W, Odenike O. A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia. Blood Adv 4(4):599-606, 2020. e-Pub 2020. PMID: 32074275.
299. Strati P, Schlette EJ, Solis Soto LM, Duenas DE, Sivina M, Kim E, Keating MJ, Wierda WG, Ferrajoli A, Kantarjian H, Estrov Z, Jain N, Thompson PA, Wistuba II, Burger JA. Achieving Complete Remission in CLL Patients Treated with Ibrutinib: Clinical Significance and Predictive Factors. Blood 135(7):510-513, 2020. e-Pub 2020. PMID: 31895947.
300. Jain N, Stock W, Zeidan A, Atallah E, McCloskey J, Heffner L, Tomlinson B, Bhatnagar B, Feingold J, Ungar D, Chao G, Zhang X, Qin Y, Havenith K, Kantarjian H, Wieduwilt MJ. Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia. Blood Adv 4(3):449-457, 2020. e-Pub 2020. PMID: 32012214.
301. Yilmaz M, Kantarjian H, Wang X, Khoury JD, Ravandi F, Jorgensen J, Short NJ, Loghavi S, Cortes J, Garcia-Manero G, Kadia T, Sasaki K, Konopleva M, Takahashi K, Wierda W, Jain N, Verstovsek S, Estrov Z, Bose P, Pierce S, Garris R, O'Brien S, Jabbour E. The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival. Am J Hematol 95(2):144-150, 2020. e-Pub 2020. PMID: 31682008.
302. Bose P, Verstovsek S, Cortes JE, Tse S, Gasior Y, Jain N, Jabbour EJ, Estrov Z, Alvarado Y, DiNardo CD, Pemmaraju N, Kornblau SM, Kadia TM, Daver NG, Naqvi K, Short NJ, Masarova L, Villareal J, Pierce SA, Nogueras-Gonzalez G, Huang X, Garcia-Manero G, Kantarjian HM, Ravandi F. A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia. Leukemia. e-Pub 2020. PMID: 32099037.
303. Alfayez M, Thakral B, Jain P, Ravandi F, Ferrajoli A, Jain N, Pemmaraju N, Wierda W, Kadia T. First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL). Leuk Lymphoma 61(2):1-5, 2020. e-Pub 2020. PMID: 31566032.
304. Hadid T, Hernandez M, Zeni A, Jain N. Pinch-off syndrome: a rare and serious complication of central venous catheters. BMJ Case Rep 13(1), 2020. e-Pub 2020. PMID: 31937632.
305. Naqvi K, Jabbour E, Skinner J, Anderson K, Dellasala S, Yilmaz M, Ferrajoli A, Bose P, Thompson P, Alvarado Y, Jain N, Takahashi K, Burger J, Estrov Z, Borthakur G, Pemmaraju N, Paul S, Cortes J, Kantarjian HM. Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia. Cancer 126(1):67-75, 2020. e-Pub 2020. PMID: 31553487.
306. Jain NB, Peterson E, Ayers GD, Song A, Kuhn JE. US Geographical Variation in Rates of Shoulder and Knee Arthroscopy and Association With Orthopedist Density. JAMA Netw Open 2(12):e1917315, 2019. e-Pub 2019. PMID: 31825507.
307. Kim E, Ten Hacken E, Sivina M, Clarke A, Thompson PA, Jain N, Ferrajoli A, Estrov Z, Keating MJ, Wierda WG, Bhalla KN, Burger JA. The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment. Leukemia. e-Pub 2019. PMID: 31862959.
308. Abou Dalle I, Kantarjian HM, Short NJ, Konopleva M, Jain N, Garcia-Manero G, Garris R, Qiao W, Cortes JE, O'Brien S, Kebriaei P, Kadia T, Jabbour E, Ravandi F. Philadelphia chromosome-positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors. Am J Hematol 94(12):1388-1395, 2019. e-Pub 2019. PMID: 31595534.
309. Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger JA, Bose P, Thompson PA, Jain N, Wierda WG, Uziel O, Keating MJ, Estrov Z. STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage. J Immunol 203(11):3078-3085, 2019. e-Pub 2019. PMID: 31645416.
310. Jain N, O'Brien S. The Shifting Paradigm in Chronic Lymphocytic Leukemia: Is Chemotherapy Still Relevant?. Cancer J 25(6):374-377, 2019. e-Pub 2019. PMID: 31764117.
311. Thompson PA, Srivastava J, Peterson C, Strati P, Jorgensen JL, Hether T, Keating MJ, O'Brien SM, Ferrajoli A, Burger JA, Estrov Z, Jain N, Wierda WG. Undetectable MRD Using Next Generation Sequencing is Associated With Improved PFS After Treatment with FCR for CLL. Blood 134(22):1951-1959, 2019. e-Pub 2019. PMID: 31537528.
312. Jain N, Keating MJ, Thompson PA, Ferrajoli A, Burger JA, Borthakur GM, Takahashi K, Estrov ZE, Fowler NH, Kadia TM, Konopleva MY, Alvarado Y, Yilmaz M, DiNardo CD, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen JL, Wang SA, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian HM, Gandhi V, Wierda WG. Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL). Blood 134(Supplement_1):34, 2019. e-Pub 2019. PMID: 31724006.
313. Tallis E, Loghavi S, Jorgensen JL, Wang S, Khoury JD, Bueso-Ramos CB, Jain N, Borthakur G, Pemmaraju N. Patient with mixed-phenotype acute leukemia with CBFB rearrangement. Leuk Lymphoma 60(11):1-3, 2019. e-Pub 2019. PMID: 31012358.
314. Jain NB, Ayers GD, Fan R, Kuhn JE, Warner JJP, Baumgarten KM, Matzkin E, Higgins LD. Comparative Effectiveness of Operative Versus Nonoperative Treatment for Rotator Cuff Tears: A Propensity Score Analysis From the ROW Cohort. Am J Sports Med 47(13):3065-3072, 2019. e-Pub 2019. PMID: 31518155.
315. Hu B, Patel KP, Chen HC, Wang X, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating M, Wierda WG. Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients. Br J Haematol 187(3):307-318, 2019. e-Pub 2019. PMID: 31243771.
316. Strati P, Wang F, Tambaro FP, Thompson PA, Burger JA, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Futreal A, Takahashi K, Wierda WG. The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype. Br J Haematol 187(1):e1-e4, 2019. e-Pub 2019. PMID: 31344256.
317. Dabija DI, Guan H, Neviaser A, Jain NB. Readmissions, revisions, and mortality after treatment for proximal humeral fractures in three large states. BMC Musculoskelet Disord 20(1):419, 2019. e-Pub 2019. PMID: 31506075.
318. Boddu P, Schlette E, Thakral B, Tang G, Pemmaraju N, Kadia T, Ferrajoli A, Ravandi F, Wierda W, Jain N. Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia-A case report. Hematol Oncol Stem Cell Ther 12(3):161-165, 2019. e-Pub 2019. PMID: 28830803.
319. Chamoun K, Kantarjian HM, Wang X, Naqvi K, Aung F, Garcia-Manero G, Borthakur G, Jabbour E, Kadia T, Daver N, DiNardo CD, Jain N, Konopleva M, Cortes J, Ravandi F, Yilmaz M. Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia. Cancer 125(18):3219-3224, 2019. e-Pub 2019. PMID: 31150121.
320. Jain NB, Ayers GD, Koudelkova H, Archer KR, Dickinson R, Richardson B, Derryberry M, Kuhn JE. Operative vs Nonoperative Treatment for Atraumatic Rotator Cuff Tears: A Trial Protocol for the Arthroscopic Rotator Cuff Pragmatic Randomized Clinical Trial. JAMA Netw Open 2(8):e199050, 2019. e-Pub 2019. PMID: 31397866.
321. Jain N, Gandhi V, Wierda W. Ibrutinib and Venetoclax for First-Line Treatment of CLL. Reply. N Engl J Med 381(8):789, 2019. e-Pub 2019. PMID: 31433937.
322. Dabija DI, Pennings JS, Archer KR, Ayers GD, Higgins LD, Kuhn JE, Baumgarten KM, Matzkin E, Jain NB. Which Is the Best Outcome Measure for Rotator Cuff Tears?. Clin Orthop Relat Res 477(8):1869-1878, 2019. e-Pub 2019. PMID: 31335605.
323. Dabija DI, Jain NB. Minimal Clinically Important Difference of Shoulder Outcome Measures and Diagnoses: A Systematic Review. Am J Phys Med Rehabil 98(8):671-676, 2019. e-Pub 2019. PMID: 31318747.
324. Ramiro S, Page MJ, Whittle SL, Huang H, Verhagen AP, Beaton DE, Richards P, Voshaar M, Shea B, van der Windt DA, Kopkow C, Lenza M, Jain NB, Richards B, Hill C, Gill TK, Koes B, Foster NE, Conaghan PG, Smith T, Malliaras P, Roe Y, Gagnier JJ, Buchbinder R. The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders. J Rheumatol 46(8):969-975, 2019. e-Pub 2019. PMID: 30709947.
325. Jabbour EJ, Sasaki K, Ravandi F, Short NJ, Garcia-Manero G, Daver N, Kadia T, Konopleva M, Jain N, Cortes J, Issa GC, Jacob J, Kwari M, Thompson P, Garris R, Pemmaraju N, Yilmaz M, O'Brien SM, Kantarjian HM. Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis. Cancer 125(15):2579-2586, 2019. e-Pub 2019. PMID: 30985931.
326. Khogeer H, Rahman H, Jain N, Angelova EA, Yang H, Quesada A, Ok CY, Sui D, Wei P, Al Fattani A, Pierce S, Loghavi S, Lamb A, Hu P, Thakral B, Kanagal-Shamanna R, Jorgensen JL, Jabbour EJ, Kantarjian HM, Medeiros LJ, Khoury JD. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy. Br J Haematol 186(4):538-548, 2019. e-Pub 2019. PMID: 31115909.
327. Kazma J, Johnson C, Jain N, Gali VL, Young KH, Jazaeri AA. B-cell acute lymphoblastic leukemia/lymphoma in relapse presenting as a cervical mass: A case report and review of literature. Gynecol Oncol Rep 29:94-97, 2019. e-Pub 2019. PMID: 31467959.
328. Ragon BK, Odenike O, Baer MR, Stock W, Borthakur G, Patel K, Han L, Chen H, Ma H, Joseph L, Zhao Y, Baggerly K, Konopleva M, Jain N. Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study. Clin Lymphoma Myeloma Leuk 19(7):431-440.e13, 2019. e-Pub 2019. PMID: 31056348.
329. Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, Oo TH. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther 12(2):115-118, 2019. e-Pub 2019. PMID: 29409729.
330. Hu B, Patel KP, Chen HC, Wang X, Wang F, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Wierda WG. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. Br J Haematol 185(5):852-864, 2019. e-Pub 2019. PMID: 30924136.
331. Jain N. Optimizing drug dosing for the treatment of chronic lymphocytic leukemia. Clin Adv Hematol Oncol 17(6):330-331, 2019. e-Pub 2019. PMID: 31437134.
332. Dickinson RN, Ayers GD, Archer KR, Fan R, Page C, Higgins LD, Kuhn JE, Baumgarten KM, Matzkin E, Jain NB. Physical therapy versus natural history in outcomes of rotator cuff tears: the Rotator Cuff Outcomes Workgroup (ROW) cohort study. J Shoulder Elbow Surg 28(5):833-838, 2019. e-Pub 2019. PMID: 30553798.
333. Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W. Ibrutinib and Venetoclax for First-Line Treatment of CLL. N Engl J Med 380(22):2095-2103, 2019. e-Pub 2019. PMID: 31141631.
334. Brown PA, Wieduwilt M, Logan A, DeAngelo DJ, Wang ES, Fathi A, Cassaday RD, Litzow M, Advani A, Aoun P, Bhatnagar B, Boyer MW, Bryan T, Burke PW, Coccia PF, Coutre SE, Jain N, Kirby S, Liu A, Massaro S, Mattison RJ, Oluwole O, Papadantonakis N, Park J, Rubnitz JE, Uy GL, Gregory KM, Ogba N, Shah B. Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2019. J Natl Compr Canc Netw 17(5):414-423, 2019. e-Pub 2019. PMID: 31085755.
335. Strati P, Takahashi K, Peterson CB, Keating MJ, Thompson PA, Daver NG, Jain N, Burger JA, Estrov Z, O'Brien SM, Kantarjian HM, Wierda WG, Futreal PA, Ferrajoli A. Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL. Blood Adv 3(9):1533-1539, 2019. e-Pub 2019. PMID: 31076409.
336. Kantarjian HM, Jabbour EJ, Garcia-Manero G, Kadia TM, DiNardo CD, Daver NG, Borthakur G, Jain N, Waukau JB, Kwari MI, Ravandi F, Anderson BD, Iizuka K, Jin C, Zhang C, Plunkett WK. Phase 1/2 study of DFP-10917 administered by continuous intravenous infusion in patients with recurrent or refractory acute myeloid leukemia. Cancer 125(10):1665-1673, 2019. e-Pub 2019. PMID: 30668890.
337. Paul S, Jain N, Ferrajoli A, O'Brien S, Burger J, Keating M, Wierda W. A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia. Br J Haematol 185(3):606-608, 2019. e-Pub 2019. PMID: 30406944.
338. Kumar A, Agarwal A, Sharma A, Agarwal D, Jain N, Gupta P. Myxoedema coma following commencement of anti-TNF therapy and tuberculosis prophylaxis in a patient with RA and latent tuberculosis infection. Postgrad Med J 95(1123):281, 2019. e-Pub 2019. PMID: 31085622.
339. Gale RP, Mahmood S, Devonport H, Patel PJ, Ross AH, Walters G, Downey L, El-Sherbiny S, Freeman M, Berry S, Jain N. Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service. Eye (Lond) 33(Suppl 1):1-21, 2019. e-Pub 2019. PMID: 30926932.
340. Jain N, Friedman SH. Multiple weak intercalation as a strategy for the inhibition of polymerases. Bioorg Med Chem Lett 29(3):424-429, 2019. e-Pub 2019. PMID: 30579791.
341. Chamoun K, Kantarjian H, Atallah R, Gonzalez GN, Issa GC, Rios MB, Garcia-Manero G, Borthakur G, Ravandi F, Jain N, Daver N, Konopleva M, DiNardo CD, Kadia T, Pemmaraju N, Jabbour E, Cortes J. Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience. J Hematol Oncol 12(1):1, 2019. e-Pub 2019. PMID: 30606227.
342. Short NJ, Kantarjian HM, Loghavi S, Huang X, Qiao W, Borthakur G, Kadia TM, Daver N, Ohanian M, Dinardo CD, Estrov Z, Kanagal-Shamanna R, Maiti A, Benton CB, Bose P, Alvarado Y, Jabbour E, Kornblau SM, Pemmaraju N, Jain N, Gasior Y, Richie MA, Pierce S, Cortes J, Konopleva M, Garcia-Manero G, Ravandi F. Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial. Lancet Haematol 6(1):e29-e37, 2019. e-Pub 2019. PMID: 30545576.
343. Kanagal-Shamanna R, Jain P, Patel KP, Routbort M, Bueso-Ramos C, Alhalouli T, Khoury JD, Luthra R, Ferrajoli A, Keating M, Jain N, Burger J, Estrov Z, Wierda W, Kantarjian HM, Medeiros LJ. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation. Cancer. e-Pub 2018. PMID: 30508305.
344. Jabbour E, Short NJ, Ravandi F, Huang X, Daver N, DiNardo CD, Konopleva M, Pemmaraju N, Wierda W, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Khoury JD, Jorgensen J, Jain N, Alvarez J, O'Brien S, Kantarjian H. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study. Lancet Haematol 5(12):e618-e627, 2018. e-Pub 2018. PMID: 30501869.
345. Burger JA, Sivina M, Jain N, Kim E, Kadia T, Estrov Z, Nogueras-Gonzalez GM, Huang X, Jorgensen J, Li J, Cheng M, Clow F, Ohanian M, Andreeff M, Mathew T, Thompson P, Kantarjian H, O'Brien S, Wierda WG, Ferrajoli A, Keating MJ. Randomized trial of ibrutinib versus ibrutinib plus rituximab in patients with chronic lymphocytic leukemia. Blood. e-Pub 2018. PMID: 30530801.
346. Boddu P, Thakral B, Alhuraiji A, Pemmaraju N, Kadia T, Ohanian M, Ravandi F, Jabbour E, Wierda W, Khoury JD, Jain N. Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation. J Clin Pathol. e-Pub 2018. PMID: 30467242.
347. Chen LS, Bose P, Cruz ND, Jiang Y, Wu Q, Thompson PA, Feng S, Kroll MH, Qiao W, Huang X, Jain N, Wierda WG, Keating MJ, Gandhi V. A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia. Blood 132(21):2249-2259, 2018. e-Pub 2018. PMID: 30254130.
348. Liu Z, Lemmonds S, Huang J, Tyagi M, Hong L, Jain N. Entropic contribution to enhanced thermal stability in the thermostable P450 CYP119. Proc Natl Acad Sci U S A 115(43):E10049-E10058, 2018. e-Pub 2018. PMID: 30297413.
349. Jabbour E, Sasaki K, Ravandi F, Huang X, Short NJ, Khouri M, Kebriaei P, Burger J, Khoury J, Jorgensen J, Jain N, Konopleva M, Garcia-Manero G, Kadia T, Cortes J, Jacob J, Montalbano K, Garris R, O'Brien S, Kantarjian HM. Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage. Cancer 124(20):4044-4055, 2018. e-Pub 2018. PMID: 30307611.
350. Ok CY, Medeiros LJ, Thakral B, Tang G, Jain N, Jabbour E, Pierce SA, Konoplev S. High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma. Mod Pathol. e-Pub 2018. PMID: 30181564.
351. Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z. STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells. Oncotarget 9(72):33710-33718, 2018. e-Pub 2018. PMID: 30263097.
352. Jain NB, Ayers GD, Fan R, Kuhn JE, Baumgarten K, Matzkin E, Higgins LD. Predictors of Pain and Functional Outcomes After the Nonoperative Treatment of Rotator Cuff Tears. Orthop J Sports Med 6(8):2325967118788531, 2018. e-Pub 2018. PMID: 30094270.
353. Jain NB, Ayers GD, Fan R, Kuhn JE, Baumgarten KM, Matzkin E, Higgins LD. Predictors of pain and functional outcomes after operative treatment for rotator cuff tears. J Shoulder Elbow Surg 27(8):1393-1400, 2018. e-Pub 2018. PMID: 30016692.
354. O'Brien S, Patel M, Kahl BS, Horwitz SM, Foss FM, Porcu P, Jones J, Burger J, Jain N, Allen K, Faia K, Douglas M, Stern HM, Sweeney J, Kelly P, Kelly V, Flinn I. Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a Phase 1 study. Am J Hematol. e-Pub 2018. PMID: 30094870.
355. Benton CB, Chien KS, Tefferi A, Rodriguez J, Ravandi F, Daver N, Jabbour E, Jain N, Alvarado Y, Kwari M, Pierce S, Maiti A, Hornbaker M, Santos MA, Martinez S, Siguero M, Zblewski D, Al-Kali A, Hogan WJ, Kantarjian H, Pardanani A, Garcia-Manero G. Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome. Hematol Oncol. e-Pub 2018. PMID: 30153704.
356. Jain NB, Fan R, Higgins LD, Kuhn JE, Ayers GD. Does My Patient With Shoulder Pain Have a Rotator Cuff Tear?: A Predictive Model From the ROW Cohort. Orthop J Sports Med 6(7):2325967118784897, 2018. e-Pub 2018. PMID: 30038917.
357. Takahashi K, Wang F, Morita K, Yan Y, Hu P, Zhao P, Zhar AA, Wu CJ, Gumbs C, Little L, Tippen S, Thornton R, Coyle M, Mendoza M, Thompson E, Zhang J, DiNardo CD, Jain N, Ravandi F, Cortes JE, Garcia-Manero G, Kornblau S, Andreeff M, Jabbour E, Bueso-Ramos C, Takaori-Kondo A, Konopleva M, Patel K, Kantarjian H, Futreal PA. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes. Nat Commun 9(1):2670, 2018. e-Pub 2018. PMID: 29991687.
358. Naqvi K, Jabbour E, Skinner J, Yilmaz M, Ferrajoli A, Bose P, Thompson P, Alvarado Y, Jain N, Takahashi K, Burger J, Estrov Z, Borthakur G, Pemmaraju N, Paul S, Cortes J, Kantarjian HM. Early results of lower dose dasatinib (50?mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia. Cancer 124(13):2740-2747, 2018. e-Pub 2018. PMID: 29723397.
359. Assi R, Kantarjian HM, Kadia TM, Pemmaraju N, Jabbour E, Jain N, Daver N, Estrov Z, Uehara T, Owa T, Cortes JE, Borthakur G. Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Cancer 124(13):2758-2765, 2018. e-Pub 2018. PMID: 29660836.
360. Kantarjian HM, DiNardo CD, Nogueras-Gonzalez GM, Kadia TM, Jabbour E, Bueso-Ramos CE, O'Brien SM, Konopleva M, Jain N, Daver NG, Shpall EJ, Champlin RE, Simkins A, Garcia-Manero G, Keating MJ, Huang X, Cortes JE, Pierce SA, Ravandi F, Freireich EJ. Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Cancer 124(12):2534-2540, 2018. e-Pub 2018. PMID: 29645075.
361. Jain NB, Schneider B. In Lumbar Spinal Stenosis, Adding Corticosteroids to Lidocaine Epidural Injections Did Not Improve Pain or Function at 12 Months. J Bone Joint Surg Am 100(10):884, 2018. e-Pub 2018. PMID: 29762288.
362. Jain NB. Do These Crystals Really Sparkle?: Commentary on an article by Philip G. Conaghan, MBBS, PhD, FRACP, FRCP, et al.: "Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain. A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study". J Bone Joint Surg Am 100(8):e56, 2018. e-Pub 2018. PMID: 29664865.
363. Coronado RA, Seitz AL, Pelote E, Archer KR, Jain NB. Are Psychosocial Factors Associated With Patient-reported Outcome Measures in Patients With Rotator Cuff Tears? A Systematic Review. Clin Orthop Relat Res 476(4):810-829, 2018. e-Pub 2018. PMID: 29481342.
364. Kondo K, Shaim H, Thompson PA, Burger JA, Keating M, Estrov Z, Harris D, Kim E, Ferrajoli A, Daher M, Basar R, Muftuoglu M, Imahashi N, Alsuliman A, Sobieski C, Gokdemir E, Wierda W, Jain N, Liu E, Shpall EJ, Rezvani K. Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. Leukemia 32(4):960-970, 2018. e-Pub 2018. PMID: 28972595.
365. Thompson PA, Peterson CB, Strati P, Jorgensen J, Keating MJ, O'Brien SM, Ferrajoli A, Burger JA, Estrov Z, Jain N, Kadia TM, Borthakur G, DiNardo CD, Daver N, Jabbour E, Wierda WG. Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies. Leukemia. e-Pub 2018. PMID: 29769624.
366. Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z. STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells. Oncotarget 9(30):21268-21280, 2018. e-Pub 2018. PMID: 29765537.
367. Takahashi K, Hu B, Wang F, Yan Y, Kim E, Vitale C, Patel KP, Strati P, Gumbs C, Little L, Tippen S, Song X, Zhang J, Jain N, Thompson P, Garcia-Manero G, Kantarjian H, Estrov Z, Do KA, Keating M, Burger JA, Wierda WG, Futreal PA, Ferrajoli A. Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide. Blood 131(16):1820-1832, 2018. e-Pub 2018. PMID: 29358183.
368. Jabbour E, Düll J, Yilmaz M, Khoury JD, Ravandi F, Jain N, Einsele H, Garcia-Manero G, Konopleva M, Short NJ, Thompson PA, Wierda W, Daver N, Cortes J, O'brien S, Kantarjian H, Topp MS. Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression. Am J Hematol 93(3):371-374, 2018. e-Pub 2018. PMID: 29178361.
369. DiNardo CD, Rausch CR, Benton C, Kadia T, Jain N, Pemmaraju N, Daver N, Covert W, Marx KR, Mace M, Jabbour E, Cortes J, Garcia-Manero G, Ravandi F, Bhalla KN, Kantarjian H, Konopleva M. Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. Am J Hematol 93(3):401-407, 2018. e-Pub 2018. PMID: 29218851.
370. Jain N, Vergish S, Khurana JP. Validation of house-keeping genes for normalization of gene expression data during diurnal/circadian studies in rice by RT-qPCR. Sci Rep 8(1):3203, 2018. e-Pub 2018. PMID: 29453432.
371. Strati P, Ferrajoli A, Wierda WG, Jain N, Thompson PA, O'Brien SM, Rezvani K, Kantarjian HM, Burger JA, Hinojosa CO, Keating MJ, Estrov Z. Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia. Leukemia. e-Pub 2018. PMID: 29479067.
372. Kantarjian H, Ravandi F, Short NJ, Huang X, Jain N, Sasaki K, Daver N, Pemmaraju N, Khoury JD, Jorgensen J, Alvarado Y, Konopleva M, Garcia-Manero G, Kadia T, Yilmaz M, Bortakhur G, Burger J, Kornblau S, Wierda W, DiNardo C, Ferrajoli A, Jacob J, Garris R, O'Brien S, Jabbour E. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Lancet Oncol 19(2):240-248, 2018. e-Pub 2018. PMID: 29352703.
373. Flinn IW, O'Brien S, Kahl B, Patel M, Oki Y, Foss FF, Porcu P, Jones J, Burger JA, Jain N, Kelly VM, Allen K, Douglas M, Sweeney J, Kelly P, Horwitz S. Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies. Blood 131(8):877-887, 2018. e-Pub 2018. PMID: 29191916.
374. Neelapu SS, Tummala S, Kebriaei P, Wierda W, Locke FL, Lin Y, Jain N, Daver N, Gulbis AM, Adkins S, Rezvani K, Hwu P, Shpall EJ. Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'. Nat Rev Clin Oncol. e-Pub 2018. PMID: 29434334.
375. Rozovski U, Harris DM, Li P, Liu Z, Jain P, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z. Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia. Leuk Lymphoma:1-6. e-Pub 2018. PMID: 29465264.
376. Zhang Q, Shi C, Han L, Jain N, Roberts KG, Ma H, Cai T, Cavazos A, Tabe Y, Jacamo RO, Mu H, Zhao Y, Wang J, Wu SC, Cao F, Zeng Z, Zhou J, Mi Y, Jabbour EJ, Levine R, Tasian SK, Mullighan CG, Weinstock DM, Fruman DA, Konopleva M. Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade inCRLF2rearranged and/orJAKdriven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia. Oncotarget 9(8):8027-8041, 2018. e-Pub 2018. PMID: 29487712.
377. Jain P, Nogueras González GM, Kanagal-Shamanna R, Rozovski U, Sarwari N, Tam C, Wierda WG, Thompson PA, Jain N, Luthra R, Quesada A, Sanchez-Petitto G, Ferrajoli A, Burger J, Kantarjian H, Cortes J, O'Brien S, Keating MJ, Estrov Z. The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. Br J Haematol 180(1):33-40, 2018. e-Pub 2018. PMID: 29164608.
378. Abaza Y, M Kantarjian H, Faderl S, Jabbour E, Jain N, Thomas D, Kadia T, Borthakur G, D Khoury J, Burger J, Wierda W, O'Brien S, Konopleva M, Ferrajoli A, Kebriaei P, Dabaja B, Kornblau S, Alvarado Y, Daver N, Pemmaraju N, Bose P, Thompson P, Al Azzawi H, Kelly M, Garris R, Jain P, Garcia-Manero G, Cortes J, Ravandi F. Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. Am J Hematol 93(1):91-99, 2018. e-Pub 2018. PMID: 29047158.
379. Jain N, Friedman SH. A Tetra-Orthogonal Strategy for the Efficient Synthesis of Scaffolds Based on Cyclic Peptides. Int J Pept Res Ther 24(4):535-542, 2018. e-Pub 2018. PMID: 30416404.
380. Schliffke S, Sivina M, Kim E, von Wenserski L, Thiele B, Akyüz N, Falker-Gieske C, Statovci D, Oberle A, Thenhausen T, Krohn-Grimberghe A, Bokemeyer C, Jain N, Estrov Z, Ferrajoli A, Wierda W, Keating M, Burger JA, Binder M. Dynamic changes of the normal B lymphocyte repertoire in CLL in response to ibrutinib or FCR chemo-immunotherapy. Oncoimmunology 7(4):e1417720, 2018. e-Pub 2018. PMID: 29632735.
381. Buchbinder R, Page MJ, Huang H, Verhagen AP, Beaton D, Kopkow C, Lenza M, Jain NB, Richards B, Richards P, Voshaar M, van der Windt D, Gagnier JJ. A Preliminary Core Domain Set for Clinical Trials of Shoulder Disorders: A Report from the OMERACT 2016 Shoulder Core Outcome Set Special Interest Group. J Rheumatol 44(12):1880-1883, 2017. e-Pub 2017. PMID: 28089972.
382. Jain NB, Schneider BJ, Kuhn JE, Murrell WD, Stark S, Archer KR. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 99(22):1956-1963, 2017. e-Pub 2017. PMID: 29135672.
383. Boddu P, Shah AR, Borthakur G, Verstovsek S, Garcia-Manero G, Daver N, Kadia T, Ravandi F, Jain N, Alhuraiji A, Burger J, Kornblau S, Pierce S, Dellasala S, Jabbour E, Kantarjian H, Cortes J. Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting. Leuk Lymphoma:1-11. e-Pub 2017. PMID: 28972430.
384. Jain P, Kantarjian H, Jain N, Short NJ, Yin CC, Kanagal-Shamanna R, Khoury J, Konopleva M, Sasaki K, Kadia TM, Garris R, Pierce S, Estrov Z, Wierda W, Cortes J, O'Brien S, Ravandi F, Jabbour E. Clinical characteristics and outcomes of previously untreated patients with adult onset T-ALL and T-lymphoblastic lymphoma (T-LL) with Hyper-CVAD based regimens. Am J Hematol 92(10):E595-E597, 2017. e-Pub 2017. PMID: 28646517.
385. Sajeed S, Minshull C, Jain N, Makarov V. Invisible Trojan-horse attack. Sci Rep 7(1):8403, 2017. e-Pub 2017. PMID: 28827553.
386. Boddu PC, Kantarjian HM, Ravandi F, Garcia-Manero G, Verstovsek S, Jabbour EJ, Takahashi K, Bhalla K, Konopleva M, DiNardo CD, Ohanian M, Pemmaraju N, Jain N, Pierce S, Wierda WG, Cortes JE, Kadia TM. Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach. Cancer 123(16):3050-3060, 2017. e-Pub 2017. PMID: 28387922.
387. Boddu P, Garcia-Manero G, Ravandi F, Borthakur G, Jabbour E, DiNardo C, Jain N, Daver N, Pemmaraju N, Anderlini P, Parmar S, Kc D, Akosile M, Pierce SA, Champlin R, Cortes J, Kantarjian H, Kadia T. Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience. Am J Hematol. e-Pub 2017. PMID: 28850699.
388. Jabbour E, Ravandi F, Kebriaei P, Huang X, Short NJ, Thomas D, Sasaki K, Rytting M, Jain N, Konopleva M, Garcia-Manero G, Champlin R, Marin D, Kadia T, Cortes J, Estrov Z, Takahashi K, Patel Y, Khouri MR, Jacob J, Garris R, O'Brien S, Kantarjian H. Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial. JAMA Oncol. e-Pub 2017. PMID: 28859185.
389. Jain N, Lu X, Daver N, Thakral B, Wang SA, Konoplev S, Patel K, Kanagal-Shamanna R, Valentine M, Tang G, Pemmaraju N, Jorgensen J, Kebriaei P, Nunez CA, Wierda W, Jabbour E, Roberts KG, Mullighan CG, Kantarjian H, Konopleva M. Concurrent diagnosis of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients. Haematologica. e-Pub 2017. PMID: 28860345.
390. Assi R, Kantarjian H, Short NJ, Daver N, Takahashi K, Garcia-Manero G, DiNardo C, Burger J, Cortes J, Jain N, Wierda W, Chamoun S, Konopleva M, Jabbour E. Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia. Clin Lymphoma Myeloma Leuk. e-Pub 2017. PMID: 28927784.
391. Liu Z, Huang J, Tyagi M, O'Neill H, Zhang Q, Mamontov E, Jain N, Wang Y, Zhang J, Smith JC, Hong L. Dynamical Transition of Collective Motions in Dry Proteins. Phys Rev Lett 119(4):048101, 2017. e-Pub 2017. PMID: 29341744.
392. Jabbour E, Short NJ, Ravandi F, Huang X, Xiao L, Garcia-Manero G, Plunkett W, Gandhi V, Sasaki K, Pemmaraju N, Daver NG, Borthakur G, Jain N, Konopleva M, Estrov Z, Kadia TM, Wierda WG, DiNardo CD, Brandt M, O'Brien SM, Cortes JE, Kantarjian H. A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia. Cancer. e-Pub 2017. PMID: 28708931.
393. Short NJ, Kantarjian H, Ravandi F, Huang X, Xiao L, Garcia-Manero G, Plunkett W, Gandhi V, Sasaki K, Pemmaraju N, Daver NG, Borthakur G, Jain N, Konopleva M, Estrov Z, Kadia TM, Wierda WG, DiNardo CD, Brandt M, O'Brien SM, Cortes JE, Jabbour E. A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia. Leuk Lymphoma:1-8. e-Pub 2017. PMID: 28718728.
394. Kantarjian HM, Schuster MW, Jain N, Advani A, Jabbour E, Gamelin E, Rasmussen E, Juan G, Anderson A, Chow VF, Friberg G, Vogl FD, Sekeres MA. A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia. Am J Hematol 92(7):660-667, 2017. e-Pub 2017. PMID: 28370201.
395. Rozovski U, Harris DM, Li P, Liu Z, Jain P, Veletic I, Ferrajoli A, Burger J, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells. Int J Cancer. e-Pub 2017. PMID: 28722170.
396. Sharma SK, Katoch K, Sarin R, Balambal R, Kumar Jain N, Patel N, Murthy KJR, Singla N, Saha PK, Khanna A, Singh U, Kumar S, Sengupta A, Banavaliker JN, Chauhan DS, Sachan S, Wasim M, Tripathi S, Dutt N, Jain N, Joshi N, Penmesta SRR, Gaddam S, Gupta S, Khamar B, Dey B, Mitra DK, Arora SK, Bhaskar S, Rani R. Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial. Sci Rep 7(1):3354, 2017. e-Pub 2017. PMID: 28611374.
397. Dabija DI, Gao C, Edwards TL, Kuhn JE, Jain NB. Genetic and familial predisposition to rotator cuff disease: a systematic review. J Shoulder Elbow Surg 26(6):1103-1112, 2017. e-Pub 2017. PMID: 28162885.
398. Sun B, Fiskus W, Qian Y, Rajapakshe K, Raina K, Coleman KG, Crew AP, Shen A, Saenz DT, Mill CP, Nowak AJ, Jain N, Zhang L, Wang M, Khoury JD, Coarfa C, Crews CM, Bhalla KN. BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells. Leukemia. e-Pub 2017. PMID: 28663582.
399. Kanagal-Shamanna R, Jain P, Takahashi K, Short NJ, Tang G, Issa GC, Ravandi F, Garcia-Manero G, Yin CC, Luthra R, Patel KP, Khoury JD, Montalban-Bravo G, Sasaki K, Kadia TM, Borthakur G, Konopleva M, Jain N, Garris R, Pierce S, Wierda W, Estrov Z, Cortes J, O'Brien S, Kantarjian H, Jabbour E. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer. e-Pub 2017. PMID: 28608976.
400. Jain P, Thompson PA, Keating M, Estrov Z, Ferrajoli A, Jain N, Kantarjian H, Burger JA, O'Brien S, Wierda WG. Long-term outcomes for patients with chronic lymphocytic leukemia who discontinue ibrutinib. Cancer 123(12):2268-2273, 2017. e-Pub 2017. PMID: 28171709.
401. Rozovski U, Harris DM, Li P, Liu Z, Jain P, Veletic I, Ferrajoli A, Burger J, O'Brien S, Bose P, Thompson P, Jain N, Wierda W, Keating MJ, Estrov Z. Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex. Mol Cancer Res 15(5):610-618, 2017. e-Pub 2017. PMID: 28130399.
402. Konoplev S, Lu X, Konopleva M, Jain N, Ouyang J, Goswami M, Roberts KG, Valentine M, Mullighan CG, Bueso-Ramos C, Zweidler-McKay PA, Jorgensen JL, Wang SA. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience. Am J Clin Pathol 147(4):357-363, 2017. e-Pub 2017. PMID: 28340183.
403. Pemmaraju N, Jain P, Medeiros LJ, Jorgenson JL, Jain N, Willis J, Kontoyiannis DP, Estrov Z, Wierda WG. PET-positive lymphadenopathy in CLL-Not always Richter transformation. Am J Hematol 92(4):405-406, 2017. e-Pub 2017. PMID: 27677095.
404. Jain P, Aoki E, Keating M, Wierda WG, O'Brien S, Gonzalez GN, Ferrajoli A, Jain N, Thompson PA, Jabbour E, Shamanna RK, Pierce S, Alousi A, Hosing C, Khouri I, Estrov Z, Cortes J, Kantarjian H, Ravandi F, Kadia TM. Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). Ann Oncol. e-Pub 2017. PMID: 28379307.
405. Manurkar P, Jain N, Kumar P, Kanter GS. Programmable optical waveform reshaping on a picosecond timescale. Opt Lett 42(5):951-954, 2017. e-Pub 2017. PMID: 28248339.
406. Jain NB, Luz J, Higgins LD, Dong Y, Warner JJ, Matzkin E, Katz JN. The Diagnostic Accuracy of Special Tests for Rotator Cuff Tear: The ROW Cohort Study. Am J Phys Med Rehabil 96(3):176-183, 2017. e-Pub 2017. PMID: 27386812.
407. Pemmaraju N, Kantarjian H, Jorgensen JL, Jabbour E, Jain N, Thomas D, O'Brien S, Wang X, Huang X, Wang SA, Konopleva M, Konoplev S, Kadia T, Garris R, Pierce S, Garcia-Manero G, Cortes J, Ravandi F. Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission. Am J Hematol 92(3):279-285, 2017. e-Pub 2017. PMID: 28052371.
408. Jain P, Keating M, Renner S, Cleeland C, Xuelin H, Gonzalez GN, Harris D, Li P, Liu Z, Veletic I, Rozovski U, Jain N, Thompson P, Bose P, DiNardo C, Ferrajoli A, O'Brien S, Burger J, Wierda W, Verstovsek S, Kantarjian H, Estrov Z. Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial. Lancet Haematol 4(2):e67-e74, 2017. e-Pub 2017. PMID: 28089238.
409. Yin Q, Sivina M, Robins H, Yusko E, Vignali M, O'Brien S, Keating MJ, Ferrajoli A, Estrov Z, Jain N, Wierda WG, Burger JA. Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia. J Immunol 198(4):1740-1747, 2017. e-Pub 2017. PMID: 28077600.
410. Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, Zweidler-McKay P, Lu X, Fawcett G, Wang SA, Konoplev S, Harvey RC, Chen IM, Payne-Turner D, Valentine M, Thomas D, Garcia-Manero G, Ravandi F, Cortes J, Kornblau S, O'Brien S, Pierce S, Jorgensen J, Shaw KR, Willman CL, Mullighan CG, Kantarjian H, Konopleva M. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood 129(5):572-581, 2017. e-Pub 2017. PMID: 27919910.
411. Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Dorsal Column Myelopathy after Intrathecal Chemotherapy for Leukemia. Am J Hematol 92(2):155-160, 2017. e-Pub 2017. PMID: 27874212.
412. Montalban-Bravo G, Huang X, Jabbour E, Borthakur G, DiNardo CD, Pemmaraju N, Cortes J, Verstovsek S, Kadia T, Daver N, Wierda W, Alvarado Y, Konopleva M, Ravandi F, Estrov Z, Jain N, Alfonso A, Brandt M, Sneed T, Chen HC, Yang H, Bueso-Ramos C, Pierce S, Estey E, Bohannan Z, Kantarjian HM, Garcia-Manero G. A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials. Leukemia 31(2):318-324, 2017. e-Pub 2017. PMID: 27795561.
413. Issa GC, Kantarjian HM, Yin CC, Qiao W, Ravandi F, Thomas D, Short NJ, Sasaki K, Garcia-Manero G, Kadia TM, Cortes JE, Daver N, Borthakur G, Jain N, Konopleva M, Khouri I, Kebriaei P, Champlin RE, Pierce S, O'Brien SM, Jabbour E. Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease. Cancer 123(3):459-467, 2017. e-Pub 2017. PMID: 27696391.
414. Vural D, Hu X, Lindner B, Jain N, Miao Y, Cheng X, Liu Z, Hong L, Smith JC. Quasielastic neutron scattering in biology: Theory and applications. Biochim Biophys Acta Gen Subj 1861(1 Pt B):3638-3650, 2017. e-Pub 2017. PMID: 27316321.
415. Chen Q, Jain N, Ayer T, Wierda WG, Flowers CR, O'Brien SM, Keating MJ, Kantarjian HM, Chhatwal J. Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States. J Clin Oncol 35(2):JCO2016682856, 2017. e-Pub 2017. PMID: 27870563.
416. Khan M, Paul S, Farooq S, Oo TH, Ramshesh P, Jain N. Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency. Curr Drug Saf. e-Pub 2017. PMID: 28078984.
417. Jabbour E, Short NJ, Jorgensen JL, Yilmaz M, Ravandi F, Wang SA, Thomas DA, Khoury J, Champlin RE, Khouri I, Kebriaei P, O'Brien SM, Garcia-Manero G, Cortes JE, Sasaki K, Dinardo CD, Kadia TM, Jain N, Konopleva M, Garris R, Kantarjian HM. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Cancer 123(2):294-302, 2017. e-Pub 2017. PMID: 27602508.
418. Boddu P, Yin CC, Kanagal-Shamanna R, Tang G, Thakral B, Kadia T, Konopleva M, Jabbour E, Jain N. An Unsuspected Finding of t(9;22): A Rare Case of Philadelphia Chromosome-Positive B-Lymphoblastic Lymphoma. Case Rep Hematol 2017:2413587, 2017. e-Pub 2017. PMID: 29075538.
419. Sasaki K, Jabbour EJ, Ravandi F, Short NJ, Thomas DA, Garcia-Manero G, Daver NG, Kadia TM, Konopleva MY, Jain N, Issa GC, Jeanis V, Moore HG, Garris RS, Pemmaraju N, Cortes JE, O'Brien SM, Kantarjian HM. Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis. Cancer 122(23):3650-3656, 2016. e-Pub 2016. PMID: 27479888.
420. Short NJ, Kantarjian HM, Sasaki K, Cortes JE, Ravandi F, Thomas DA, Garcia-Manero G, Khouri I, Kebriaei P, Champlin RE, Pierce S, Issa GC, Konopleva M, Kadia TM, Bueso-Ramos C, Khoury JD, Jain N, O'Brien SM, Jabbour E. Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Cancer 122(24):3812-3820, 2016. e-Pub 2016. PMID: 27508525.
421. Patel VM, Balakrishnan K, Douglas M, Tibbitts T, Xu EY, Kutok JL, Ayers M, Sarkar A, Guerrieri R, Wierda WG, O'Brien S, Jain N, Stern HM, Gandhi V. Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199). Leukemia. e-Pub 2016. PMID: 28017967.
422. Short NJ, Kantarjian HM, Sasaki K, Ravandi F, Ko H, Yin CC, Garcia-Manero G, Cortes JE, Garris R, O'Brien SM, Patel K, Khouri M, Thomas D, Jain N, Kadia TM, Daver N, Benton CB, Issa GC, Konopleva M, Jabbour E. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor. Am J Hematol. e-Pub 2016. PMID: 28006851.
423. Abaza Y, Kantarjian HM, Garcia-Manero G, Estey E, Borthakur G, Jabbour E, Faderl S, O'Brien S, Wierda W, Pierce S, Brandt M, McCue D, Luthra R, Patel K, Kornblau S, Kadia T, Daver N, DiNardo C, Jain N, Verstovsek S, Ferrajoli A, Andreeff M, Konopleva M, Estrov Z, Foudray M, McCue D, Cortes J, Ravandi F. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. e-Pub 2016. PMID: 28003274.
424. Kharga B, Sharma BK, Singh VK, Nishant K, Bhutia P, Tamang R, Jain N. Obesity Not Necessary, Risk of Symptomatic Cholelithiasis Increases as a Function of BMI. J Clin Diagn Res 10(10):PC28-PC32, 2016. e-Pub 2016. PMID: 27891394.
425. Hong L, Jain N, Cheng X, Bernal A, Tyagi M, Smith JC. Determination of functional collective motions in a protein at atomic resolution using coherent neutron scattering. Sci Adv 2(10):e1600886, 2016. e-Pub 2016. PMID: 27757419.
426. Pemmaraju N, Jain P, Medeiros LJ, Jorgenson JL, Jain N, Willis J, Kontoyiannis DP, Estrov Z, Wierda W. PET-positive lymphadenopathy in CLL - Not always Richter transformation. American Journal of Hematology, 2016. e-Pub 2016.
427. Jain N, Balakrishnan K, Ferrajoli A, O'Brien SM, Burger JA, Kadia TM, Cortes JE, Ayres ML, Tambaro FP, Keating MJ, Gandhi V, Wierda WG. A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL. Oncotarget. e-Pub 2016. PMID: 27655665.
428. Sareen R, Jain N, Dhar KL. Curcumin-Zn(II) complex for enhanced solubility and stability: an approach for improved delivery and pharmacodynamic effects. Pharm Dev Technol 21(5):630-5, 2016. e-Pub 2016. PMID: 25923136.
429. Sasaki K, Popat U, Jain P, Kadia T, Patel K, Patel K, Jain N, Takahashi K, Young K, Miranda RN, Oo TH, Lu H, Pemmaraju N. Successful treatment of aplastic anemia-paroxysmal nocturnal hemoglobinuria associated with eosinophilic fasciitis with matched unrelated donor allogeneic peripheral blood stem cell transplantation. Clin Case Rep 4(8):765-7, 2016. e-Pub 2016. PMID: 27525080.
430. Vitale C, Ahn IE, Sivina M, Ferrajoli A, Wierda WG, Estrov Z, Konoplev SN, Jain N, O'Brien S, Farooqui M, Keating MJ, Wiestner A, Burger JA. Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib. Haematologica 101(6):e254-8, 2016. e-Pub 2016. PMID: 27013651.
431. Short NJ, Kantarjian HM, Jabbour EJ, O'Brien SM, Faderl S, Burger JA, Garris R, Qiao W, Huang X, Jain N, Konopleva M, Kadia TM, Daver N, Borthakur G, Cortes JE, Ravandi F. Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia. Am J Hematol 91(4):385-9, 2016. e-Pub 2016. PMID: 26800008.
432. Alhuraiji A, Jain N. Immunofluorescence staining with an antipromyelocytic leukemia antibody for a rapid diagnosis of acute promyelocytic leukemia. Hematol Oncol Stem Cell Ther. e-Pub 2016. PMID: 27362439.
433. Jain P, Kanagal-Shamanna R, Wierda W, Ferrajoli A, Keating M, Jain N. Membranoproliferative glomerulonephritis and acute renal failure in a patient with chronic lymphocytic leukemia: Response to obinutuzumab. Hematol Oncol Stem Cell Ther. e-Pub 2016. PMID: 27352257.
434. Jain N, Lamb AV, O'Brien S, Ravandi F, Konopleva M, Jabbour E, Zuo Z, Jorgensen J, Lin P, Pierce S, Thomas D, Rytting M, Borthakur G, Kadia T, Cortes J, Kantarjian HM, Khoury JD. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood 127(15):1863-9, 2016. e-Pub 2016. PMID: 26747249.
435. Thompson PA, O'Brien SM, Xiao L, Wang X, Burger JA, Jain N, Ferrajoli A, Estrov Z, Keating MJ, Wierda WG. β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia. Cancer 122(4):565-73, 2016. e-Pub 2016. PMID: 26588193.
436. Ravandi F, Jorgensen JL, O'Brien SM, Jabbour E, Thomas DA, Borthakur G, Garris R, Huang X, Garcia-Manero G, Burger JA, Ferrajoli A, Wierda W, Kadia T, Jain N, Wang SA, Konoplev S, Kebriaei P, Champlin RE, McCue D, Estrov Z, Cortes JE, Kantarjian HM. Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia. Br J Haematol 172(3):392-400, 2016. e-Pub 2016. PMID: 26492205.
437. Miller JE, Higgins LD, Dong Y, Collins JE, Bean JF, Seitz AL, Katz JN, Jain NB. Association of Strength Measurement with Rotator Cuff Tear in Patients with Shoulder Pain: The Rotator Cuff Outcomes Workgroup Study. Am J Phys Med Rehabil 95(1):47-56, 2016. e-Pub 2016. PMID: 26098921.
438. Sareen R, Jain N, Rajkumari A, Dhar KL. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation. Drug Deliv 23(1):55-62, 2016. e-Pub 2016. PMID: 24758141.
439. Luz J, Siddiqui I, Jain NB, Kohler MJ, Donovan J, Gerrard P, Borg-Stein J. Resident-Perceived Benefit of a Diagnostic and Interventional Musculoskeletal Ultrasound Curriculum: A Multifaceted Approach Using Independent Study, Peer Teaching, and Interdisciplinary Collaboration. Am J Phys Med Rehabil 94(12):1095-103, 2015. e-Pub 2015. PMID: 26098924.
440. Page MJ, McKenzie JE, Green SE, Beaton DE, Jain NB, Lenza M, Verhagen AP, Surace S, Deitch J, Buchbinder R. Core domain and outcome measurement sets for shoulder pain trials are needed: systematic review of physical therapy trials. J Clin Epidemiol 68(11):1270-81, 2015. e-Pub 2015. PMID: 26092288.
441. Jabbour E, Kantarjian H, Ravandi F, Thomas D, Huang X, Faderl S, Pemmaraju N, Daver N, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Yin CC, Khoury JD, Jorgensen J, Estrov Z, Bohannan Z, Konopleva M, Kadia T, Jain N, DiNardo C, Wierda W, Jeanis V, O'Brien S. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. Lancet Oncol 16(15):1547-55, 2015. e-Pub 2015. PMID: 26432046.
442. Thompson PA, O'Brien SM, Wierda WG, Ferrajoli A, Stingo F, Smith SC, Burger JA, Estrov Z, Jain N, Kantarjian HM, Keating MJ. Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens. Cancer 121(20):3612-21, 2015. e-Pub 2015. PMID: 26193999.
443. Jain NB, Ayers GD, Peterson EN, Harris MB, Morse L, O'Connor KC, Garshick E. Traumatic spinal cord injury in the United States, 1993-2012. JAMA 313(22):2236-43, 2015. e-Pub 2015. PMID: 26057284.
444. Rozovski U, Grgurevic S, Bueso-Ramos C, Harris DM, Li P, Liu Z, Wu JY, Jain P, Wierda W, Burger J, O'Brien S, Jain N, Ferrajoli A, Keating MJ, Estrov Z. Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells. Mol Cancer Res 13(5):944-53, 2015. e-Pub 2015. PMID: 25733697.
445. Black EM, Lin A, Srikumaran U, Jain N, Freehill MT. Arthroscopic transosseous rotator cuff repair: technical note, outcomes, and complications. Orthopedics 38(5):e352-8, 2015. e-Pub 2015. PMID: 25970360.
446. Curry EJ, Matzkin EE, Dong Y, Higgins LD, Katz JN, Jain NB. Structural Characteristics Are Not Associated With Pain and Function in Rotator Cuff Tears: The ROW Cohort Study. Orthop J Sports Med 3(5):2325967115584596, 2015. e-Pub 2015. PMID: 26675985.
447. Jain NB, Collins J, Newman JS, Katz JN, Losina E, Higgins LD. Reliability of magnetic resonance imaging assessment of rotator cuff: the ROW study. PM R 7(3):245-54.e3; quiz 254, 2015. e-Pub 2015. PMID: 25180471.
448. Jain P, Keating M, Wierda W, Estrov Z, Ferrajoli A, Jain N, George B, James D, Kantarjian H, Burger J, O'Brien S. Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib. Blood 125(13):2062-7, 2015. e-Pub 2015. PMID: 25573991.
449. Pemmaraju N, Shah D, Kantarjian H, Orlowski RZ, Nogueras González GM, Baladandayuthapani V, Jain N, Wagner V, Garcia-Manero G, Shah J, Ravandi F, Pierce S, Takahashi K, Daver N, Nazha A, Verstovsek S, Jabbour E, De Lima M, Champlin R, Cortes J, Qazilbash MH. Characteristics and Outcomes of Patients With Multiple Myeloma Who Develop Therapy-Related Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk 15(2):110-4, 2015. e-Pub 2015. PMID: 25107338.
450. Yin CC, Jain N, Mehrotra M, Zhagn J, Protopopov A, Zuo Z, Pemmaraju N, DiNardo C, Hirsch-Ginsberg C, Wang SA, Medeiros LJ, Chin L, Patel KP, Ravandi F, Futreal A, Bueso-Ramos CE. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. J Natl Compr Canc Netw 13(1):19-22, 2015. e-Pub 2015. PMID: 25583766.
451. Jain NB, Yamaguchi K. The contribution of reverse shoulder arthroplasty to utilization of primary shoulder arthroplasty. J Shoulder Elbow Surg 23(12):1905-1912, 2014. e-Pub 2014. PMID: 25304043.
452. Song A, Higgins LD, Newman J, Jain NB. Glenohumeral corticosteroid injections in adhesive capsulitis: a systematic search and review. PM R 6(12):1143-56, 2014. e-Pub 2014. PMID: 24998406.
453. Mascarinas AL, Newman JS, Warner JJ, Jain NB. Ultrasound of the pectoralis major muscle after reverse shoulder arthroplasty: a case report. Am J Phys Med Rehabil 93(12):e9-e14, 2014. e-Pub 2014. PMID: 25251253.
454. Jain S, Jain N. Comment on case report entitled: adenomyosis of uterus with adenomyoma of fallopian tube. J Obstet Gynaecol India 64(5):375, 2014. e-Pub 2014. PMID: 25368467.
455. Song A, Katz JN, Higgins LD, Newman J, Gomoll A, Jain NB. Outcomes of Ultrasound-guided Glen Humeral Corticosteroid Injections in Adhesive Capsulitis. Br J Med Med Res 5(5):570-578, 2014. e-Pub 2014. PMID: 27066399.
456. Strati P, Keating MJ, O'Brien SM, Ferrajoli A, Burger J, Faderl S, Tambaro FP, Jain N, Wierda WG. Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion. Haematologica 99(8):1350-5, 2014. e-Pub 2014. PMID: 24859876.
457. Neuhaus V, Bot AG, Swellengrebel CH, Jain NB, Warner JJ, Ring DC. Treatment choice affects inpatient adverse events and mortality in older aged inpatients with an isolated fracture of the proximal humerus. J Shoulder Elbow Surg 23(6):800-6, 2014. e-Pub 2014. PMID: 24135421.
458. Jain NB, Yamaguchi K. History and physical examination provide little guidance on diagnosis of rotator cuff tears. Evid Based Med 19(3):108, 2014. e-Pub 2014. PMID: 24347201.
459. Strati P, Keating MJ, O'Brien SM, Burger J, Ferrajoli A, Jain N, Tambaro FP, Estrov Z, Jorgensen J, Challagundla P, Faderl SH, Wierda WG. Eradication of bone marrow minimal residual disease with first-line chemoimmunotherapy may prompt early treatment discontinuation in chronic lymphocytic leukemia. Blood 123(24):3727-32, 2014. e-Pub 2014. PMID: 24705492.
460. Rozovski U, Wu JY, Harris DM, Liu Z, Li P, Hazan-Halevy I, Ferrajoli A, Burger JA, O'Brien S, Jain N, Verstovsek S, Wierda WG, Keating MJ, Estrov Z. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells. Blood 123(24):3797-802, 2014. e-Pub 2014. PMID: 24778152.
461. Falchi L, Keating MJ, Marom EM, Truong MT, Schlette EJ, Sargent RL, Trinh L, Wang X, Smith SC, Jain N, Estrov Z, O'Brien S, Wierda WG, Lerner S, Ferrajoli A. Correlation between FDG/PET findings, histological features, clinical characteristics and survival in 332 patients with chronic lymphocytic leukemia. Blood 123(18):2783-90, 2014. e-Pub 2014. PMID: 24615780.
462. DiNardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos C, Yin CC, Pierce S, Jabbour E, Cortes JE, Kantarjian HM, Garcia-Manero G, Verstovsek S. Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy. Leukemia 28(4):958-61, 2014. e-Pub 2014. PMID: 24492324.
463. Pemmaraju N, Shetty AV, Prieto VG, Jain N, Kontoyiannis DP, Borthakur G. Disseminated Saprochaete capitata (formerly known as Geotrichum capitatum, and Blastoschizomyces capitatus) in a patient with acute myeloid leukemia. Eur J Haematol. e-Pub 2014. PMID: 24592915.
464. Jain NB, Higgins LD, Losina E, Collins J, Blazar PE, Katz JN. Epidemiology of musculoskeletal upper extremity ambulatory surgery in the United States. BMC Musculoskelet Disord 15:4, 2014. e-Pub 2014. PMID: 24397703.
465. Jain N, Curran E, Iyengar NM, Diaz-Flores E, Kunnavakkam R, Popplewell L, Kirschbaum MH, Karrison T, Erba HP, Green M, Poire X, Koval G, Shannon K, Reddy PL, Joseph L, Atallah EL, Dy P, Thomas SP, Smith SE, Doyle LA, Stadler WM, Larson RA, Stock W, Odenike O. Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clin Cancer Res 20(2):490-8, 2014. e-Pub 2014. PMID: 24178622.
466. Sareen R, Nath K, Jain N, Dhar KL. Curcumin loaded microsponges for colon targeting in inflammatory bowel disease: fabrication, optimization, and in vitro and pharmacodynamic evaluation. Biomed Res Int 2014:340701, 2014. e-Pub 2014. PMID: 25093165.
467. Jain N, Sareen R, Mahindroo N, Dhar KL. Development and optimization of osmotically controlled asymmetric membrane capsules for delivery of solid dispersion of lycopene. ScientificWorldJournal 2014:438528, 2014. e-Pub 2014. PMID: 24605053.
468. Pakrashi S, Jain N, Dalai S, Jayakumar J, Chandrasekaran PT, Raichur AM, Chandrasekaran N, Mukherjee A. In vivo genotoxicity assessment of titanium dioxide nanoparticles by Allium cepa root tip assay at high exposure concentrations. PLoS One 9(2):e87789, 2014. e-Pub 2014. PMID: 24504252.
469. Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Medeiros LJ, Khoury JD. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow. Am J Hematol 88(12):1055-61, 2013. e-Pub 2013. PMID: 23940084.
470. Jain N, Khoury JD, Pemmaraju N, Kollipara P, Kantarjian H, Verstovsek S. Imatinib Therapy in a Patient with Suspected Chronic Neutrophilic Leukemia and FIP1L1-PDGFRA Rearrangement. Blood 122(19):3387-8, 2013. e-Pub 2013. PMID: 24203930.
471. Sareen R, Jain N, Dhar KL. Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease. Curr Drug Deliv 10(5):564-71, 2013. e-Pub 2013. PMID: 23360241.
472. Magu S, Agarwal S, Jain N, Dalal N. Diaphragmatic hernia mimicking hydropneumothorax: common error in emergency department. BMJ Case Rep 2013, 2013. e-Pub 2013. PMID: 23907963.
473. Rohilla S, Jain N, Yadav R, Dhaulakhandi DB. Hepatic visceral larva migrans. BMJ Case Rep 2013, 2013. e-Pub 2013. PMID: 23853189.
474. Jain N, Liu H, Artz AS, Anastasi J, Odenike O, Godley LA, Joseph L, Marino S, Kline J, Nguyen V, Schouten V, Kunnavakkam R, Larson RA, Stock W, Ulaszek J, Savage PA, Wickrema A, van Besien K. Immune Reconstitution after Combined Haploidentical and Umbilical Cord Blood Transplantation. Leuk Lymphoma 54(6):1242-9, 2013. e-Pub 2013. PMID: 23088744.
475. Jain NB, Kuye I, Higgins LD, Warner JJ. Surgeon volume is associated with cost and variation in surgical treatment of proximal humeral fractures. Clin Orthop Relat Res 471(2):655-64, 2013. e-Pub 2013. PMID: 22826013.
476. Rohilla S, Jain N, Yadav R. Plantaris rupture: why is it important?. BMJ Case Rep 2013, 2013. e-Pub 2013. PMID: 23345486.
477. Salem ME, Jain N, Dyson G, Taylor S, El-Refai SM, Choi M, Shields AF, Critchfield J, Philip PA. Radiographic parameters in predicting outcome of patients with hepatocellular carcinoma treated with yttrium-90 microsphere radioembolization. ISRN Oncol 2013:538376, 2013. e-Pub 2013. PMID: 24167742.
478. Miao Y, Yi Z, Glass DC, Hong L, Tyagi M, Baudry J, Jain N, Smith JC. Temperature-dependent dynamical transitions of different classes of amino acid residue in a globular protein. J Am Chem Soc 134(48):19576-9, 2012. e-Pub 2012. PMID: 23140218.
479. Hossain N, Jain N, Steinmetz J, McConville J, Anastasi J, Odenike O. A 32-year-old man with persistent cough, shortness of breath, eosinophilic pneumonia, and peripheral blood eosinophilia. Myeloid neoplasm associated with eosinophilia and platelet-derived growth factor receptor-alpha rearrangement. Chest 142(6):1680-3, 2012. e-Pub 2012. PMID: 23208343.
480. Miao Y, Yi Z, Cantrell C, Glass DC, Baudry J, Jain N, Smith JC. Coupled flexibility change in cytochrome P450cam substrate binding determined by neutron scattering, NMR, and molecular dynamics simulation. Biophys J 103(10):2167-76, 2012. e-Pub 2012. PMID: 23200050.
481. Jain NB. Joint replacement costs in the era of healthcare reform: commentary on an article by James C. Robinson, PhD, MPH, et al.: "Variability in costs associated with total hip and knee replacement implants". J Bone Joint Surg Am 94(18):e140(1-2), 2012. e-Pub 2012. PMID: 22878364.
482. Jain N, Francis S, Friedman SH. Inhibition of therapeutically important polymerases with high affinity bis-intercalators. Bioorg Med Chem Lett 22(14):4844-8, 2012. e-Pub 2012. PMID: 22695131.
483. Chressanthis GA, Khedkar P, Jain N, Poddar P, Seiders MG. Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent events with diabetes and lipid drugs. J Clin Hypertens (Greenwich) 14(7):435-46, 2012. e-Pub 2012. PMID: 22747616.
484. Yi Z, Miao Y, Baudry J, Jain N, Smith JC. Derivation of mean-square displacements for protein dynamics from elastic incoherent neutron scattering. J Phys Chem B 116(16):5028-36, 2012. e-Pub 2012. PMID: 22471396.
485. Kuye IO, Jain NB, Warner L, Herndon JH, Warner JJ. Economic evaluations in shoulder pathologies: a systematic review of the literature. J Shoulder Elbow Surg 21(3):367-75, 2012. e-Pub 2012. PMID: 21865060.
486. Rohilla S, Jain N, Sharma R, Dhaulakhandi DB. Macrodystrophia lipomatosa involving multiple nerves. J Orthop Traumatol 13(1):41-5, 2012. e-Pub 2012. PMID: 21948052.
487. Jain NB, Omar I, Kelikian AS, van Holsbeeck L, Grant TH. Prevalence of and factors associated with posterior tibial tendon pathology on sonographic assessment. PM R 3(11):998-1004, 2011. e-Pub 2011. PMID: 22108227.
488. Jain N, Wittmann C, Lydersen L, Wiechers C, Elser D, Marquardt C, Makarov V, Leuchs G. Device calibration impacts security of quantum key distribution. Phys Rev Lett 107(11):110501, 2011. e-Pub 2011. PMID: 22026652.
489. Jain NR, Jethani J, Narendran K, Kanth L. Synergistic convergence and split pons in horizontal gaze palsy and progressive scoliosis in two sisters. Indian J Ophthalmol 59(2):162-5, 2011. e-Pub 2011. PMID: 21350292.
490. Jain N, Akhter S, Jain GK, Khan ZI, Khar RK, Ahmad FJ. Antiepileptic intranasal Amiloride loaded mucoadhesive nanoemulsion: development and safety assessment. J Biomed Nanotechnol 7(1):142-3, 2011. e-Pub 2011. PMID: 21485842.
491. Jain NB, Higgins LD, Katz JN, Garshick E. Association of shoulder pain with the use of mobility devices in persons with chronic spinal cord injury. PM R 2(10):896-900, 2010. e-Pub 2010. PMID: 20970758.
492. Jain N, Huisman SR, Bimbard E, Lvovsky AI. A bridge between the single-photon and squeezed-vacuum states. Opt Express 18(17):18254-9, 2010. e-Pub 2010. PMID: 20721217.
493. Garcia JS, Jain N, Godley LA. An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes. Onco Targets Ther 3:1-13, 2010. e-Pub 2010. PMID: 20616953.
494. Jain NK, Jain SK. Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin. AAPS PharmSciTech 11(2):686-97, 2010. e-Pub 2010. PMID: 20414758.
495. Santos FP, Kantarjian HM, Jain N, Manshouri T, Thomas DA, Garcia-Manero G, Kennedy D, Estrov Z, Cortes J, Verstovsek S. Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. Blood 115(6):1131-6, 2010. e-Pub 2010. PMID: 20008298.
496. Sever M, Kantarjian H, Pierce S, Jain N, Estrov Z, Cortes J, Verstovsek S. Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation. Int J Hematol 90(4):522-5, 2009. e-Pub 2009. PMID: 19728024.
497. Jain N, Wierda W, Ferrajoli A, Wong F, Lerner S, Keating M, O'Brien S. A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia. Cancer 115(19):4533-9, 2009. e-Pub 2009. PMID: 19637351.
498. Weisskopf MG, Jain N, Nie H, Sparrow D, Vokonas P, Schwartz J, Hu H. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. Circulation 120(12):1056-64, 2009. e-Pub 2009. PMID: 19738141.
499. Huisman SR, Jain N, Babichev SA, Vewinger F, Zhang AN, Youn SH, Lvovsky AI. Instant single-photon Fock state tomography. Opt Lett 34(18):2739-41, 2009. e-Pub 2009. PMID: 19756089.
500. Khare P, Jain A, Jain NK, Soni V, Jain SK. Glutamate-conjugated liposomes of dopamine hydrochloride for effective management of parkinsonism's. PDA J Pharm Sci Technol 63(5):372-9, 2009. e-Pub 2009. PMID: 20158043.
501. Jain N, Reuben JM, Kantarjian H, Li C, Gao H, Lee BN, Cohen EN, Ebarb T, Scheinberg DA, Cortes J. Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial. Cancer 115(17):3924-34, 2009. e-Pub 2009. PMID: 19536894.
502. Borthakur G, Lin E, Jain N, Estey EE, Cortes JE, O'Brien S, Faderl S, Ravandi F, Pierce S, Kantarjian H. Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia. Cancer 115(14):3217-21, 2009. e-Pub 2009. PMID: 19441109.
503. Jain N, Cortes J, Quintás-Cardama A, Manshouri T, Luthra R, Garcia-Manero G, Kantarjian H, Verstovsek S. Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRalpha mutation status. Leuk Res 33(6):837-9, 2009. e-Pub 2009. PMID: 19013640.
504. Fava C, Kantarjian HM, Jabbour E, O'Brien S, Jain N, Rios MB, Garcia-Manero G, Ravandi F, Verstovsek S, Borthakur G, Shan J, Cortes J. Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase. Blood 113(21):5058-63, 2009. e-Pub 2009. PMID: 19282457.
505. Waddimba AC, Jain NB, Stolzmann K, Gagnon DR, Burgess JF Jr, Kazis LE, Garshick E. Predictors of cardiopulmonary hospitalization in chronic spinal cord injury. Arch Phys Med Rehabil 90(2):193-200, 2009. e-Pub 2009. PMID: 19236973.
506. Albright S, Agrawal P, Jain NU. NMR spectral mapping of Lipid A molecular patterns affected by interaction with the innate immune receptor CD14. Biochem Biophys Res Commun 378(4):721-6, 2009. e-Pub 2009. PMID: 19059378.
507. Millham F, Jain NB. Are there racial disparities in trauma care?. World J Surg 33(1):23-33, 2009. e-Pub 2009. PMID: 19023623.
508. Jain NU. Use of residual dipolar couplings in structural analysis of protein-ligand complexes by solution NMR spectroscopy. Methods Mol Biol 544:231-52, 2009. e-Pub 2009. PMID: 19488703.
509. Zhang W, Pochapsky SS, Pochapsky TC, Jain NU. Solution NMR structure of putidaredoxin-cytochrome P450cam complex via a combined residual dipolar coupling-spin labeling approach suggests a role for Trp106 of putidaredoxin in complex formation. J Mol Biol 384(2):349-63, 2008. e-Pub 2008. PMID: 18835276.
510. Jain NB, Losina E, Ward DM, Harris MB, Katz JN. Trends in surgical management of femoral neck fractures in the United States. Clin Orthop Relat Res 466(12):3116-22, 2008. e-Pub 2008. PMID: 18648899.
511. Jain N, Symes T, Doorgakant A, Dawson M. Clinical audit of the management of stable ankle fractures. Ann R Coll Surg Engl 90(6):483-7, 2008. e-Pub 2008. PMID: 18765028.
512. Stepp EL, Brown R, Tun CG, Gagnon DR, Jain NB, Garshick E. Determinants of lung volumes in chronic spinal cord injury. Arch Phys Med Rehabil 89(8):1499-506, 2008. e-Pub 2008. PMID: 18674986.
513. Chaurasia M, Chourasia MK, Jain NK, Jain A, Soni V, Gupta Y, Jain SK. Methotrexate bearing calcium pectinate microspheres: a platform to achieve colon-specific drug release. Curr Drug Deliv 5(3):215-9, 2008. e-Pub 2008. PMID: 18673265.
514. Albright S, Chen B, Holbrook K, Jain NU. Solution NMR studies provide structural basis for endotoxin pattern recognition by the innate immune receptor CD14. Biochem Biophys Res Commun 368(2):231-7, 2008. e-Pub 2008. PMID: 18230335.
515. Morse LR, Stolzmann K, Nguyen HP, Jain NB, Zayac C, Gagnon DR, Tun CG, Garshick E. Association between mobility mode and C-reactive protein levels in men with chronic spinal cord injury. Arch Phys Med Rehabil 89(4):726-31, 2008. e-Pub 2008. PMID: 18374004.
516. Jain N, Hubbard J, Vega F, Vidal G, Garcia-Manero G, Borthakur G. Spontaneous Remission of Acute Myeloid Leukemia: report of three patients and review of literature. Clinical Leukemia 2(1):64-67, 2008. e-Pub 2008.
517. Jain NB, Al-Adawi S, Dorvlo AS, Burke DT. Association between body mass index and functional independence measure in patients with deconditioning. Am J Phys Med Rehabil 87(1):21-5, 2008. e-Pub 2008. PMID: 18158429.
518. Jain N, Kantarjian H, Ault P, Cortes J. Scrotal edema associated with the use of dasatinib in patients with chronic myeloid leukemia. Clinical Leukemia 1(6):357-58, 2007. e-Pub 2007.
519. Jain N, Fisk D, Sotir M, Kehl KS. West Nile encephalitis, status epilepticus and West Nile pneumonia in a renal transplant patient. Transplant International 20(9):800-3, 2007. e-Pub 2007. PMID: 17630998.
520. Jain N, Dawson MJ. Bilateral spontaneous and simultaneous rupture of the Achilles tendons secondary to exercises for limb ischemia: a case report. J Vasc Nurs 25(2):26-8, 2007. e-Pub 2007. PMID: 17531935.
521. Jain NB, Potula V, Schwartz J, Vokonas PS, Sparrow D, Wright RO, Nie H, Hu H. Lead levels and ischemic heart disease in a prospective study of middle-aged and elderly men: the VA Normative Aging Study. Environ Health Perspect 115(6):871-5, 2007. e-Pub 2007. PMID: 17589593.
522. Jain N, Patel D, Pfeifer KJ. An unusual case of vertebral osteomyelitis in a young healthy adult. Wisconsin Medical Journal 106(3):152-54, 2007. e-Pub 2007. PMID: 17642354.
523. Jain NB, Sullivan M, Kazis LE, Tun CG, Garshick E. Factors associated with health-related quality of life in chronic spinal cord injury. Am J Phys Med Rehabil 86(5):387-96, 2007. e-Pub 2007. PMID: 17449983.
524. Cho HJ, Shashkin P, Gleissner CA, Dunson D, Jain N, Lee JK, Miller Y, Ley K. Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics 29(2):149-60, 2007. e-Pub 2007. PMID: 17244792.
525. Weber WP, Guller U, Jain NB, Pietrobon R, Oertli D. Impact of surgeon and hospital caseload on the likelihood of performing laparoscopic vs open sigmoid resection for diverticular disease: a study based on 55,949 patients. Arch Surg 142(3):253-9; discussion 259, 2007. e-Pub 2007. PMID: 17372050.
526. Jain NB, Hart JE, Smith TJ, Garshick E, Laden F. Smoking behavior in trucking industry workers. Am J Ind Med 49(12):1013-20, 2006. e-Pub 2006. PMID: 17096359.
527. Jain NB, Brown R, Tun CG, Gagnon D, Garshick E. Determinants of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC in chronic spinal cord injury. Arch Phys Med Rehabil 87(10):1327-33, 2006. e-Pub 2006. PMID: 17023241.
528. Narasimhan B, Kumari M, Jain N, Dhake A, Sundaravelan C. Correlation of antibacterial activity of some N-[5-(2-furanyl)-2-methyl-4-oxo-4H-thieno[2,3-d]pyrimidin-3-yl]-carboxamide and 3-substituted-5-(2-furanyl)-2-methyl-3H-thieno[2,3-d]pyrimidin-4-ones with topological indices using Hansch analysis. Bioorg Med Chem Lett 16(18):4951-8, 2006. e-Pub 2006. PMID: 16814544.
529. Chaurasia M, Chourasia MK, Jain NK, Jain A, Soni V, Gupta Y, Jain SK. Cross-linked guar gum microspheres: a viable approach for improved delivery of anticancer drugs for the treatment of colorectal cancer. AAPS PharmSciTech 7(3):74, 2006. e-Pub 2006. PMID: 17025254.
530. Elmarsafawy SF, Jain NB, Schwartz J, Sparrow D, Nie H, Hu H. Dietary calcium as a potential modifier of the relationship of lead burden to blood pressure. Epidemiology 17(5):531-7, 2006. e-Pub 2006. PMID: 16878040.
531. Jain NB, Higgins LD, Guller U, Pietrobon R, Katz JN. Trends in the epidemiology of total shoulder arthroplasty in the United States from 1990-2000. Arthritis Rheum 55(4):591-7, 2006. e-Pub 2006. PMID: 16874781.
532. Shashkin PN, Jain N, Miller YI, Rissing BA, Huo Y, Keller SR, Vandenhoff GE, Nadler JL, McIntyre TM. Insulin and glucose play a role in foam cell formation and function. Cardiovasc Diabetol 5:13, 2006. e-Pub 2006. PMID: 16787541.
533. Jain NB, Hu H. Childhood correlates of blood lead levels in Mumbai and Delhi. Environ Health Perspect 114(3):466-70, 2006. e-Pub 2006. PMID: 16507473.
534. Jain NB, Higgins LD, Ozumba D, Guller U, Cronin M, Pietrobon R, Katz JN. Trends in epidemiology of knee arthroplasty in the United States, 1990-2000. Arthritis Rheum 52(12):3928-33, 2005. e-Pub 2005. PMID: 16320340.
535. Guller U, Safford S, Pietrobon R, Heberer M, Oertli D, Jain NB. High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg 29(8):994-9; discussion 999-1000, 2005. e-Pub 2005. PMID: 15988622.
536. Grandas NF, Jain NB, Denckla JB, Brown R, Tun CG, Gallagher ME, Garshick E. Dyspnea during daily activities in chronic spinal cord injury. Arch Phys Med Rehabil 86(8):1631-5, 2005. e-Pub 2005. PMID: 16084818.
537. Jain N, Cho H, O'Connell M, Lee JK. Rank-invariant resampling based estimation of false discovery rate for analysis of small sample microarray data. BMC Bioinformatics 6:187, 2005. e-Pub 2005. PMID: 16042779.
538. Jain NB, Pietrobon R, Guller U, Ahluwalia AS, Higgins LD. Influence of provider volume on length of stay, operating room time, and discharge status for rotator cuff repair. J Shoulder Elbow Surg 14(4):407-13, 2005. e-Pub 2005. PMID: 16015241.
539. Jain SK, Chourasia MK, Masuriha R, Soni V, Jain A, Jain NK, Gupta Y. Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Deliv 12(4):207-15, 2005. e-Pub 2005. PMID: 16036715.
540. Jain NB, Hocker S, Pietrobon R, Guller U, Bathia N, Higgins LD. Total arthroplasty versus hemiarthroplasty for glenohumeral osteoarthritis: role of provider volume. J Shoulder Elbow Surg 14(4):361-7, 2005. e-Pub 2005. PMID: 16015234.
541. Jain NU, Tjioe E, Savidor A, Boulie J. Redox-dependent structural differences in putidaredoxin derived from homologous structure refinement via residual dipolar couplings. Biochemistry 44(25):9067-78, 2005. e-Pub 2005. PMID: 15966730.
542. Jain NB, Guller U, Pietrobon R, Bond TK, Higgins LD. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res(435):232-8, 2005. e-Pub 2005. PMID: 15930944.
543. Jain NB, Laden F, Guller U, Shankar A, Kazani S, Garshick E. Relation between blood lead levels and childhood anemia in India. Am J Epidemiol 161(10):968-73, 2005. e-Pub 2005. PMID: 15870161.
544. Jain N, Pietrobon R, Guller U, Shankar A, Ahluwalia AS, Higgins LD. Effect of provider volume on resource utilization for surgical procedures of the knee. Knee Surg Sports Traumatol Arthrosc 13(4):302-12, 2005. e-Pub 2005. PMID: 15875162.
545. Jain N, Ottino JM, Lueptow RM. Combined size and density segregation and mixing in noncircular tumblers. Phys Rev E Stat Nonlin Soft Matter Phys 71(5 Pt 1):051301, 2005. e-Pub 2005. PMID: 16089522.
546. Gupta V, Jain N, Sadasukhi TC, Sharma KK, Yadav RG, Mathur R, Tomar V, Yadav SS, Priyadarshi S. Protrusion of bladder mucosa in exstrophy mimicking cloacal exstrophy. J Pediatr Urol 1(2):105-6, 2005. e-Pub 2005. PMID: 18947546.
547. Socie BA, Umbanhowar P, Lueptow RM, Jain N, Ottino JM. Creeping motion in granular flow. Phys Rev E Stat Nonlin Soft Matter Phys 71(3 Pt 1):031304, 2005. e-Pub 2005. PMID: 15903423.
548. Jain NU, Wyckoff TJ, Raetz CR, Prestegard JH. Rapid analysis of large protein-protein complexes using NMR-derived orientational constraints: the 95 kDa complex of LpxA with acyl carrier protein. J Mol Biol 343(5):1379-89, 2004. e-Pub 2004. PMID: 15491619.
549. Guller U, Jain N, Curtis LH, Oertli D, Heberer M, Pietrobon R. Insurance status and race represent independent predictors of undergoing laparoscopic surgery for appendicitis: secondary data analysis of 145,546 patients. J Am Coll Surg 199(4):567-75; discussion 575-7, 2004. e-Pub 2004. PMID: 15454140.
550. Guller U, Jain N, Peterson ED, Muhlbaier LH, Eubanks S, Pietrobon R. Laparoscopic appendectomy in the elderly. Surgery 135(5):479-88, 2004. e-Pub 2004. PMID: 15118584.
551. Jain N, Pietrobon R, Hocker S, Guller U, Shankar A, Higgins LD. The relationship between surgeon and hospital volume and outcomes for shoulder arthroplasty. J Bone Joint Surg Am 86(3):496-505, 2004. e-Pub 2004. PMID: 14996874.
552. Prasad K, Singhal T, Jain N, Gupta PK. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis, 2004. e-Pub 2004.
553. Guller U, Jain N, Hervey S, Purves H, Pietrobon R. Laparoscopic vs open colectomy: outcomes comparison based on large nationwide databases. Arch Surg 138(11):1179-86, 2003. e-Pub 2003. PMID: 14609864.
554. Jain N, Thatte J, Braciale T, Ley K, O'Connell M, Lee JK. Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 19(15):1945-51, 2003. e-Pub 2003. PMID: 14555628.
555. Jain NU, Noble S, Prestegard JH. Structural characterization of a mannose-binding protein-trimannoside complex using residual dipolar couplings. J Mol Biol 328(2):451-62, 2003. e-Pub 2003. PMID: 12691753.

Invited Articles

1. Strati P, Jain N, O'Brien S. Chronic Lymphocytic Leukemia: Diagnosis and Treatment. Mayo Clin Proc 93(5):651-664, 2018. e-Pub 2018. PMID: 29728204.
2. Boddu P, Jain N. Update on signal inhibitors in chronic lymphocytic leukemia. Clin Adv Hematol Oncol 16(4):279-288, 2018. e-Pub 2018. PMID: 29742083.
3. Jain N. Examining the Safety of CLL Medication. CURE Today, 2017. e-Pub 2017.
4. Wells J, Jain N, Konopleva M. Philadelphia chromosome-like acute lymphoblastic leukemia: progress in a new cancer subtype. Clin Adv Hematol Oncol 15(7):554-561, 2017. e-Pub 2017. PMID: 28749919.
5. Vangapandu HV, Jain N, Gandhi V. Duvelisib: a phosphoinositide-3 kinase δ/γ inhibitor for chronic lymphocytic leukemia. Expert Opin Investig Drugs 26(5):625-632, 2017. e-Pub 2017. PMID: 28388280.
6. Jain N, O'Brien S. First-line therapy for young patients with CLL. Hematology Am Soc Hematol Educ Program 2016(1):146-148, 2016. e-Pub 2016. PMID: 27913473.
7. Agbay RL, Jain N, Loghavi S, Medeiros LJ, Khoury JD. Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 91(10):1036-43, 2016. e-Pub 2016. PMID: 27414262.
8. Jain N, Keating MJ. Richter transformation of CLL. Expert Rev Hematol 9(8):793-801, 2016. e-Pub 2016. PMID: 27351634.
9. Jain N, O'Brien S. Targeted therapies for CLL: Practical issues with the changing treatment paradigm. Blood Rev 30(3):233-44, 2016. e-Pub 2016. PMID: 26776345.
10. George B, Kantarjian H, Jabbour E, Jain N. Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia. Immunotherapy 8(2):135-43, 2016. e-Pub 2016. PMID: 26780449.
11. Jain N, O'Brien S. Initial treatment of CLL: integrating biology and functional status. Blood 126(4):463-70, 2015. e-Pub 2015. PMID: 26065656.
12. Jain N. New developments in Richter syndrome. Clin Adv Hematol Oncol 13(4):220-2, 2015. e-Pub 2015. PMID: 26352579.
13. Jain N, O'Brien S, Thomas D, Kantarjian H. Inotuzumab Ozogamicin in the treatment of acute lymphoblastic leukemia. Front Biosci (Elite Ed) 6:40-5, 2014. e-Pub 2014. PMID: 24389139.
14. Jain N, O'Brien S. The frontline treatment of chronic myeloid leukemia in the chronic phase: current clinical decisions and future prospects for treatment. Expert Rev Hematol 6(5):575-86, 2013. e-Pub 2013. PMID: 24083594.
15. Jain N, O'Brien S. Ibrutinib (PCI-32765) in Chronic Lymphocytic Leukemia. Hematol Oncol Clin North Am 27(4):851-60, 2013. e-Pub 2013. PMID: 23915749.
16. Van Besien K, Liu H, Jain N, Stock W, Artz A. Umbilical Cord Blood Transplantation Supported by Third-Party Donor Cells: Rationale, Results, and Applications. Biol Blood Marrow Transplant 19(5):682-91, 2013. e-Pub 2013. PMID: 23142329.
17. Jain N, O'Brien S. Chronic lymphocytic leukemia with deletion 17p: emerging treatment options. Oncology (Williston Park) 11(11):1067-70, 2012. e-Pub 2012. PMID: 23330347.
18. Jain N, van Besien K. Chronic Myelogenous Leukemia. Elsevier's First Consult online, 2012. e-Pub 2012.
19. Quintás-Cardama A, Jain N, Verstovsek S. Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis. Cancer 117(24):5439-49, 2011. e-Pub 2011. PMID: 21692073.
20. Jain N, van Besien K. Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era. Hematol Oncol Clin North Am 25(5):1025-48, vi, 2011. e-Pub 2011. PMID: 22054733.
21. Jain N, Odenike O. The Emerging Role of the Histone deactylase inhibitor Romidepsin in Hematologic Malignancies. Expert Opinion on Pharmacotherapy 11(18):3073-84, 2010. e-Pub 2010.
22. Garcia JS, Jain N, Godley LA. An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes. OncoTargets and Therapy 24(3):1-13, 2010. e-Pub 2010.
23. Jain N, Lamanna N. Incorporating Prognostic Information into Treatment Decisions in CLL. Current Oncology Reports 11(5):353-9, 2009. e-Pub 2009.
24. Jain N, Rossi A, Garcia-Manero G. Epigenetic therapy of leukemia: An update. The International Journal of Biochemistry and Cell Biology 41(1):72-80, 2009. e-Pub 2009.
25. Jain N, Verstovsek S. Systemic Mastocytosis. Drugs of the Future 33(2):187-92, 2008. e-Pub 2008.

Review Articles

1. Prakash R, Aagesen AL, Javed N, Yanik EL, Jain NB. Demographic and anatomic predictors of glenoid morphology: a systematic review. JSES Rev Rep Tech 6(2):100676, 2026. e-Pub 2026. PMID: 41809068.
2. Kantarjian, HM, Chifotides, H, Haddad, FG, Jabbour, EJ, Jain, N, Kadia, TM, Ravandi-Kashani, F, Welch, MA, Wierda, WG, Freireich, EJ. The Care and Cure of the Leukemias in 2026. American journal of hematology 101(4):807-831, 2026. e-Pub 2026. PMID: 41761287.
3. Kantarjian, HM, Borthakur, G, Daver, N, DiNardo, C, Garcia-Manero, G, Issa, GC, Jabbour, EJ, Jain, N, Kadia, TM, Loghavi, S, Ravandi-Kashani, F, Tang, G, Welch, MA, Wierda, WG. A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens. Cancer 131(21), 2025. e-Pub 2025. PMID: 41129068.
4. Haddad, FG, Kantarjian, HM, Senapati, J, Jain, N, Short, NJ, Jabbour, EJ. SOHO State of the Art Updates and Next Questions | Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Can Be Treated with Chemotherapy-Free Regimens without Transplant. Clinical Lymphoma, Myeloma and Leukemia 25(10):711-719, 2025. e-Pub 2025. PMID: 40683769.
5. Haddad, FG, Kantarjian, HM, Short, NJ, Jain, N, Senapati, J, Ravandi-Kashani, F, Jabbour, EJ. Incorporation of Immunotherapy Into Adult B-Cell Acute Lymphoblastic Leukemia Therapy. JNCCN Journal of the National Comprehensive Cancer Network 23(8), 2025. e-Pub 2025. PMID: 40659041.
6. Senapati J, Kantarjian H, Habib D, Haddad FG, Jain N, Short NJ, Jabbour E. Frontline immunotherapeutic combination strategies in adult B-cell acute lymphoblastic leukemia: reducing chemotherapy intensity and toxicity and harnessing efficacy. Leuk Lymphoma 66(6):989-1000, 2025. e-Pub 2025. PMID: 39791458.
7. Kantarjian, HM, Jain, N, Litzow, M, Luger, SM, Papayannidis, C, Ribera, JM, Short, NJ, Chifotides, H, Jabbour, EJ. The evolving therapeutic revolution in adult acute lymphoblastic leukemia. Cancer 131(10), 2025. e-Pub 2025. PMID: 40323723.
8. Harris JC, Pierson CJ, Konda C, Jain NB. A Systematic Review of Temporary Peripheral Nerve Stimulation for Postoperative Pain Management in Orthopedic Surgery. Anesthesiol Res Pract 2025:8477771, 2025. e-Pub 2025. PMID: 41409093.
9. Jain NB, Khazzam MS. Degenerative Rotator-Cuff Disorders. N Engl J Med 391(21):2027-2034, 2024. e-Pub 2024. PMID: 39602631.
10. Cuglievan, B, Kantarjian, HM, Rubnitz, JE, Cooper, T, Zwaan, CM, Pollard, J, DiNardo, C, Kadia, TM, Guest, E, Short, NJ, McCall, DC, Daver, N, Nunez, CA, Haddad, FG, Garcia, MB, Bhalla, K, Maiti, A, Catueno, S, Fiskus, WC, Carter, BZ, Gibson, A, Roth, M, Khazal, SJ, Tewari, P, Abbas, HA, Bourgeois, W, Andreeff, M, Shukla, N, Truong, D, Connors, JS, Ludwig, JA, Stutterheim, J, Salzer, E, Juul-Dam, KL, Sasaki, K, Mahadeo, KM, Tasian, SK, Borthakur, G, Dickson, S, Jain, N, Jabbour, EJ, Meshinchi, S, Garcia-Manero, G, Ravandi, F, Stein, EM, Kolb, EA, Issa, GC. Menin inhibitors in pediatric acute leukemia. Leukemia 38(10):2073-2084, 2024. e-Pub 2024. PMID: 39179671.
11. Timofeeva, N, Jain, N, Gandhi, VV. Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia. Blood Neoplasia 1(3), 2024. e-Pub 2024. PMID: 39949788.
12. Jain, N, Wierda, WG, O’Brien, S. Chronic lymphocytic leukaemia. The Lancet 404(10453):694-706, 2024. e-Pub 2024. PMID: 39068951.
13. Herzberg SD, Garriga GA, Jain NB, Giri A. Elevated Body Mass Index Is Associated With Rotator Cuff Disease: A Systematic Review and Meta-analysis. Arthrosc Sports Med Rehabil 6(4):100953, 2024. e-Pub 2024. PMID: 39421344.
14. Haddad FG, Jabbour E, Short NJ, Jain N, Kantarjian H. SOHO State of the Art Updates and Next Questions: Update on the Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 24(5):271-276, 2024. e-Pub 2024. PMID: 38185587.
15. Short NJ, Jabbour E, Jain N, Kantarjian H. Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions. J Hematol Oncol 17(1):32, 2024. e-Pub 2024. PMID: 38734670.
16. Hooper N, Marathe A, Jain NB, Jayaram P. Cell-Based Therapies for Rotator Cuff Injuries: An Updated Review of the Literature. Int J Mol Sci 25(6), 2024. e-Pub 2024. PMID: 38542113.
17. Senapati J, Kantarjian H, Haddad FG, Short NJ, Welch MA, Jain N, Jabbour E. SOHO State of the Art Updates and Next Questions | Next Questions: Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. e-Pub 2024. PMID: 38195323.
18. Strati, P, Gregory, T, Majhail, NS, Jain, N. Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies. JCO Oncology Practice 19(9):706-713, 2023. e-Pub 2023. PMID: 37406255.
19. Jabbour E, Short NJ, Jain N, Haddad FG, Welch MA, Ravandi F, Kantarjian H. The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades. J Hematol Oncol 16(1):22, 2023. e-Pub 2023. PMID: 36927623.
20. Kantarjian HM, Jain N, Garcia-Manero G, Welch MA, Ravandi F, Wierda WG, Jabbour EJ. The cure of leukemia through the optimist's prism. Cancer. e-Pub 2021. PMID: 34614211.
21. Cherng HJ, |Jain N. First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both?. Hematol Oncol Clin North Am 35(4):725-738, 2021. e-Pub 2021. PMID: 34174983.
22. Thakral B, Jain N, Tang G, Konoplev S, Vega F, Medeiros LJ, Wang SA. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia. Ann Diagn Pathol 53:151767. e-Pub 2021. PMID: 34118580.
23. Gandhi D, Boregowda U, Sharma P, Ahuja K, Jain N, Khanna K, Gupta N. A review of commonly performed bariatric surgeries: Imaging features and its complications. Clin Imaging 72:122-135, 2021. e-Pub 2021. PMID: 33232899.
24. Gandhi D, Jain N, Khanna K, Li S, Patel L, Gupta N. Current role of imaging in COVID-19 infection with recent recommendations of point of care ultrasound in the contagion: a narrative review. Ann Transl Med 8(17):1094, 2020. e-Pub 2020. PMID: 33145313.
25. Paul S, Rausch CR, Jain N, Kadia T, Ravandi F, DiNardo CD, Welch MA, Dabaja BS, Daver N, Garcia-Manero G, Wierda W, Pemmaraju N, Montalban Bravo G, Thompson P, Verstovsek S, Konopleva M, Kantarjian H, Jabbour E. Treating Leukemia in the Time of COVID-19. Acta Haematol:1-13. e-Pub 2020. PMID: 32392559.
26. Boregowda U, Gandhi D, Jain N, Khanna K, Gupta N. Comprehensive Literature Review and Evidence evaluation of Experimental Treatment in COVID 19 Contagion. Clin Med Insights Circ Respir Pulm Med 14:1179548420964140, 2020. e-Pub 2020. PMID: 35173507.
27. Anevlavis S, Varga C, Nam TH, Man RWC, Demetriou A, Jain N, Lanfranco A, Froudarakis ME. Is there any role for thoracoscopy in the diagnosis of benign pleural effusions. Clin Respir J 13(2):73-81, 2019. e-Pub 2019. PMID: 30578625.
28. Jain NB, Schneider BJ, Murrell WB, Hettrich CM, Archer KR. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 100(22):1993-1999, 2018. e-Pub 2018. PMID: 30480605.
29. Jain N. Selecting Frontline Therapy for CLL in 2018. Hematology Am Soc Hematol Educ Program 2018(1):242-247, 2018. e-Pub 2018. PMID: 30504317.
30. Jain N, Thompson P, Ferrajoli A, Nabhan C, Mato AR, O'Brien S. Approaches to Chronic Lymphocytic Leukemia Therapy in the Era of New Agents: The Conundrum of Many Options. Am Soc Clin Oncol Educ Book(38):580-591, 2018. e-Pub 2018. PMID: 30231393.
31. Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, Komanduri KV, Lin Y, Jain N, Daver N, Westin J, Gulbis AM, Loghin ME, de Groot JF, Adkins S, Davis SE, Rezvani K, Hwu P, Shpall EJ. Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol. e-Pub 2017. PMID: 28925994.
32. Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, Chourasia MK. Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release 252:28-49, 2017. e-Pub 2017. PMID: 28279798.
33. Jain NB, Kuhn JE, Murrell WD, Archer KR. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 98(22):1937-1942, 2016. e-Pub 2016. PMID: 27852914.
34. Abdul-Wahab TA, Betancourt JP, Hassan F, Thani SA, Choueiri H, Jain NB, Malanga GA, Murrell WD, Prasad A, Verborgt O. Initial treatment of complete rotator cuff tear and transition to surgical treatment: systematic review of the evidence. Muscles Ligaments Tendons J 6(1):35-47, 2016. e-Pub 2016. PMID: 27331030.
35. Garg T, Jain NK, Rath G, Goyal AK. Nanotechnology-Based Photodynamic Therapy: Concepts, Advances, and Perspectives. Crit Rev Ther Drug Carrier Syst 32(5):389-439, 2015. e-Pub 2015. PMID: 26559433.
36. Drake T, Jain N, Bryant T, Wilson I, Somani BK. Should low-dose computed tomography kidneys, ureter and bladder be the new investigation of choice in suspected renal colic?: A systematic review. Indian J Urol 30(2):137-43, 2014. e-Pub 2014. PMID: 24744508.
37. Sareen R, Jain N, Pandit V. Curcumin: a boon to colonic diseases. Curr Drug Targets 14(10):1210-8, 2013. e-Pub 2013. PMID: 23768171.
38. Kumar D, Saini N, Jain N, Sareen R, Pandit V. Gold nanoparticles: an era in bionanotechnology. Expert Opin Drug Deliv 10(3):397-409, 2013. e-Pub 2013. PMID: 23289421.
39. Jain NB, Wilcox RB 3rd, Katz JN, Higgins LD. Clinical examination of the rotator cuff. PM R 5(1):45-56, 2013. e-Pub 2013. PMID: 23332909.
40. Sharma A, Jain N, Sareen R. Nanocarriers for diagnosis and targeting of breast cancer. Biomed Res Int 2013:960821, 2013. e-Pub 2013. PMID: 23865076.
41. Jain N, Robinson S. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 4: Investigating flank pain: can the CT stay low?. Emerg Med J 29(8):687-8, 2012. e-Pub 2012. PMID: 22787241.
42. Sareen R, Jain N, Kumar D. An insight to osmotic drug delivery. Curr Drug Deliv 9(3):285-96, 2012. e-Pub 2012. PMID: 22452403.
43. Jain N, Odenike O. Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignancies. Expert Opin Pharmacother 11(18):3073-84, 2010. e-Pub 2010. PMID: 21080855.
44. Jain N, Lamanna N. Incorporating prognostic information into treatment decisions in chronic lymphocytic leukemia. Curr Oncol Rep 11(5):353-9, 2009. e-Pub 2009. PMID: 19679010.
45. Pathan SA, Iqbal Z, Zaidi SM, Talegaonkar S, Vohra D, Jain GK, Azeem A, Jain N, Lalani JR, Khar RK, Ahmad FJ. CNS drug delivery systems: novel approaches. Recent Pat Drug Deliv Formul 3(1):71-89, 2009. e-Pub 2009. PMID: 19149731.
46. Jain N, Rossi A, Garcia-Manero G. Epigenetic therapy of leukemia: An update. Int J Biochem Cell Biol 41(1):72-80, 2009. e-Pub 2009. PMID: 18948224.
47. Khare P, Jain A, Gulbake A, Soni V, Jain NK, Jain SK. Bioconjugates: harnessing potential for effective therapeutics. Crit Rev Ther Drug Carrier Syst 26(2):119-55, 2009. e-Pub 2009. PMID: 19673689.
48. Verma D, Kantarjian H, Jain N, Cortes J. Sustained complete molecular response after imatinib discontinuation in a patient with chronic myeloid leukemia not previously exposed to interferon alpha. Leuk Lymphoma 49(7):1399-402, 2008. e-Pub 2008. PMID: 18452066.

Other Articles

1. DiNardo CD, Jen WY, Takahashi K, Kadia TM, Loghavi S, Daver NG, Xiao L, Reville PK, Issa GC, Short NJ, Sasaki K, Wang SA, Mullin JK, Pierce S, Bradley C, Borthakur G, Maiti A, Alvarado Y, Pemmaraju N, Ferrajoli A, Swaminathan M, Ohanian M, Abbas HA, Hammond D, Burger J, Haddad F, Montalban-Bravo G, Chien K, Masarova L, Yilmaz M, Jain N, Andreeff M, Garcia-Manero G, Kornblau S, Ravandi F, Jabbour E, Konopleva MY, Kantarjian HM Correction: Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia. Leukemia 40(1):262, 2026. PMID: 41372600.
2. Uryu, H, Saeki, K, Haeno, H, Kapadia, C, Furudate, D.M.D., Ph.D., K, Nangalia, J, Spencer Chapman, M, Zhang, L, Padilla, J, Zhao, L, Hsu, JI, Zhao, C, Chen, S, Tanaka, T, Li, Z, Ogata, S, Hanache, S, Yang, H, DiNardo, C, Daver, N, Pemmaraju, N, Jain, N, Ravandi-Kashani, F, Zhang, J, Song, X, Thompson, EJ, Tang, H, Little, L, Gumbs, C, Orlowski, R, Qazilbash, MH, Bhalla, K, Colla, S, Kantarjian, HM, Kanagal Shamanna, R, Bueso-Ramos, CE, Nakada, D, Al-Atrash, G, Molldrem, JJ, Futreal, A, Shpall, E, Goodell, MA, Garcia-Manero, G, Takahashi, K Author Correction. Nature Genetics 57(9):2339, 2025. PMID: 40789920.
3. Cleland T, Jain NB, Chae J, Hansen KM, Hisel TZ, Gunzler DD, Whitehair VC, Kim CH, Wilson RD Correction: The protocol for a multisite, double blind, randomized, placebo-controlled trial of axillary nerve stimulation for chronic shoulder pain. Trials 26(1):277, 2025. PMID: 40775782.
4. Shadman, M, Fakhri, B, Jain, N Consensus in CLL. Blood Advances 9(5):1210-1212, 2025. PMID: 40067336.
5. Jain, N Doublet vs Triplet Combinations for Frontline Treatment of Chronic Lymphocytic Leukemia. Clinical Advances in Hematology and Oncology 22(8):364-366, 2024. PMID: 39356813.
6. Prakash R, Gardner JE, Petric UB, Pathak R, Atem F, Jain NB Association of Age and Sex at Onset With Glenohumeral Osteoarthritis: A Systematic Review and Meta-analysis. Am J Phys Med Rehabil 103(7):611-616, 2024. PMID: 38207175.
7. Alaggio, R, Amador, C, Anagnostopoulos, I, Attygalle, AD, de Oliveira Araujo, IB, Berti, E, Bhagat, G, Borges, AM, Boyer, DF, Calaminici, M, Chadburn, A, Chan, JK, Cheuk, W, Chng, WJ, Choi, JK, Chuang, SS, Coupland, SE, Czader, M, Dave, SS, De Jong, D, DiNapoli, A, Du, MQ, Elenitoba-Johnson, KS, Ferry, JA, Geyer, JT, Gratzinger, D, Guitart, J, Gujral, S, Harris, MH, Harrison, CJ, Hartmann, S, Hochhaus, A, Jansen, PM, Karube, K, Kempf, W, Khoury, J, Kimura, H, Klapper, W, Kovach, AE, Kumar, SK, Lazar, A, Lazzi, S, Leoncini, L, Leung, N, Leventaki, V, Medeiros, LJ, Miranda, R, Vega Vazquez, F, Burger, JA, Jain, N Correction. Leukemia 37(9):1944-1951, 2023. PMID: 37468552.
8. Giri A, O'Hanlon D, Jain NB Risk factors for rotator cuff disease: A systematic review and meta-analysis of diabetes, hypertension, and hyperlipidemia. Ann Phys Rehabil Med 66(1):101631, 2023. PMID: 35257948.
9. Grusky AZ, Giri A, O'Hanlon D, Jain NB The Relationship of Aging and Smoking With Rotator Cuff Disease: A Systematic Review and Meta-analysis. Am J Phys Med Rehabil 101(4):331-340, 2022. PMID: 34121068.
10. Giri A, Freeman TH, Kim P, Kuhn JE, Garriga GA, Khazzam M, Higgins LD, Matzkin E, Baumgarten KM, Bishop JY, Brophy RH, Carey JL, Dunn WR, Jones GL, Ma CB, Marx RG, McCarty EC, Poddar SK, Smith MV, Spencer EE, Vidal AF, Wolf BR, Wright RW, Jain NB Obesity and sex influence fatty infiltration of the rotator cuff: the Rotator Cuff Outcomes Workgroup (ROW) and Multicenter Orthopaedic Outcomes Network (MOON) cohorts. J Shoulder Elbow Surg 31(4):726-735, 2022. PMID: 35032677.
11. Karjalainen TV, Jain NB, Heikkinen J, Johnston RV, Page CM, Buchbinder R Surgery for rotator cuff tears. Cochrane Database Syst Rev 12(12):CD013502, 2019. PMID: 31813166.
12. Betancourt JP, Eleeh P, Stark S, Jain NB Impact of Ankle-Foot Orthosis on Gait Efficiency in Ambulatory Children With Cerebral Palsy: A Systematic Review and Meta-analysis. Am J Phys Med Rehabil 98(9):759-770, 2019. PMID: 30920399.
13. Karjalainen TV, Jain NB, Page CM, Lahdeoja TA, Johnston RV, Salamh P, Kavaja L, Ardern CL, Agarwal A, Vandvik PO, Buchbinder R Subacromial decompression surgery for rotator cuff disease. Cochrane Database Syst Rev 1(1):CD005619, 2019. PMID: 30707445.
14. Sajeed S, Minshull C, Jain N, Makarov V Publisher Correction: Invisible Trojan-horse attack. Sci Rep 7(1):16387, 2017. PMID: 29167444.
15. Lange T, Matthijs O, Jain NB, Schmitt J, Lutzner J, Kopkow C Reliability of specific physical examination tests for the diagnosis of shoulder pathologies: a systematic review and meta-analysis. Br J Sports Med 51(6):511-518, 2017. PMID: 27993843.
16. . PMID: 17592713.

Editorials

1. Jain, N, Ferrajoli, A, O'Brien, S, Wierda, WG. Is CLL curable?. HemaSphere 10(2), 2026. PMID: 41743268.
2. Jain, N, Jabbour, EJ, Konopleva, M. BCL2 inhibition in adult acute lymphoblastic leukemia. Haematologica 110(5):1053-1054, 2025. PMID: 39945010.
3. Kasitinon D, Williams R, Gharib M, Kim L, Raiser S, Jain NB. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 105(22):1743-1749, 2023. PMID: 37708292.
4. Cleland TL, Gharib M, Williams R, Jain NB. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 103(22):2063-2069, 2021. PMID: 34546999.
5. Cleland TL, Wilson R, Kim C, Jain NB. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 102(22):1923-1929, 2020. PMID: 32947594.
6. Cleland TL, Wilson R, Kim C, Jain NB. What's New in Orthopaedic Rehabilitation. J Bone Joint Surg Am 101(22):1983-1989, 2019. PMID: 31764360.
7. Jain N, O'Brien S. BCR inhibitor failure in CLL: an unmet need. Blood 128(18):2193-2194, 2016. PMID: 27811187.
8. Jain N, Steensma D, Stewart DJ, Kantarjian H. Insurance Denial of Coverage for Patients Enrolled in Cancer Clinical Trials Is Still a Problem in the Affordable Care Act Era. J Oncol Pract 12(4):283-5, 2016. PMID: 26907450.
9. Jain N, Kantarjian H. Insurers play to win, but the patients lose. Houston Chronicle, 2015.

Book Chapters

1. Afrough, A, Im, JS, Jain, N, Kebriaei, P. Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia, 233-245, 2023.
2. Jain N, Bueso-Ramos C, O'Brien S, Wierda WG. Chronic Lymphocytic Leukemia and Associated Disorders. In: MD Anderson Manual of Medical Oncology. 3rd Edition. McGraw-Hill, 2016.
3. Jain N, Faderl S, Kantarjian H, O'Brien S. Acute Lymphoblastic Leukemia. In: Holland-Frei Cancer Medicine. 9th Edition, 2016.
4. Jain N, O'Brien S, Ravandi-Kashani F. Targeted Therapy for Acute Lymphoblastic Leukemia. In: Targeted Therapy in Translational Cancer Research (Translational Oncology). 1st Edition. Wiley-Blackwell, 2015.
5. Jain N, Gurbuxani S, Rhee C, Stock W. Acute Lymphocytic Leukemia in Adults. In: Hematology: Basic Principles and Practice (Hoffman's). 6th Edition. Churchill Livingstone, 2012.
6. Jain N, Verstovsek S. Philadelphia-chromosome negative myeloproliferative disorders. In: The MD Anderson Manual of Medical Oncology. 2nd Edition. McGraw-Hill Professional, 2011.

Letters to the Editor

1. Jabbour E, Goulart H, Sasaki K, Rausch CR, Jain N, Kadia TM, DiNardo C, Daver N, Pemmaraju N, Ravandi F, Montalban-Bravo G, Garcia-Manero G, Hammond D, Swaminathan M, Hachem M, Khouri R, Ohanian M, Garris R, Short NJ, Kantarjian HM. Hyper-CVAD Versus Hyper-CVAD Plus Blinatumomab With or Without Inotuzumab Ozogamicin for Adult Patients With Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Propensity-Score Analysis. Am J Hematol, 2026.
2. Sasaki K, Kantarjian H, Rausch CR, Goulart H, Jain N, Huang X, Hachem M, Wierda WG, Kadia TM, Borthakur G, Issa GC, Alvarado Y, Pemmaraju N, Garris R, Ravandi F, Garcia-Manero G, Short NJ, Jabbour E. Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis. Am J Hematol, 2026.
3. Tantawy, S, Aslan, B, Manyam, GC, Iles, LR, Timofeeva, N, Singh, N, Jain, N, Ferrajoli, A, Thompson, PA, Patel, KP, Desikan, SP, Wierda, WG, Gandhi, VV. Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression. Blood cancer journal 15, 2025.
4. Swaminathan, M, DiNardo, C, Maiti, A, Pemmaraju, N, Ohanian, M, Daver, NG, Garcia-Manero, G, Issa, GC, Borthakur, G, Ravandi-Kashani, F, Montalban Bravo, G, Kadia, TM, Alvarado, Y, Jabbour, EJ, Short, NJ, Wierda, WG, Jain, N, Kornblau, SM, Masarova, L, Pierce, S, Qiao, W, Ning, J, Kantarjian, HM, Konopleva, M. VEN in combination with 10-day DEC in newly diagnosed elderly or relapsed/refractory acute myeloid leukemia, and high-risk myelodysplastic syndrome. Blood cancer journal 15, 2025.
5. Goulart, H, Jabbour, EJ, Short, NJ, Jain, N, Issa, GC, Atluri, H, Bataller Torralba, A, Kadia, TM, Daver, N, DiNardo, C, Garris, R, Senapati, J, Ravandi-Kashani, F, Kantarjian, HM. Contemporary Outcomes of Adults With Acute Lymphoblastic Leukemia With KMT2A Rearrangements Treated With Immunotherapy-Based Regimens. American journal of hematology 100: 2128-2133, 2025.
6. Zhou, T, Short, NJ, Jain, N, Patel, KP, Jabbour, EJ, Kantarjian, HM, Medeiros, LJ, Iorgulescu, JB. Age-related prognoses of genetic subtypes in B-cell acute lymphoblastic leukemia/lymphoma (B-ALL). Leukemia 39: 1769-1772, 2025.
7. Senapati, J, Garcia-Manero, G, DiNardo, C, Deshmukh, I, Borthakur, G, Kadia, TM, Jabbour, EJ, Short, NJ, Abbas, HA, Pemmaraju, N, Jain, N, Haddad, FG, Issa, GC, Maiti, A, Shpall, E, Popat, UR, Loghavi, S, Tang, G, Yilmaz, M, Alvarado, Y, Montalban Bravo, G, Ravandi-Kashani, F, Kantarjian, HM, Daver, N. Barriers to allogeneic stem cell transplantation in responding patients with TP53-mutated acute myeloid leukemia. Bone marrow transplantation 60: 910-913, 2025.
8. Rafaeli N, Costa DM, Ledesma C, Jain N, Tewari P, Khouri I, Alatrash G, Short N, Jabbour E, Rezvani K, Alousi A, Popat U, Champlin R, Shpall E, Kebriaei P. Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 25: e374-e377, 2025.
9. Senapati, J, Jabbour, EJ, Short, NJ, Jain, N, Haddad, FG, Bathala, TK, Kovalenko, I, Bidikian, A, Ravandi-Kashani, F, Khouri, IF, Kadia, TM, Garris, R, Montalban Bravo, G, Chien, KS, Shpall, E, Kebriaei, P, Kantarjian, HM. Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14, 2024.
10. Senapati, J, Jabbour, EJ, Short, NJ, Jain, N, Haddad, FG, Bathala, TK, Kovalenko, I, Bidikian, A, Ravandi-Kashani, F, Khouri, IF, Kadia, TM, Garris, R, Montalban Bravo, G, Chien, KS, Shpall, E, Kebriaei, P, Kantarjian, HM. Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14, 2024.
11. Ravandi, F, Senapati, J, Jain, N, Short, NJ, Kadia, TM, Borthakur, G, Konopleva, M, Wierda, WG, Huang, X, Maiti, A, Issa, GC, Balkin, H, Garris, R, Ferrajoli, A, Garcia-Manero, G, Alvarado, Y, Kebriaei, P, Jabbour, EJ, Kantarjian, HM. Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma. Leukemia 38: 2717-2721, 2024.
12. Jen, WY, Jabbour, EJ, Short, NJ, Issa, GC, Haddad, FG, Jain, N, Pemmaraju, N, Daver, N, Masarova, L, Borthakur, G, Chien, KS, Garris, R, Kantarjian, H. A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American journal of hematology 99: 2229-2232, 2024.
13. Singh A, Singhal S, Jain N, Talwar D. Managing hemoptysis: What to do or what not to do?. Lung India 35: 449-452, 2018.
14. Chen Q, Jain N, Flowers CR, Chhatwal J. Reply to C. Nabhan et al. J Clin Oncol 35: 1864-1865, 2017.
15. Jain NB, Harris MB, Garshick E. Trends in Traumatic Spinal Cord Injury--Reply. JAMA 314: 1643-4, 2015.
16. Jain NB, Wilcox R, Katz JN, Higgins LD. Reply: To PMID 23332909. PM R 5: 446-7, 2013.
17. Chressanthis G, Khedkar P, Jain N, Poddar P, Seiders M. Suppressing commercial speech is not in the best interests of physicians and patients. J Clin Hypertens (Greenwich) 15: 219-20, 2013.
18. Jain NB, Higgins LD. Re: "Treatment options in knee osteoarthritis: total knee arthroplasty versus platelet-rich plasma". PM R 3: 681-2; author reply 682, 2011.
19. Jain NB, Katz JN. Re: racial disparities in access to cardiac rehabilitation. Am J Phys Med Rehabil 86: 247; author reply 247-9, 2007.